Index Sample Index Original Filename Sample Name Sample ID Sample Comment Sample Type Acquisition Date & Time Rack Number Plate Number Vial Number Dilution Factor Injection Volume Operator Name Acq. Method Name IS Component Name Component Index Component Comment IS Comment Mass Info IS Mass Info IS Name Component Group Name Conc. Units Failed Query IS Failed Query Peak Comment IS Peak Comment Actual Concentration IS Actual Concentration Concentration Ratio Expected RT IS Expected RT Integration Type IS Integration Type Area IS Area Corrected Area IS Corrected Area Area Ratio Height IS Height Corrected Height IS Corrected Height Height Ratio Area / Height IS Area / Height Corrected Area/Height IS Corrected Area/Height Region Height IS Region Height Quality IS Quality Retention Time IS Retention Time Start Time IS Start Time End Time IS End Time Total Width IS Total Width Width at 50% IS Width at 50% Signal / Noise IS Signal / Noise Baseline Delta / Height IS Baseline Delta / Height Modified Relative RT Used Calculated Concentration Accuracy SF Peak Width Confidence SF Model Source SF Candidate Model Quality SF Asymmetry SF Saturated SF Integration Quality SF Group Confidence SF Num Peaks Score_IMPAQT MSSimScore_IMPAQT HeightScore_IMPAQT RTminScore_IMPAQT RankScore_IMPAQT MSSim_IMPAQT MSSimSita_IMPAQT RTminDiff_IMPAQT RankSum_IMPAQT CosSimilarity_IMPAQT CosSimilaritySita_IMPAQT Height_IMPAQT InterfereTrans_IMPAQT InterfereTransAll_IMPAQT LScore_IMPAQT LRTminScore_IMPAQT LSNScore_IMPAQT LSNAllScore_IMPAQT HLSimScore_IMPAQT HLSim_IMPAQT HLSimSita_IMPAQT BaseLine_IMPAQT BaseLineUnitNum_IMPAQT BaseLineMaxCount_IMPAQT Symbol Description 1 1 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB537978.[MT7]-EMLTTQAER.2b3_1.heavy 611.815 / 518.276 11118.0 24.30069923400879 50 20 10 10 10 4.580016651884144 17.93175113019728 0.0 3 0.99083504813953 12.881458131969369 11118.0 50.92145766590389 0.0 - - - - - - - 271.6875 22 16 MYL2 myosin, light chain 2, regulatory, cardiac, slow 3 1 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB537978.[MT7]-EMLTTQAER.2y8_1.heavy 611.815 / 949.477 28590.0 24.30069923400879 50 20 10 10 10 4.580016651884144 17.93175113019728 0.0 3 0.99083504813953 12.881458131969369 28590.0 240.26477379978604 0.0 - - - - - - - 188.1818181818182 57 11 MYL2 myosin, light chain 2, regulatory, cardiac, slow 5 1 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB537978.[MT7]-EMLTTQAER.2y6_1.heavy 611.815 / 705.353 13052.0 24.30069923400879 50 20 10 10 10 4.580016651884144 17.93175113019728 0.0 3 0.99083504813953 12.881458131969369 13052.0 50.600144927536235 0.0 - - - - - - - 184.0 26 12 MYL2 myosin, light chain 2, regulatory, cardiac, slow 7 1 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB537978.[MT7]-EMLTTQAER.2y7_1.heavy 611.815 / 818.437 13605.0 24.30069923400879 50 20 10 10 10 4.580016651884144 17.93175113019728 0.0 3 0.99083504813953 12.881458131969369 13605.0 49.21132246376811 0.0 - - - - - - - 207.0 27 15 MYL2 myosin, light chain 2, regulatory, cardiac, slow 9 2 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB536588.[MT7]-TSHPK[MT7].2y4_1.heavy 429.258 / 612.359 N/A N/A - - - - - - - - - 0.0 - - - - - - - HYAL1 hyaluronoglucosaminidase 1 11 2 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB536588.[MT7]-TSHPK[MT7].2b3_1.heavy 429.258 / 470.248 N/A N/A - - - - - - - - - 0.0 - - - - - - - HYAL1 hyaluronoglucosaminidase 1 13 2 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB536588.[MT7]-TSHPK[MT7].2b4_2.heavy 429.258 / 284.154 N/A N/A - - - - - - - - - 0.0 - - - - - - - HYAL1 hyaluronoglucosaminidase 1 15 2 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB536588.[MT7]-TSHPK[MT7].2y3_1.heavy 429.258 / 525.326 N/A N/A - - - - - - - - - 0.0 - - - - - - - HYAL1 hyaluronoglucosaminidase 1 17 3 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54268.[MT7]-LTNNSNQFQTEVGK[MT7].3b6_1.heavy 623.33 / 788.402 N/A N/A - - - - - - - - - 0.0 - - - - - - - ITGB2 integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) 19 3 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54268.[MT7]-LTNNSNQFQTEVGK[MT7].3b4_1.heavy 623.33 / 587.327 N/A N/A - - - - - - - - - 0.0 - - - - - - - ITGB2 integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) 21 3 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54268.[MT7]-LTNNSNQFQTEVGK[MT7].3b7_1.heavy 623.33 / 916.461 N/A N/A - - - - - - - - - 0.0 - - - - - - - ITGB2 integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) 23 3 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54268.[MT7]-LTNNSNQFQTEVGK[MT7].3y5_1.heavy 623.33 / 677.395 N/A N/A - - - - - - - - - 0.0 - - - - - - - ITGB2 integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) 25 4 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54269.[MT7]-FLNHC[CAM]LEHLVQYR.3y6_1.heavy 624.993 / 815.452 N/A N/A - - - - - - - - - 0.0 - - - - - - - IL2RG interleukin 2 receptor, gamma 27 4 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54269.[MT7]-FLNHC[CAM]LEHLVQYR.3y4_1.heavy 624.993 / 565.309 N/A N/A - - - - - - - - - 0.0 - - - - - - - IL2RG interleukin 2 receptor, gamma 29 4 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54269.[MT7]-FLNHC[CAM]LEHLVQYR.3b3_1.heavy 624.993 / 519.305 N/A N/A - - - - - - - - - 0.0 - - - - - - - IL2RG interleukin 2 receptor, gamma 31 4 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54269.[MT7]-FLNHC[CAM]LEHLVQYR.3y5_1.heavy 624.993 / 678.393 N/A N/A - - - - - - - - - 0.0 - - - - - - - IL2RG interleukin 2 receptor, gamma 33 5 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB53517.[MT7]-LDLEER.2b3_1.heavy 459.754 / 486.304 N/A N/A - - - - - - - - - 0.0 - - - - - - - KIAA0182;SMC1A KIAA0182;structural maintenance of chromosomes 1A 35 5 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB53517.[MT7]-LDLEER.2y4_1.heavy 459.754 / 546.288 N/A N/A - - - - - - - - - 0.0 - - - - - - - KIAA0182;SMC1A KIAA0182;structural maintenance of chromosomes 1A 37 5 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB53517.[MT7]-LDLEER.2y5_1.heavy 459.754 / 661.315 N/A N/A - - - - - - - - - 0.0 - - - - - - - KIAA0182;SMC1A KIAA0182;structural maintenance of chromosomes 1A 39 5 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB53517.[MT7]-LDLEER.2b4_1.heavy 459.754 / 615.347 N/A N/A - - - - - - - - - 0.0 - - - - - - - KIAA0182;SMC1A KIAA0182;structural maintenance of chromosomes 1A 41 6 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB542186.[MT7]-VNIEGGAIALGHPLGASGC[CAM]R.3y6_1.heavy 698.373 / 607.262 22465.0 34.90810012817383 50 20 10 10 10 12.280278281026163 8.143137941304357 0.0 3 0.9948534565294049 17.195630777899908 22465.0 39.54589376359681 0.0 - - - - - - - 295.85714285714283 44 7 ACAT2 acetyl-CoA acetyltransferase 2 43 6 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB542186.[MT7]-VNIEGGAIALGHPLGASGC[CAM]R.3b6_1.heavy 698.373 / 714.39 19213.0 34.90810012817383 50 20 10 10 10 12.280278281026163 8.143137941304357 0.0 3 0.9948534565294049 17.195630777899908 19213.0 62.5290888967281 0.0 - - - - - - - 774.1428571428571 38 7 ACAT2 acetyl-CoA acetyltransferase 2 45 6 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB542186.[MT7]-VNIEGGAIALGHPLGASGC[CAM]R.3y8_1.heavy 698.373 / 817.398 88185.0 34.90810012817383 50 20 10 10 10 12.280278281026163 8.143137941304357 0.0 3 0.9948534565294049 17.195630777899908 88185.0 161.01085047336343 0.0 - - - - - - - 337.85714285714283 176 7 ACAT2 acetyl-CoA acetyltransferase 2 47 6 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB542186.[MT7]-VNIEGGAIALGHPLGASGC[CAM]R.3b7_1.heavy 698.373 / 785.427 43156.0 34.90810012817383 50 20 10 10 10 12.280278281026163 8.143137941304357 0.0 3 0.9948534565294049 17.195630777899908 43156.0 71.70760067681896 0.0 - - - - - - - 857.1 86 10 ACAT2 acetyl-CoA acetyltransferase 2 49 7 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB53510.[MT7]-IQVFTR.2b3_1.heavy 454.278 / 485.32 N/A N/A - - - - - - - - - 0.0 - - - - - - - TRIM32 tripartite motif-containing 32 51 7 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB53510.[MT7]-IQVFTR.2y4_1.heavy 454.278 / 522.304 N/A N/A - - - - - - - - - 0.0 - - - - - - - TRIM32 tripartite motif-containing 32 53 7 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB53510.[MT7]-IQVFTR.2y5_1.heavy 454.278 / 650.362 N/A N/A - - - - - - - - - 0.0 - - - - - - - TRIM32 tripartite motif-containing 32 55 7 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB53510.[MT7]-IQVFTR.2y3_1.heavy 454.278 / 423.235 N/A N/A - - - - - - - - - 0.0 - - - - - - - TRIM32 tripartite motif-containing 32 57 8 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB541319.[MT7]-VFLDHNALPDTLK[MT7].3y3_1.heavy 591.005 / 505.347 41829.0 35.39590072631836 39 9 10 10 10 0.6864185315011502 73.02366113387873 0.0 3 0.8143286184157549 2.818571208978764 41829.0 40.57683119092478 0.0 - - - - - - - 203.0 83 1 ITGB2 integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) 59 8 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB541319.[MT7]-VFLDHNALPDTLK[MT7].3b4_1.heavy 591.005 / 619.357 30182.0 35.39590072631836 39 9 10 10 10 0.6864185315011502 73.02366113387873 0.0 3 0.8143286184157549 2.818571208978764 30182.0 32.293359896436506 0.0 - - - - - - - 671.0 60 8 ITGB2 integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) 61 8 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB541319.[MT7]-VFLDHNALPDTLK[MT7].3b5_1.heavy 591.005 / 756.416 3545.0 35.39590072631836 39 9 10 10 10 0.6864185315011502 73.02366113387873 0.0 3 0.8143286184157549 2.818571208978764 3545.0 7.582649041585444 0.0 - - - - - - - 627.8 7 10 ITGB2 integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) 63 8 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB541319.[MT7]-VFLDHNALPDTLK[MT7].3y5_1.heavy 591.005 / 717.426 88317.0 35.39590072631836 39 9 10 10 10 0.6864185315011502 73.02366113387873 0.0 3 0.8143286184157549 2.818571208978764 88317.0 111.35407352294975 0.0 - - - - - - - 709.2 176 5 ITGB2 integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) 65 9 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB537164.[MT7]-NAIHPGDR.2y3_1.heavy 512.276 / 347.167 37648.0 18.345399856567383 50 20 10 10 10 3.824627177299892 20.813805103705473 0.0 3 0.9905823062438703 12.707164732731632 37648.0 73.94644024721308 0.0 - - - - - - - 703.0 75 7 LIMK2 LIM domain kinase 2 67 9 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB537164.[MT7]-NAIHPGDR.2b6_1.heavy 512.276 / 734.407 6365.0 18.345399856567383 50 20 10 10 10 3.824627177299892 20.813805103705473 0.0 3 0.9905823062438703 12.707164732731632 6365.0 30.90714347965997 0.0 - - - - - - - 186.66666666666666 12 33 LIMK2 LIM domain kinase 2 69 9 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB537164.[MT7]-NAIHPGDR.2b7_1.heavy 512.276 / 849.433 25315.0 18.345399856567383 50 20 10 10 10 3.824627177299892 20.813805103705473 0.0 3 0.9905823062438703 12.707164732731632 25315.0 75.42741152751422 0.0 - - - - - - - 162.66666666666666 50 30 LIMK2 LIM domain kinase 2 71 9 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB537164.[MT7]-NAIHPGDR.2b5_1.heavy 512.276 / 677.385 25420.0 18.345399856567383 50 20 10 10 10 3.824627177299892 20.813805103705473 0.0 3 0.9905823062438703 12.707164732731632 25420.0 75.36203304309446 0.0 - - - - - - - 199.6 50 30 LIMK2 LIM domain kinase 2 73 10 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54538.[MT7]-AVLDGVK[MT7].2y4_1.heavy 495.315 / 562.332 10575.0 26.96750020980835 31 15 2 6 8 3.5366661068764644 28.275216539544537 0.03479957580566406 4 0.9577321274402434 5.981573667142342 10575.0 11.545954583969262 2.0 - - - - - - - 1240.0 72 10 RAPGEF1 Rap guanine nucleotide exchange factor (GEF) 1 75 10 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54538.[MT7]-AVLDGVK[MT7].2y5_1.heavy 495.315 / 675.416 9189.0 26.96750020980835 31 15 2 6 8 3.5366661068764644 28.275216539544537 0.03479957580566406 4 0.9577321274402434 5.981573667142342 9189.0 16.400620253164558 0.0 - - - - - - - 700.9230769230769 18 13 RAPGEF1 Rap guanine nucleotide exchange factor (GEF) 1 77 10 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54538.[MT7]-AVLDGVK[MT7].2b4_1.heavy 495.315 / 543.326 17284.0 26.96750020980835 31 15 2 6 8 3.5366661068764644 28.275216539544537 0.03479957580566406 4 0.9577321274402434 5.981573667142342 17284.0 30.941726158198236 0.0 - - - - - - - 1240.0 34 10 RAPGEF1 Rap guanine nucleotide exchange factor (GEF) 1 79 10 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54538.[MT7]-AVLDGVK[MT7].2y6_1.heavy 495.315 / 774.484 6928.0 26.96750020980835 31 15 2 6 8 3.5366661068764644 28.275216539544537 0.03479957580566406 4 0.9577321274402434 5.981573667142342 6928.0 12.489829009088858 3.0 - - - - - - - 267.6666666666667 106 3 RAPGEF1 Rap guanine nucleotide exchange factor (GEF) 1 81 11 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54671.[MT7]-SWDIFFR.2y4_1.heavy 557.794 / 582.34 6809.0 45.30870056152344 38 15 10 3 10 2.712532965528303 28.129781507146507 0.059600830078125 3 0.9574085037358806 5.958642143628647 6809.0 25.28759359268721 0.0 - - - - - - - 218.9090909090909 13 22 OGDH oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide) 83 11 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54671.[MT7]-SWDIFFR.2b3_1.heavy 557.794 / 533.248 5525.0 45.30870056152344 38 15 10 3 10 2.712532965528303 28.129781507146507 0.059600830078125 3 0.9574085037358806 5.958642143628647 5525.0 14.830530654976116 0.0 - - - - - - - 249.2941176470588 11 17 OGDH oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide) 85 11 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54671.[MT7]-SWDIFFR.2b4_1.heavy 557.794 / 646.332 1863.0 45.30870056152344 38 15 10 3 10 2.712532965528303 28.129781507146507 0.059600830078125 3 0.9574085037358806 5.958642143628647 1863.0 3.8477379296963425 1.0 - - - - - - - 242.95652173913044 3 23 OGDH oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide) 87 11 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54671.[MT7]-SWDIFFR.2y6_1.heavy 557.794 / 883.446 2184.0 45.30870056152344 38 15 10 3 10 2.712532965528303 28.129781507146507 0.059600830078125 3 0.9574085037358806 5.958642143628647 2184.0 16.605286964980547 0.0 - - - - - - - 136.3125 4 16 OGDH oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide) 89 12 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB55033.[MT7]-AADGFLFVVGC[CAM]DR.2b3_1.heavy 785.894 / 402.211 25877.0 42.92390060424805 43 13 10 10 10 2.3061728995488933 43.36188323935332 0.0 3 0.9192892918904898 4.314510827867296 25877.0 39.781564264898 0.0 - - - - - - - 1256.888888888889 51 9 ARNTL aryl hydrocarbon receptor nuclear translocator-like 91 12 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB55033.[MT7]-AADGFLFVVGC[CAM]DR.2b6_1.heavy 785.894 / 719.385 5811.0 42.92390060424805 43 13 10 10 10 2.3061728995488933 43.36188323935332 0.0 3 0.9192892918904898 4.314510827867296 5811.0 10.397844161744661 0.0 - - - - - - - 765.125 11 8 ARNTL aryl hydrocarbon receptor nuclear translocator-like 93 12 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB55033.[MT7]-AADGFLFVVGC[CAM]DR.2y10_1.heavy 785.894 / 1169.58 8910.0 42.92390060424805 43 13 10 10 10 2.3061728995488933 43.36188323935332 0.0 3 0.9192892918904898 4.314510827867296 8910.0 25.72523737443236 0.0 - - - - - - - 714.4444444444445 17 9 ARNTL aryl hydrocarbon receptor nuclear translocator-like 95 12 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB55033.[MT7]-AADGFLFVVGC[CAM]DR.2y7_1.heavy 785.894 / 852.403 6043.0 42.92390060424805 43 13 10 10 10 2.3061728995488933 43.36188323935332 0.0 3 0.9192892918904898 4.314510827867296 6043.0 11.80442652329749 0.0 - - - - - - - 262.15384615384613 12 13 ARNTL aryl hydrocarbon receptor nuclear translocator-like 97 13 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB55138.[MT7]-QISHFFSENEDFR.3y7_1.heavy 600.62 / 896.375 24447.0 34.89802551269531 42 17 10 5 10 5.399010671591568 18.521911898818516 0.0402984619140625 3 0.9761401117124159 7.973717523234335 24447.0 73.30200956937799 0.0 - - - - - - - 219.11111111111111 48 9 TRIM32 tripartite motif-containing 32 99 13 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB55138.[MT7]-QISHFFSENEDFR.3b4_1.heavy 600.62 / 610.343 22387.0 34.89802551269531 42 17 10 5 10 5.399010671591568 18.521911898818516 0.0402984619140625 3 0.9761401117124159 7.973717523234335 22387.0 23.897879323069674 0.0 - - - - - - - 1264.875 44 8 TRIM32 tripartite motif-containing 32 101 13 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB55138.[MT7]-QISHFFSENEDFR.3b5_1.heavy 600.62 / 757.411 2686.0 34.89802551269531 42 17 10 5 10 5.399010671591568 18.521911898818516 0.0402984619140625 3 0.9761401117124159 7.973717523234335 2686.0 -0.29942002084400815 3.0 - - - - - - - 815.7777777777778 9 9 TRIM32 tripartite motif-containing 32 103 13 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB55138.[MT7]-QISHFFSENEDFR.3y8_1.heavy 600.62 / 1043.44 18716.0 34.89802551269531 42 17 10 5 10 5.399010671591568 18.521911898818516 0.0402984619140625 3 0.9761401117124159 7.973717523234335 18716.0 22.6430890251631 0.0 - - - - - - - 767.4285714285714 37 7 TRIM32 tripartite motif-containing 32 105 14 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB55139.[MT7]-AQNDQLGWLWGQSR.2y8_1.heavy 901.956 / 989.495 8765.0 42.267099380493164 45 20 10 5 10 5.67028892394747 17.635785643597025 0.040599822998046875 3 0.9912716798754451 13.200203954272535 8765.0 22.16326619907032 0.0 - - - - - - - 269.6923076923077 17 13 HYAL1 hyaluronoglucosaminidase 1 107 14 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB55139.[MT7]-AQNDQLGWLWGQSR.2y5_1.heavy 901.956 / 633.31 6097.0 42.267099380493164 45 20 10 5 10 5.67028892394747 17.635785643597025 0.040599822998046875 3 0.9912716798754451 13.200203954272535 6097.0 24.22139061665432 0.0 - - - - - - - 291.29411764705884 12 17 HYAL1 hyaluronoglucosaminidase 1 109 14 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB55139.[MT7]-AQNDQLGWLWGQSR.2b4_1.heavy 901.956 / 573.275 13643.0 42.267099380493164 45 20 10 5 10 5.67028892394747 17.635785643597025 0.040599822998046875 3 0.9912716798754451 13.200203954272535 13643.0 50.55038895632 0.0 - - - - - - - 676.625 27 8 HYAL1 hyaluronoglucosaminidase 1 111 14 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB55139.[MT7]-AQNDQLGWLWGQSR.2b5_1.heavy 901.956 / 701.333 4116.0 42.267099380493164 45 20 10 5 10 5.67028892394747 17.635785643597025 0.040599822998046875 3 0.9912716798754451 13.200203954272535 4116.0 14.49928337609484 0.0 - - - - - - - 240.57894736842104 8 19 HYAL1 hyaluronoglucosaminidase 1 113 15 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB538265.[MT7]-LEYTEHQGR.3b5_1.heavy 426.218 / 780.39 18272.0 21.31100082397461 47 17 10 10 10 5.949381026660616 16.808471259762285 0.0 3 0.9734795772846899 7.561494516331448 18272.0 127.9950753894081 0.0 - - - - - - - 194.45454545454547 36 22 ARNTL aryl hydrocarbon receptor nuclear translocator-like 115 15 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB538265.[MT7]-LEYTEHQGR.3b3_1.heavy 426.218 / 550.299 46771.0 21.31100082397461 47 17 10 10 10 5.949381026660616 16.808471259762285 0.0 3 0.9734795772846899 7.561494516331448 46771.0 71.7391379769468 0.0 - - - - - - - 1262.3 93 10 ARNTL aryl hydrocarbon receptor nuclear translocator-like 117 15 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB538265.[MT7]-LEYTEHQGR.3y4_1.heavy 426.218 / 497.258 93328.0 21.31100082397461 47 17 10 10 10 5.949381026660616 16.808471259762285 0.0 3 0.9734795772846899 7.561494516331448 93328.0 110.68894271972755 0.0 - - - - - - - 788.2857142857143 186 7 ARNTL aryl hydrocarbon receptor nuclear translocator-like 119 15 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB538265.[MT7]-LEYTEHQGR.3y5_1.heavy 426.218 / 626.3 26060.0 21.31100082397461 47 17 10 10 10 5.949381026660616 16.808471259762285 0.0 3 0.9734795772846899 7.561494516331448 26060.0 104.45669999065683 0.0 - - - - - - - 765.8 52 10 ARNTL aryl hydrocarbon receptor nuclear translocator-like 121 16 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB53792.[MT7]-ILLNIEHR.2y5_1.heavy 576.354 / 668.347 3073.0 38.33767509460449 41 18 10 3 10 6.072294730992234 16.46823885039909 0.0718994140625 3 0.9811830892445594 8.982657461346994 3073.0 5.9930613425925925 0.0 - - - - - - - 792.0 6 8 MTOR mechanistic target of rapamycin (serine/threonine kinase) 123 16 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB53792.[MT7]-ILLNIEHR.2b4_1.heavy 576.354 / 598.404 960.0 38.33767509460449 41 18 10 3 10 6.072294730992234 16.46823885039909 0.0718994140625 3 0.9811830892445594 8.982657461346994 960.0 1.3452380952380953 17.0 - - - - - - - 781.7142857142857 3 7 MTOR mechanistic target of rapamycin (serine/threonine kinase) 125 16 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB53792.[MT7]-ILLNIEHR.2y6_1.heavy 576.354 / 781.432 1824.0 38.33767509460449 41 18 10 3 10 6.072294730992234 16.46823885039909 0.0718994140625 3 0.9811830892445594 8.982657461346994 1824.0 14.629999999999999 1.0 - - - - - - - 232.0 3 12 MTOR mechanistic target of rapamycin (serine/threonine kinase) 127 16 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB53792.[MT7]-ILLNIEHR.2y7_1.heavy 576.354 / 894.516 4033.0 38.33767509460449 41 18 10 3 10 6.072294730992234 16.46823885039909 0.0718994140625 3 0.9811830892445594 8.982657461346994 4033.0 8.150020833333333 1.0 - - - - - - - 281.14285714285717 8 14 MTOR mechanistic target of rapamycin (serine/threonine kinase) 129 17 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB536788.[MT7]-TGLPVK[MT7].2y4_1.heavy 451.799 / 600.42 N/A N/A - - - - - - - - - 0.0 - - - - - - - ARNTL aryl hydrocarbon receptor nuclear translocator-like 131 17 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB536788.[MT7]-TGLPVK[MT7].2y5_1.heavy 451.799 / 657.442 N/A N/A - - - - - - - - - 0.0 - - - - - - - ARNTL aryl hydrocarbon receptor nuclear translocator-like 133 17 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB536788.[MT7]-TGLPVK[MT7].2y3_1.heavy 451.799 / 487.336 N/A N/A - - - - - - - - - 0.0 - - - - - - - ARNTL aryl hydrocarbon receptor nuclear translocator-like 135 17 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB536788.[MT7]-TGLPVK[MT7].2b5_1.heavy 451.799 / 612.384 N/A N/A - - - - - - - - - 0.0 - - - - - - - ARNTL aryl hydrocarbon receptor nuclear translocator-like 137 18 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB537561.[MT7]-TFLTEVK[MT7].2y4_1.heavy 563.342 / 620.374 31003.0 33.291049003601074 46 20 10 6 10 13.798593125956344 7.247115636150715 0.033000946044921875 3 0.9919252184211754 13.724745761710102 31003.0 37.08823915855402 0.0 - - - - - - - 725.0 62 8 LIMK2 LIM domain kinase 2 139 18 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB537561.[MT7]-TFLTEVK[MT7].2y5_1.heavy 563.342 / 733.458 13119.0 33.291049003601074 46 20 10 6 10 13.798593125956344 7.247115636150715 0.033000946044921875 3 0.9919252184211754 13.724745761710102 13119.0 47.906079192546585 0.0 - - - - - - - 299.0 26 18 LIMK2 LIM domain kinase 2 141 18 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB537561.[MT7]-TFLTEVK[MT7].2y3_1.heavy 563.342 / 519.326 15674.0 33.291049003601074 46 20 10 6 10 13.798593125956344 7.247115636150715 0.033000946044921875 3 0.9919252184211754 13.724745761710102 15674.0 10.289146690901376 0.0 - - - - - - - 829.0 31 1 LIMK2 LIM domain kinase 2 143 18 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB537561.[MT7]-TFLTEVK[MT7].2y6_1.heavy 563.342 / 880.526 19265.0 33.291049003601074 46 20 10 6 10 13.798593125956344 7.247115636150715 0.033000946044921875 3 0.9919252184211754 13.724745761710102 19265.0 52.73546794219848 0.0 - - - - - - - 665.0909090909091 38 11 LIMK2 LIM domain kinase 2 145 19 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB538268.[MT7]-FHDIDDVK[MT7].3y3_1.heavy 426.231 / 505.31 83564.0 26.64859962463379 44 14 10 10 10 1.823367915984119 43.58173376230313 0.0 3 0.936121248240016 4.856738817895641 83564.0 36.48199639245561 1.0 - - - - - - - 885.0 225 4 PPA2 pyrophosphatase (inorganic) 2 147 19 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB538268.[MT7]-FHDIDDVK[MT7].3b3_2.heavy 426.231 / 272.635 205997.0 26.64859962463379 44 14 10 10 10 1.823367915984119 43.58173376230313 0.0 3 0.936121248240016 4.856738817895641 205997.0 135.32676788986004 0.0 - - - - - - - 1780.7142857142858 411 7 PPA2 pyrophosphatase (inorganic) 2 149 19 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB538268.[MT7]-FHDIDDVK[MT7].3y4_1.heavy 426.231 / 620.337 94480.0 26.64859962463379 44 14 10 10 10 1.823367915984119 43.58173376230313 0.0 3 0.936121248240016 4.856738817895641 94480.0 80.64967136891684 0.0 - - - - - - - 1794.6666666666667 188 9 PPA2 pyrophosphatase (inorganic) 2 151 19 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB538268.[MT7]-FHDIDDVK[MT7].3b3_1.heavy 426.231 / 544.264 164030.0 26.64859962463379 44 14 10 10 10 1.823367915984119 43.58173376230313 0.0 3 0.936121248240016 4.856738817895641 164030.0 125.83704021183704 0.0 - - - - - - - 2771.0 328 7 PPA2 pyrophosphatase (inorganic) 2 153 20 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB53794.[MT7]-GFFGQAIK[MT7].2y5_1.heavy 578.342 / 660.416 N/A N/A - - - - - - - - - 0.0 - - - - - - - LIMK2 LIM domain kinase 2 155 20 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB53794.[MT7]-GFFGQAIK[MT7].2b4_1.heavy 578.342 / 553.289 N/A N/A - - - - - - - - - 0.0 - - - - - - - LIMK2 LIM domain kinase 2 157 20 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB53794.[MT7]-GFFGQAIK[MT7].2y6_1.heavy 578.342 / 807.484 N/A N/A - - - - - - - - - 0.0 - - - - - - - LIMK2 LIM domain kinase 2 159 20 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB53794.[MT7]-GFFGQAIK[MT7].2b5_1.heavy 578.342 / 681.348 N/A N/A - - - - - - - - - 0.0 - - - - - - - LIMK2 LIM domain kinase 2 161 21 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB537367.[MT7]-FVFAAVK[MT7].2b3_1.heavy 535.336 / 538.315 35390.0 37.176700592041016 50 20 10 10 10 5.6694821324419244 17.63829529116597 0.0 3 0.9903593879203233 12.559158519253064 35390.0 106.11697258445906 0.0 - - - - - - - 625.2 70 10 GNA11;GNAQ;GNA14 guanine nucleotide binding protein (G protein), alpha 11 (Gq class);guanine nucleotide binding protein (G protein), q polypeptide;guanine nucleotide binding protein (G protein), alpha 14 163 21 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB537367.[MT7]-FVFAAVK[MT7].2y4_1.heavy 535.336 / 532.357 65637.0 37.176700592041016 50 20 10 10 10 5.6694821324419244 17.63829529116597 0.0 3 0.9903593879203233 12.559158519253064 65637.0 95.12608695652173 0.0 - - - - - - - 1166.7142857142858 131 7 GNA11;GNAQ;GNA14 guanine nucleotide binding protein (G protein), alpha 11 (Gq class);guanine nucleotide binding protein (G protein), q polypeptide;guanine nucleotide binding protein (G protein), alpha 14 165 21 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB537367.[MT7]-FVFAAVK[MT7].2y5_1.heavy 535.336 / 679.426 73199.0 37.176700592041016 50 20 10 10 10 5.6694821324419244 17.63829529116597 0.0 3 0.9903593879203233 12.559158519253064 73199.0 135.98779611610627 0.0 - - - - - - - 282.2 146 5 GNA11;GNAQ;GNA14 guanine nucleotide binding protein (G protein), alpha 11 (Gq class);guanine nucleotide binding protein (G protein), q polypeptide;guanine nucleotide binding protein (G protein), alpha 14 167 21 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB537367.[MT7]-FVFAAVK[MT7].2y6_1.heavy 535.336 / 778.494 41137.0 37.176700592041016 50 20 10 10 10 5.6694821324419244 17.63829529116597 0.0 3 0.9903593879203233 12.559158519253064 41137.0 120.43621393485621 0.0 - - - - - - - 239.5 82 8 GNA11;GNAQ;GNA14 guanine nucleotide binding protein (G protein), alpha 11 (Gq class);guanine nucleotide binding protein (G protein), q polypeptide;guanine nucleotide binding protein (G protein), alpha 14 169 22 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB542190.[MT7]-LLVFATDDGFHFAGDGK[MT7].4y4_1.heavy 525.277 / 520.285 34496.0 43.28464889526367 39 13 10 6 10 1.9526564084860774 37.07913125981272 0.03900146484375 3 0.9290979066741398 4.607154603337878 34496.0 20.499386047308562 0.0 - - - - - - - 349.0 68 2 ITGB2 integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) 171 22 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB542190.[MT7]-LLVFATDDGFHFAGDGK[MT7].4y5_1.heavy 525.277 / 591.322 20775.0 43.28464889526367 39 13 10 6 10 1.9526564084860774 37.07913125981272 0.03900146484375 3 0.9290979066741398 4.607154603337878 20775.0 31.66726216103735 0.0 - - - - - - - 297.3333333333333 41 6 ITGB2 integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) 173 22 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB542190.[MT7]-LLVFATDDGFHFAGDGK[MT7].4b4_1.heavy 525.277 / 617.414 29380.0 43.28464889526367 39 13 10 6 10 1.9526564084860774 37.07913125981272 0.03900146484375 3 0.9290979066741398 4.607154603337878 29380.0 49.755662813955674 0.0 - - - - - - - 310.5 58 2 ITGB2 integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) 175 22 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB542190.[MT7]-LLVFATDDGFHFAGDGK[MT7].4y6_1.heavy 525.277 / 738.39 28372.0 43.28464889526367 39 13 10 6 10 1.9526564084860774 37.07913125981272 0.03900146484375 3 0.9290979066741398 4.607154603337878 28372.0 30.105894960339715 0.0 - - - - - - - 368.25 56 4 ITGB2 integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) 177 23 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB537055.[MT7]-EVAELK[MT7].2y4_1.heavy 488.799 / 604.379 21115.0 24.833999633789062 36 18 0 10 8 2.8756716397329605 27.85835755257999 0.0 4 0.9800736831488978 8.728207197158126 21115.0 25.02263388863478 0.0 - - - - - - - 1291.142857142857 42 7 CCDC150;MAD1L1 coiled-coil domain containing 150;MAD1 mitotic arrest deficient-like 1 (yeast) 179 23 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB537055.[MT7]-EVAELK[MT7].2y5_1.heavy 488.799 / 703.447 17855.0 24.833999633789062 36 18 0 10 8 2.8756716397329605 27.85835755257999 0.0 4 0.9800736831488978 8.728207197158126 17855.0 20.3814201138827 0.0 - - - - - - - 1278.0 35 8 CCDC150;MAD1L1 coiled-coil domain containing 150;MAD1 mitotic arrest deficient-like 1 (yeast) 181 23 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB537055.[MT7]-EVAELK[MT7].2b4_1.heavy 488.799 / 573.3 14373.0 24.833999633789062 36 18 0 10 8 2.8756716397329605 27.85835755257999 0.0 4 0.9800736831488978 8.728207197158126 14373.0 2.8772801618953077 3.0 - - - - - - - 963.0 215 1 CCDC150;MAD1L1 coiled-coil domain containing 150;MAD1 mitotic arrest deficient-like 1 (yeast) 183 23 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB537055.[MT7]-EVAELK[MT7].2y3_1.heavy 488.799 / 533.341 8890.0 24.833999633789062 36 18 0 10 8 2.8756716397329605 27.85835755257999 0.0 4 0.9800736831488978 8.728207197158126 8890.0 16.301940928270042 2.0 - - - - - - - 1217.142857142857 57 7 CCDC150;MAD1L1 coiled-coil domain containing 150;MAD1 mitotic arrest deficient-like 1 (yeast) 185 24 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB55150.[MT7]-TVFDEAIIAILTPK[MT7].3b6_1.heavy 607.032 / 807.401 125844.0 53.81602382659912 37 10 10 7 10 0.9972187533054707 76.82920715981581 0.029499053955078125 3 0.8253313745606817 2.908845678801097 125844.0 -109.42956521739143 0.0 - - - - - - - 91.875 251 8 RHOQ ras homolog gene family, member Q 187 24 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB55150.[MT7]-TVFDEAIIAILTPK[MT7].3b5_1.heavy 607.032 / 736.363 52695.0 53.81602382659912 37 10 10 7 10 0.9972187533054707 76.82920715981581 0.029499053955078125 3 0.8253313745606817 2.908845678801097 52695.0 -22.910869565217354 0.0 - - - - - - - 98.42857142857143 105 7 RHOQ ras homolog gene family, member Q 189 24 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB55150.[MT7]-TVFDEAIIAILTPK[MT7].3y4_1.heavy 607.032 / 602.399 88880.0 53.81602382659912 37 10 10 7 10 0.9972187533054707 76.82920715981581 0.029499053955078125 3 0.8253313745606817 2.908845678801097 88880.0 -19.32173913043482 0.0 - - - - - - - 92.0 177 4 RHOQ ras homolog gene family, member Q 191 24 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB55150.[MT7]-TVFDEAIIAILTPK[MT7].3b7_1.heavy 607.032 / 920.485 146161.0 53.81602382659912 37 10 10 7 10 0.9972187533054707 76.82920715981581 0.029499053955078125 3 0.8253313745606817 2.908845678801097 146161.0 -42.365507246376865 0.0 - - - - - - - 142.77777777777777 292 9 RHOQ ras homolog gene family, member Q 193 25 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB540604.[MT7]-ELTLQDVELLK[MT7].3y3_1.heavy 530.318 / 517.383 217884.0 42.16699981689453 42 12 10 10 10 1.071885524884166 63.21656279462081 0.0 3 0.8916367515304573 3.7146614578296195 217884.0 309.9762929709003 0.0 - - - - - - - 379.0 435 2 TRIM32 tripartite motif-containing 32 195 25 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB540604.[MT7]-ELTLQDVELLK[MT7].3b6_1.heavy 530.318 / 844.453 120693.0 42.16699981689453 42 12 10 10 10 1.071885524884166 63.21656279462081 0.0 3 0.8916367515304573 3.7146614578296195 120693.0 666.1292509075406 0.0 - - - - - - - 714.8571428571429 241 7 TRIM32 tripartite motif-containing 32 197 25 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB540604.[MT7]-ELTLQDVELLK[MT7].3b4_1.heavy 530.318 / 601.368 117206.0 42.16699981689453 42 12 10 10 10 1.071885524884166 63.21656279462081 0.0 3 0.8916367515304573 3.7146614578296195 117206.0 199.86697855311834 0.0 - - - - - - - 689.8 234 10 TRIM32 tripartite motif-containing 32 199 25 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB540604.[MT7]-ELTLQDVELLK[MT7].3y4_1.heavy 530.318 / 646.426 204238.0 42.16699981689453 42 12 10 10 10 1.071885524884166 63.21656279462081 0.0 3 0.8916367515304573 3.7146614578296195 204238.0 382.2872330923089 0.0 - - - - - - - 693.0 408 7 TRIM32 tripartite motif-containing 32 201 26 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB537157.[MT7]-EIVPVLVSTRK[MT7].3y6_1.heavy 510.327 / 847.548 22579.0 32.83632469177246 33 7 10 6 10 2.2425138825268327 44.59281201297244 0.03569793701171875 3 0.7278461624147281 2.309795973077288 22579.0 82.1234018499486 0.0 - - - - - - - 187.3 45 10 ACAT2 acetyl-CoA acetyltransferase 2 203 26 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB537157.[MT7]-EIVPVLVSTRK[MT7].3y8_1.heavy 510.327 / 1043.67 1667.0 32.83632469177246 33 7 10 6 10 2.2425138825268327 44.59281201297244 0.03569793701171875 3 0.7278461624147281 2.309795973077288 1667.0 15.842035141117876 0.0 - - - - - - - 181.22222222222223 3 18 ACAT2 acetyl-CoA acetyltransferase 2 205 26 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB537157.[MT7]-EIVPVLVSTRK[MT7].3y8_2.heavy 510.327 / 522.338 90731.0 32.83632469177246 33 7 10 6 10 2.2425138825268327 44.59281201297244 0.03569793701171875 3 0.7278461624147281 2.309795973077288 90731.0 73.07009844955418 0.0 - - - - - - - 729.5 181 6 ACAT2 acetyl-CoA acetyltransferase 2 207 26 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB537157.[MT7]-EIVPVLVSTRK[MT7].3y5_1.heavy 510.327 / 734.464 17368.0 32.83632469177246 33 7 10 6 10 2.2425138825268327 44.59281201297244 0.03569793701171875 3 0.7278461624147281 2.309795973077288 17368.0 21.196369948817065 0.0 - - - - - - - 702.4444444444445 34 9 ACAT2 acetyl-CoA acetyltransferase 2 209 27 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB537051.[MT7]-AIQIINR.2y4_1.heavy 486.31 / 515.33 11854.0 28.85026677449544 38 20 2 6 10 7.358495427150861 13.589734612190828 0.03439903259277344 3 0.9964325144097769 20.6562775228098 11854.0 5.07172102449629 1.0 - - - - - - - 1285.6363636363637 23 11 MTOR mechanistic target of rapamycin (serine/threonine kinase) 211 27 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB537051.[MT7]-AIQIINR.2y5_1.heavy 486.31 / 643.389 22475.0 28.85026677449544 38 20 2 6 10 7.358495427150861 13.589734612190828 0.03439903259277344 3 0.9964325144097769 20.6562775228098 22475.0 24.162516835016834 1.0 - - - - - - - 1316.142857142857 44 7 MTOR mechanistic target of rapamycin (serine/threonine kinase) 213 27 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB537051.[MT7]-AIQIINR.2b4_1.heavy 486.31 / 570.373 15903.0 28.85026677449544 38 20 2 6 10 7.358495427150861 13.589734612190828 0.03439903259277344 3 0.9964325144097769 20.6562775228098 15903.0 11.128542790642822 0.0 - - - - - - - 2153.7 31 10 MTOR mechanistic target of rapamycin (serine/threonine kinase) 215 27 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB537051.[MT7]-AIQIINR.2y6_1.heavy 486.31 / 756.473 N/A 28.85026677449544 38 20 2 6 10 7.358495427150861 13.589734612190828 0.03439903259277344 3 0.9964325144097769 20.6562775228098 23121.0 9.800738294900281 1.0 - - - - - - - 312.8333333333333 113 6 MTOR mechanistic target of rapamycin (serine/threonine kinase) 217 28 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB542194.[MT7]-ALYPSIYMPAVLEGTGK[MT7].3y6_1.heavy 700.055 / 748.432 20180.0 44.444525718688965 44 18 10 6 10 12.79172633467592 7.817553110788429 0.038097381591796875 3 0.983383383813828 9.560659685534278 20180.0 41.976359223300975 0.0 - - - - - - - 712.375 40 8 HYAL1 hyaluronoglucosaminidase 1 219 28 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB542194.[MT7]-ALYPSIYMPAVLEGTGK[MT7].3y4_1.heavy 700.055 / 506.306 50518.0 44.444525718688965 44 18 10 6 10 12.79172633467592 7.817553110788429 0.038097381591796875 3 0.983383383813828 9.560659685534278 50518.0 82.59774517426544 0.0 - - - - - - - 792.3636363636364 101 11 HYAL1 hyaluronoglucosaminidase 1 221 28 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB542194.[MT7]-ALYPSIYMPAVLEGTGK[MT7].3y5_1.heavy 700.055 / 635.348 27867.0 44.444525718688965 44 18 10 6 10 12.79172633467592 7.817553110788429 0.038097381591796875 3 0.983383383813828 9.560659685534278 27867.0 42.865692020831986 0.0 - - - - - - - 755.0 55 8 HYAL1 hyaluronoglucosaminidase 1 223 28 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB542194.[MT7]-ALYPSIYMPAVLEGTGK[MT7].3b7_1.heavy 700.055 / 952.526 30269.0 44.444525718688965 44 18 10 6 10 12.79172633467592 7.817553110788429 0.038097381591796875 3 0.983383383813828 9.560659685534278 30269.0 96.73300869205298 0.0 - - - - - - - 257.5 60 12 HYAL1 hyaluronoglucosaminidase 1 225 29 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB537845.[MT7]-ELGLNPEK[MT7].2y4_1.heavy 594.347 / 631.353 10153.0 27.65530014038086 46 16 10 10 10 3.887480516131258 25.723601593640396 0.0 3 0.9692529036771104 7.020066314405384 10153.0 29.65608418367347 0.0 - - - - - - - 288.2352941176471 20 17 ACAT2 acetyl-CoA acetyltransferase 2 227 29 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB537845.[MT7]-ELGLNPEK[MT7].2y3_1.heavy 594.347 / 517.31 21637.0 27.65530014038086 46 16 10 10 10 3.887480516131258 25.723601593640396 0.0 3 0.9692529036771104 7.020066314405384 21637.0 44.14978333333333 0.0 - - - - - - - 750.0 43 7 ACAT2 acetyl-CoA acetyltransferase 2 229 29 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB537845.[MT7]-ELGLNPEK[MT7].2y6_1.heavy 594.347 / 801.459 9663.0 27.65530014038086 46 16 10 10 10 3.887480516131258 25.723601593640396 0.0 3 0.9692529036771104 7.020066314405384 9663.0 18.112896103896105 0.0 - - - - - - - 750.9090909090909 19 11 ACAT2 acetyl-CoA acetyltransferase 2 231 29 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB537845.[MT7]-ELGLNPEK[MT7].2b5_1.heavy 594.347 / 671.385 13444.0 27.65530014038086 46 16 10 10 10 3.887480516131258 25.723601593640396 0.0 3 0.9692529036771104 7.020066314405384 13444.0 44.78132380952381 0.0 - - - - - - - 647.5 26 8 ACAT2 acetyl-CoA acetyltransferase 2 233 30 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB540607.[MT7]-RTHPTVPGIPGGTR.3y7_1.heavy 530.638 / 657.368 6383.0 24.117050170898438 43 20 10 3 10 5.672063134118331 17.630269204601166 0.077301025390625 3 0.9929093381346201 14.647450133074933 6383.0 10.50152167151116 0.0 - - - - - - - 226.75 12 8 ARNTL aryl hydrocarbon receptor nuclear translocator-like 235 30 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB540607.[MT7]-RTHPTVPGIPGGTR.3b6_1.heavy 530.638 / 836.486 4787.0 24.117050170898438 43 20 10 3 10 5.672063134118331 17.630269204601166 0.077301025390625 3 0.9929093381346201 14.647450133074933 4787.0 16.715531833970466 1.0 - - - - - - - 169.5 9 12 ARNTL aryl hydrocarbon receptor nuclear translocator-like 237 30 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB540607.[MT7]-RTHPTVPGIPGGTR.3b3_1.heavy 530.638 / 539.317 22339.0 24.117050170898438 43 20 10 3 10 5.672063134118331 17.630269204601166 0.077301025390625 3 0.9929093381346201 14.647450133074933 22339.0 39.830287777577176 0.0 - - - - - - - 693.0 44 9 ARNTL aryl hydrocarbon receptor nuclear translocator-like 239 30 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB540607.[MT7]-RTHPTVPGIPGGTR.3y8_1.heavy 530.638 / 754.421 37933.0 24.117050170898438 43 20 10 3 10 5.672063134118331 17.630269204601166 0.077301025390625 3 0.9929093381346201 14.647450133074933 37933.0 127.87487960456632 0.0 - - - - - - - 297.5 75 10 ARNTL aryl hydrocarbon receptor nuclear translocator-like 241 31 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB541328.[MT7]-IQSIAPSLQVITSK[MT7].3b4_1.heavy 591.696 / 586.368 24746.0 39.044424057006836 46 20 10 6 10 6.530827731229688 15.311994760145208 0.03549957275390625 3 0.9954354271999394 18.25983988178098 24746.0 20.243902771479316 0.0 - - - - - - - 1205.75 49 8 MTOR mechanistic target of rapamycin (serine/threonine kinase) 243 31 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB541328.[MT7]-IQSIAPSLQVITSK[MT7].3b5_1.heavy 591.696 / 657.405 87838.0 39.044424057006836 46 20 10 6 10 6.530827731229688 15.311994760145208 0.03549957275390625 3 0.9954354271999394 18.25983988178098 87838.0 135.7413924377339 0.0 - - - - - - - 365.375 175 8 MTOR mechanistic target of rapamycin (serine/threonine kinase) 245 31 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB541328.[MT7]-IQSIAPSLQVITSK[MT7].3b7_1.heavy 591.696 / 841.49 9883.0 39.044424057006836 46 20 10 6 10 6.530827731229688 15.311994760145208 0.03549957275390625 3 0.9954354271999394 18.25983988178098 9883.0 61.29962025316456 0.0 - - - - - - - 232.61111111111111 19 18 MTOR mechanistic target of rapamycin (serine/threonine kinase) 247 31 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB541328.[MT7]-IQSIAPSLQVITSK[MT7].3y5_1.heavy 591.696 / 691.447 23719.0 39.044424057006836 46 20 10 6 10 6.530827731229688 15.311994760145208 0.03549957275390625 3 0.9954354271999394 18.25983988178098 23719.0 62.98641558063644 0.0 - - - - - - - 304.7142857142857 47 14 MTOR mechanistic target of rapamycin (serine/threonine kinase) 249 32 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB541699.[MT7]-FLNHC[CAM]LEHLVQYR.4y5_1.heavy 468.997 / 678.393 24691.0 36.01210021972656 44 14 10 10 10 2.7086706508844616 36.91847879968243 0.0 3 0.9480117641004637 5.38902400126821 24691.0 51.92078672629562 0.0 - - - - - - - 580.5555555555555 49 9 IL2RG interleukin 2 receptor, gamma 251 32 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB541699.[MT7]-FLNHC[CAM]LEHLVQYR.4y4_1.heavy 468.997 / 565.309 67003.0 36.01210021972656 44 14 10 10 10 2.7086706508844616 36.91847879968243 0.0 3 0.9480117641004637 5.38902400126821 67003.0 68.39184120706072 0.0 - - - - - - - 653.125 134 8 IL2RG interleukin 2 receptor, gamma 253 32 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB541699.[MT7]-FLNHC[CAM]LEHLVQYR.4b4_1.heavy 468.997 / 656.364 8811.0 36.01210021972656 44 14 10 10 10 2.7086706508844616 36.91847879968243 0.0 3 0.9480117641004637 5.38902400126821 8811.0 24.928682926829268 0.0 - - - - - - - 644.0 17 7 IL2RG interleukin 2 receptor, gamma 255 32 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB541699.[MT7]-FLNHC[CAM]LEHLVQYR.4b3_1.heavy 468.997 / 519.305 27252.0 36.01210021972656 44 14 10 10 10 2.7086706508844616 36.91847879968243 0.0 3 0.9480117641004637 5.38902400126821 27252.0 16.784535795439897 0.0 - - - - - - - 307.25 54 4 IL2RG interleukin 2 receptor, gamma 257 33 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB537155.[MT7]-LLDENK[MT7].2y4_1.heavy 510.302 / 649.327 N/A N/A - - - - - - - - - 0.0 - - - - - - - TBC1D9B;MAP3K7 TBC1 domain family, member 9B (with GRAM domain);mitogen-activated protein kinase kinase kinase 7 259 33 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB537155.[MT7]-LLDENK[MT7].2y5_1.heavy 510.302 / 762.411 N/A N/A - - - - - - - - - 0.0 - - - - - - - TBC1D9B;MAP3K7 TBC1 domain family, member 9B (with GRAM domain);mitogen-activated protein kinase kinase kinase 7 261 33 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB537155.[MT7]-LLDENK[MT7].2b4_1.heavy 510.302 / 615.347 N/A N/A - - - - - - - - - 0.0 - - - - - - - TBC1D9B;MAP3K7 TBC1 domain family, member 9B (with GRAM domain);mitogen-activated protein kinase kinase kinase 7 263 33 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB537155.[MT7]-LLDENK[MT7].2y3_1.heavy 510.302 / 534.3 N/A N/A - - - - - - - - - 0.0 - - - - - - - TBC1D9B;MAP3K7 TBC1 domain family, member 9B (with GRAM domain);mitogen-activated protein kinase kinase kinase 7 265 34 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB540945.[MT7]-LVTNLSGQLSELK[MT7].3b4_1.heavy 564.004 / 572.352 40398.0 39.470624923706055 37 11 10 6 10 0.8560434624964153 63.57038137337981 0.03549957275390625 3 0.8655805718008805 3.327683505359663 40398.0 84.58727901298805 0.0 - - - - - - - 687.8333333333334 80 6 ITPR1 inositol 1,4,5-triphosphate receptor, type 1 267 34 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB540945.[MT7]-LVTNLSGQLSELK[MT7].3b5_1.heavy 564.004 / 685.437 41021.0 39.470624923706055 37 11 10 6 10 0.8560434624964153 63.57038137337981 0.03549957275390625 3 0.8655805718008805 3.327683505359663 41021.0 55.2019817745237 0.0 - - - - - - - 363.0 82 3 ITPR1 inositol 1,4,5-triphosphate receptor, type 1 269 34 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB540945.[MT7]-LVTNLSGQLSELK[MT7].3y4_1.heavy 564.004 / 620.374 126878.0 39.470624923706055 37 11 10 6 10 0.8560434624964153 63.57038137337981 0.03549957275390625 3 0.8655805718008805 3.327683505359663 126878.0 248.48185907170125 0.0 - - - - - - - 807.625 253 8 ITPR1 inositol 1,4,5-triphosphate receptor, type 1 271 34 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB540945.[MT7]-LVTNLSGQLSELK[MT7].3y5_1.heavy 564.004 / 733.458 29268.0 39.470624923706055 37 11 10 6 10 0.8560434624964153 63.57038137337981 0.03549957275390625 3 0.8655805718008805 3.327683505359663 29268.0 50.39729654540972 0.0 - - - - - - - 294.0 58 9 ITPR1 inositol 1,4,5-triphosphate receptor, type 1 273 35 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB538138.[MT7]-EIVPVLVSTR.3b5_1.heavy 419.595 / 682.426 38232.0 36.77180099487305 41 11 10 10 10 0.8922451349299915 66.33511051308966 0.0 3 0.8562675188961911 3.2154390642988657 38232.0 55.06295574103949 0.0 - - - - - - - 187.28571428571428 76 7 ACAT2 acetyl-CoA acetyltransferase 2 275 35 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB538138.[MT7]-EIVPVLVSTR.3y4_1.heavy 419.595 / 462.267 147781.0 36.77180099487305 41 11 10 10 10 0.8922451349299915 66.33511051308966 0.0 3 0.8562675188961911 3.2154390642988657 147781.0 258.29299821671685 0.0 - - - - - - - 303.0 295 1 ACAT2 acetyl-CoA acetyltransferase 2 277 35 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB538138.[MT7]-EIVPVLVSTR.3b3_1.heavy 419.595 / 486.304 91292.0 36.77180099487305 41 11 10 10 10 0.8922451349299915 66.33511051308966 0.0 3 0.8562675188961911 3.2154390642988657 91292.0 95.96703387096775 0.0 - - - - - - - 302.6 182 5 ACAT2 acetyl-CoA acetyltransferase 2 279 35 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB538138.[MT7]-EIVPVLVSTR.3y5_1.heavy 419.595 / 575.351 126699.0 36.77180099487305 41 11 10 10 10 0.8922451349299915 66.33511051308966 0.0 3 0.8562675188961911 3.2154390642988657 126699.0 137.9509568577604 0.0 - - - - - - - 269.3333333333333 253 6 ACAT2 acetyl-CoA acetyltransferase 2 281 36 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB55253.[MT7]-TVDWALAEYMAFGSLLK[MT7].3b6_1.heavy 735.062 / 830.453 N/A N/A - - - - - - - - - 0.0 - - - - - - - OGDH;OGDHL oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide);oxoglutarate dehydrogenase-like 283 36 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB55253.[MT7]-TVDWALAEYMAFGSLLK[MT7].3b5_1.heavy 735.062 / 717.369 N/A N/A - - - - - - - - - 0.0 - - - - - - - OGDH;OGDHL oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide);oxoglutarate dehydrogenase-like 285 36 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB55253.[MT7]-TVDWALAEYMAFGSLLK[MT7].3y5_1.heavy 735.062 / 661.437 N/A N/A - - - - - - - - - 0.0 - - - - - - - OGDH;OGDHL oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide);oxoglutarate dehydrogenase-like 287 36 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB55253.[MT7]-TVDWALAEYMAFGSLLK[MT7].3b7_1.heavy 735.062 / 901.49 N/A N/A - - - - - - - - - 0.0 - - - - - - - OGDH;OGDHL oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide);oxoglutarate dehydrogenase-like 289 37 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB536980.[MT7]-DYWGK[MT7].2b3_1.heavy 478.758 / 609.279 3568.0 27.663899898529053 46 20 10 6 10 12.269790497734451 8.150098407830553 0.03439903259277344 3 0.998663636898094 33.75606040475306 3568.0 6.261140907666779 0.0 - - - - - - - 718.5333333333333 7 15 LIMK2 LIM domain kinase 2 291 37 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB536980.[MT7]-DYWGK[MT7].2y4_1.heavy 478.758 / 697.379 18569.0 27.663899898529053 46 20 10 6 10 12.269790497734451 8.150098407830553 0.03439903259277344 3 0.998663636898094 33.75606040475306 18569.0 47.33763191007466 0.0 - - - - - - - 655.4375 37 16 LIMK2 LIM domain kinase 2 293 37 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB536980.[MT7]-DYWGK[MT7].2b4_1.heavy 478.758 / 666.3 1529.0 27.663899898529053 46 20 10 6 10 12.269790497734451 8.150098407830553 0.03439903259277344 3 0.998663636898094 33.75606040475306 1529.0 2.93822309765706 6.0 - - - - - - - 634.0588235294117 8 17 LIMK2 LIM domain kinase 2 295 37 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB536980.[MT7]-DYWGK[MT7].2y3_1.heavy 478.758 / 534.316 22137.0 27.663899898529053 46 20 10 6 10 12.269790497734451 8.150098407830553 0.03439903259277344 3 0.998663636898094 33.75606040475306 22137.0 18.9919647611839 0.0 - - - - - - - 1224.7272727272727 44 11 LIMK2 LIM domain kinase 2 297 38 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB542059.[MT7]-DLTQAWDLYYHVFR.3b4_1.heavy 657.668 / 602.327 26779.0 47.48379898071289 50 20 10 10 10 13.585451984755311 7.360815091924312 0.0 3 0.9951345820638906 17.685854640050795 26779.0 47.363197029618036 0.0 - - - - - - - 734.1428571428571 53 7 MTOR mechanistic target of rapamycin (serine/threonine kinase) 299 38 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB542059.[MT7]-DLTQAWDLYYHVFR.3b5_1.heavy 657.668 / 673.364 38941.0 47.48379898071289 50 20 10 10 10 13.585451984755311 7.360815091924312 0.0 3 0.9951345820638906 17.685854640050795 38941.0 120.48495151807776 0.0 - - - - - - - 234.55555555555554 77 18 MTOR mechanistic target of rapamycin (serine/threonine kinase) 301 38 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB542059.[MT7]-DLTQAWDLYYHVFR.3y4_1.heavy 657.668 / 558.315 32318.0 47.48379898071289 50 20 10 10 10 13.585451984755311 7.360815091924312 0.0 3 0.9951345820638906 17.685854640050795 32318.0 42.83765374189878 0.0 - - - - - - - 1137.6923076923076 64 13 MTOR mechanistic target of rapamycin (serine/threonine kinase) 303 38 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB542059.[MT7]-DLTQAWDLYYHVFR.3y5_1.heavy 657.668 / 721.378 29749.0 47.48379898071289 50 20 10 10 10 13.585451984755311 7.360815091924312 0.0 3 0.9951345820638906 17.685854640050795 29749.0 90.77615420560748 0.0 - - - - - - - 264.4736842105263 59 19 MTOR mechanistic target of rapamycin (serine/threonine kinase) 305 39 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB55254.[MT7]-EYAPNVPFLLIGTQIDLR.3y7_1.heavy 735.08 / 802.442 46497.0 50.88090133666992 43 13 10 10 10 1.7712044367885509 39.84740740363914 0.0 3 0.9105411236227281 4.095044043971951 46497.0 124.74366210740867 0.0 - - - - - - - 652.1666666666666 92 12 LOC100510206;RHOQ rho-related GTP-binding protein RhoQ-like;ras homolog gene family, member Q 307 39 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB55254.[MT7]-EYAPNVPFLLIGTQIDLR.3b6_1.heavy 735.08 / 818.417 56568.0 50.88090133666992 43 13 10 10 10 1.7712044367885509 39.84740740363914 0.0 3 0.9105411236227281 4.095044043971951 56568.0 275.52100880073556 0.0 - - - - - - - 273.375 113 8 LOC100510206;RHOQ rho-related GTP-binding protein RhoQ-like;ras homolog gene family, member Q 309 39 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB55254.[MT7]-EYAPNVPFLLIGTQIDLR.3b5_1.heavy 735.08 / 719.348 32628.0 50.88090133666992 43 13 10 10 10 1.7712044367885509 39.84740740363914 0.0 3 0.9105411236227281 4.095044043971951 32628.0 84.0144983045157 0.0 - - - - - - - 682.2857142857143 65 7 LOC100510206;RHOQ rho-related GTP-binding protein RhoQ-like;ras homolog gene family, member Q 311 39 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB55254.[MT7]-EYAPNVPFLLIGTQIDLR.3b3_1.heavy 735.08 / 508.252 40915.0 50.88090133666992 43 13 10 10 10 1.7712044367885509 39.84740740363914 0.0 3 0.9105411236227281 4.095044043971951 40915.0 93.60939208138097 0.0 - - - - - - - 728.8888888888889 81 9 LOC100510206;RHOQ rho-related GTP-binding protein RhoQ-like;ras homolog gene family, member Q 313 40 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TPX_ECO57.AQTFTLVAK.2y7.peptide 489.78 / 779.47 991010.0 30.820600509643555 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 991010.0 1637.6779525990744 0.0 - - - - - - - 592.0 1982 1 315 40 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TPX_ECO57.AQTFTLVAK.2y6.peptide 489.78 / 678.42 366035.0 30.820600509643555 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 366035.0 218.10708323536872 0.0 - - - - - - - 485.0 732 1 317 40 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TPX_ECO57.AQTFTLVAK.2y5.peptide 489.78 / 531.35 394034.0 30.820600509643555 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 394034.0 228.9239978225536 0.0 - - - - - - - 3210.625 788 8 319 41 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB55145.[MT7]-LAENNIQPIFAVTSR.2y8_1.heavy 909.005 / 890.509 16879.0 39.47927474975586 35 12 10 3 10 0.9148159598864921 72.47897377051066 0.070098876953125 3 0.8967734975903396 3.807659359187107 16879.0 54.90007961870682 0.0 - - - - - - - 283.25 33 8 ITGB2 integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) 321 41 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB55145.[MT7]-LAENNIQPIFAVTSR.2y9_1.heavy 909.005 / 1018.57 14769.0 39.47927474975586 35 12 10 3 10 0.9148159598864921 72.47897377051066 0.070098876953125 3 0.8967734975903396 3.807659359187107 14769.0 11.746815162805767 0.0 - - - - - - - 714.2857142857143 29 7 ITGB2 integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) 323 41 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB55145.[MT7]-LAENNIQPIFAVTSR.2b4_1.heavy 909.005 / 572.316 4298.0 39.47927474975586 35 12 10 3 10 0.9148159598864921 72.47897377051066 0.070098876953125 3 0.8967734975903396 3.807659359187107 4298.0 19.967809744935728 0.0 - - - - - - - 300.53846153846155 8 13 ITGB2 integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) 325 41 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB55145.[MT7]-LAENNIQPIFAVTSR.2b5_1.heavy 909.005 / 686.359 11096.0 39.47927474975586 35 12 10 3 10 0.9148159598864921 72.47897377051066 0.070098876953125 3 0.8967734975903396 3.807659359187107 11096.0 51.61441914529915 0.0 - - - - - - - 681.0 22 7 ITGB2 integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) 327 42 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54666.[MT7]-K[MT7]SEADK[MT7].2b3_1.heavy 555.33 / 633.381 N/A N/A - - - - - - - - - 0.0 - - - - - - - ACAT2 acetyl-CoA acetyltransferase 2 329 42 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54666.[MT7]-K[MT7]SEADK[MT7].2y5_1.heavy 555.33 / 693.354 N/A N/A - - - - - - - - - 0.0 - - - - - - - ACAT2 acetyl-CoA acetyltransferase 2 331 42 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54666.[MT7]-K[MT7]SEADK[MT7].2b4_1.heavy 555.33 / 704.418 N/A N/A - - - - - - - - - 0.0 - - - - - - - ACAT2 acetyl-CoA acetyltransferase 2 333 42 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54666.[MT7]-K[MT7]SEADK[MT7].2b5_1.heavy 555.33 / 819.445 N/A N/A - - - - - - - - - 0.0 - - - - - - - ACAT2 acetyl-CoA acetyltransferase 2 335 43 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB538135.[MT7]-EIVPVLVSTR.2y8_1.heavy 628.888 / 870.541 25050.0 36.77180099487305 50 20 10 10 10 8.246938759132382 12.125711481640792 0.0 3 0.9968804722035858 22.090471002294443 25050.0 25.821690259211596 0.0 - - - - - - - 707.0 50 7 ACAT2 acetyl-CoA acetyltransferase 2 337 43 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB538135.[MT7]-EIVPVLVSTR.2y5_1.heavy 628.888 / 575.351 3737.0 36.77180099487305 50 20 10 10 10 8.246938759132382 12.125711481640792 0.0 3 0.9968804722035858 22.090471002294443 3737.0 5.208461538461538 0.0 - - - - - - - 1284.142857142857 7 7 ACAT2 acetyl-CoA acetyltransferase 2 339 43 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB538135.[MT7]-EIVPVLVSTR.2y9_1.heavy 628.888 / 983.625 34949.0 36.77180099487305 50 20 10 10 10 8.246938759132382 12.125711481640792 0.0 3 0.9968804722035858 22.090471002294443 34949.0 134.9515841584158 0.0 - - - - - - - 303.0 69 6 ACAT2 acetyl-CoA acetyltransferase 2 341 43 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB538135.[MT7]-EIVPVLVSTR.2y7_1.heavy 628.888 / 771.472 116967.0 36.77180099487305 50 20 10 10 10 8.246938759132382 12.125711481640792 0.0 3 0.9968804722035858 22.090471002294443 116967.0 69.80118901890188 0.0 - - - - - - - 235.66666666666666 233 3 ACAT2 acetyl-CoA acetyltransferase 2 343 44 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54282.[MT7]-VTATEC[CAM]IQEQSFVIR.3y7_1.heavy 642.335 / 878.473 N/A N/A - - - - - - - - - 0.0 - - - - - - - ITGB2 integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) 345 44 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54282.[MT7]-VTATEC[CAM]IQEQSFVIR.3b6_1.heavy 642.335 / 806.383 N/A N/A - - - - - - - - - 0.0 - - - - - - - ITGB2 integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) 347 44 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54282.[MT7]-VTATEC[CAM]IQEQSFVIR.3b4_1.heavy 642.335 / 517.31 N/A N/A - - - - - - - - - 0.0 - - - - - - - ITGB2 integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) 349 44 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54282.[MT7]-VTATEC[CAM]IQEQSFVIR.3y5_1.heavy 642.335 / 621.372 N/A N/A - - - - - - - - - 0.0 - - - - - - - ITGB2 integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) 351 45 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB542053.[MT7]-ITSLTQLTDNLTVLK[MT7].3y3_1.heavy 650.057 / 503.367 167834.0 45.937599182128906 46 16 10 10 10 2.2505281093113436 37.42483812138063 0.0 3 0.9632749691282947 6.420119639154915 167834.0 301.35880257207464 0.0 - - - - - - - 1146.4444444444443 335 9 TRIM32 tripartite motif-containing 32 353 45 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB542053.[MT7]-ITSLTQLTDNLTVLK[MT7].3b6_1.heavy 650.057 / 788.463 110587.0 45.937599182128906 46 16 10 10 10 2.2505281093113436 37.42483812138063 0.0 3 0.9632749691282947 6.420119639154915 110587.0 520.3027704918032 0.0 - - - - - - - 265.52941176470586 221 17 TRIM32 tripartite motif-containing 32 355 45 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB542053.[MT7]-ITSLTQLTDNLTVLK[MT7].3b5_1.heavy 650.057 / 660.405 69819.0 45.937599182128906 46 16 10 10 10 2.2505281093113436 37.42483812138063 0.0 3 0.9632749691282947 6.420119639154915 69819.0 475.76116393442624 0.0 - - - - - - - 312.1764705882353 139 17 TRIM32 tripartite motif-containing 32 357 45 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB542053.[MT7]-ITSLTQLTDNLTVLK[MT7].3y4_1.heavy 650.057 / 604.415 338963.0 45.937599182128906 46 16 10 10 10 2.2505281093113436 37.42483812138063 0.0 3 0.9632749691282947 6.420119639154915 338963.0 426.9987390510823 0.0 - - - - - - - 1227.7777777777778 677 9 TRIM32 tripartite motif-containing 32 359 46 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB53531.[MT7]-FNFSK[MT7].2b3_1.heavy 465.768 / 553.289 1025.0 34.841668446858726 30 13 10 6 1 2.0950832281895737 35.18308487515585 0.0391998291015625 18 0.906795084379092 4.010611506393694 1025.0 1.028428093645485 29.0 - - - - - - - 706.0 4 15 LOC100508761;LOC390937;ETV3L;P2RX4;P2RX5;AHNAK;P2RX6 hypothetical protein LOC100508761;Ets2 repressor factor-like;ets variant 3-like;purinergic receptor P2X, ligand-gated ion channel, 4;purinergic receptor P2X, ligand-gated ion channel, 5;AHNAK nucleoprotein;purinergic receptor P2X, ligand-gated ion channel, 6 361 46 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB53531.[MT7]-FNFSK[MT7].2y4_1.heavy 465.768 / 639.358 7004.0 34.841668446858726 30 13 10 6 1 2.0950832281895737 35.18308487515585 0.0391998291015625 18 0.906795084379092 4.010611506393694 7004.0 10.122370404800638 0.0 - - - - - - - 722.0909090909091 14 11 LOC100508761;LOC390937;ETV3L;P2RX4;P2RX5;AHNAK;P2RX6 hypothetical protein LOC100508761;Ets2 repressor factor-like;ets variant 3-like;purinergic receptor P2X, ligand-gated ion channel, 4;purinergic receptor P2X, ligand-gated ion channel, 5;AHNAK nucleoprotein;purinergic receptor P2X, ligand-gated ion channel, 6 363 46 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB53531.[MT7]-FNFSK[MT7].2y3_1.heavy 465.768 / 525.315 3502.0 34.841668446858726 30 13 10 6 1 2.0950832281895737 35.18308487515585 0.0391998291015625 18 0.906795084379092 4.010611506393694 3502.0 5.078960271747157 1.0 - - - - - - - 1159.142857142857 7 7 LOC100508761;LOC390937;ETV3L;P2RX4;P2RX5;AHNAK;P2RX6 hypothetical protein LOC100508761;Ets2 repressor factor-like;ets variant 3-like;purinergic receptor P2X, ligand-gated ion channel, 4;purinergic receptor P2X, ligand-gated ion channel, 5;AHNAK nucleoprotein;purinergic receptor P2X, ligand-gated ion channel, 6 365 47 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54241.[MT7]-LSESQLELNWNNR.2y5_1.heavy 873.948 / 703.327 N/A N/A - - - - - - - - - 0.0 - - - - - - - IL2RG interleukin 2 receptor, gamma 367 47 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54241.[MT7]-LSESQLELNWNNR.2y6_1.heavy 873.948 / 816.411 N/A N/A - - - - - - - - - 0.0 - - - - - - - IL2RG interleukin 2 receptor, gamma 369 47 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54241.[MT7]-LSESQLELNWNNR.2b5_1.heavy 873.948 / 689.359 N/A N/A - - - - - - - - - 0.0 - - - - - - - IL2RG interleukin 2 receptor, gamma 371 47 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54241.[MT7]-LSESQLELNWNNR.2y7_1.heavy 873.948 / 945.454 N/A N/A - - - - - - - - - 0.0 - - - - - - - IL2RG interleukin 2 receptor, gamma 373 48 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 ODP2_ECOLI.AEAPAAAPAAK.2y7.peptide 484.26 / 599.35 942196.0 16.96150016784668 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 942196.0 2059.3764457960333 0.0 - - - - - - - 393.6 1884 5 375 48 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 ODP2_ECOLI.AEAPAAAPAAK.2y8.peptide 484.26 / 696.4 1380270.0 16.96150016784668 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 1380270.0 4803.631727644665 0.0 - - - - - - - 381.0 2760 2 377 48 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 ODP2_ECOLI.AEAPAAAPAAK.2y6.peptide 484.26 / 528.31 738554.0 16.96150016784668 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 738554.0 1092.7524290751167 0.0 - - - - - - - 427.2 1477 5 379 49 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54242.[MT7]-EK[MT7]PIC[CAM]VEQGQK[MT7].2y5_1.heavy 874.49 / 733.396 N/A N/A - - - - - - - - - 0.0 - - - - - - - RHOQ ras homolog gene family, member Q 381 49 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54242.[MT7]-EK[MT7]PIC[CAM]VEQGQK[MT7].2b4_1.heavy 874.49 / 756.486 N/A N/A - - - - - - - - - 0.0 - - - - - - - RHOQ ras homolog gene family, member Q 383 49 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54242.[MT7]-EK[MT7]PIC[CAM]VEQGQK[MT7].2y9_1.heavy 874.49 / 1202.63 N/A N/A - - - - - - - - - 0.0 - - - - - - - RHOQ ras homolog gene family, member Q 385 49 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54242.[MT7]-EK[MT7]PIC[CAM]VEQGQK[MT7].2y7_1.heavy 874.49 / 992.495 N/A N/A - - - - - - - - - 0.0 - - - - - - - RHOQ ras homolog gene family, member Q 387 50 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54143.[MT7]-LNFTGPGDPDSIR.2b3_1.heavy 766.895 / 519.305 N/A N/A - - - - - - - - - 0.0 - - - - - - - ITGB2 integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) 389 50 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54143.[MT7]-LNFTGPGDPDSIR.2y5_1.heavy 766.895 / 587.315 N/A N/A - - - - - - - - - 0.0 - - - - - - - ITGB2 integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) 391 50 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54143.[MT7]-LNFTGPGDPDSIR.2y9_1.heavy 766.895 / 913.437 N/A N/A - - - - - - - - - 0.0 - - - - - - - ITGB2 integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) 393 50 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54143.[MT7]-LNFTGPGDPDSIR.2y10_1.heavy 766.895 / 1014.49 N/A N/A - - - - - - - - - 0.0 - - - - - - - ITGB2 integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) 395 51 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB540732.[MT7]-TVLPFVNTHPDK[MT7].3b6_1.heavy 552.65 / 801.499 14679.0 33.76124954223633 46 20 10 6 10 2.9222250097180886 34.22049967659648 0.0370025634765625 3 0.9920578319252025 13.839008526699951 14679.0 36.27314479638009 0.0 - - - - - - - 634.75 29 8 ITGB2 integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) 397 51 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB540732.[MT7]-TVLPFVNTHPDK[MT7].3y3_1.heavy 552.65 / 503.295 206209.0 33.76124954223633 46 20 10 6 10 2.9222250097180886 34.22049967659648 0.0370025634765625 3 0.9920578319252025 13.839008526699951 206209.0 124.1807825240536 0.0 - - - - - - - 1396.7777777777778 412 9 ITGB2 integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) 399 51 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB540732.[MT7]-TVLPFVNTHPDK[MT7].3b5_1.heavy 552.65 / 702.431 36541.0 33.76124954223633 46 20 10 6 10 2.9222250097180886 34.22049967659648 0.0370025634765625 3 0.9920578319252025 13.839008526699951 36541.0 43.207636625910155 0.0 - - - - - - - 725.2857142857143 73 7 ITGB2 integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) 401 51 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB540732.[MT7]-TVLPFVNTHPDK[MT7].3y9_2.heavy 552.65 / 599.82 33730.0 33.76124954223633 46 20 10 6 10 2.9222250097180886 34.22049967659648 0.0370025634765625 3 0.9920578319252025 13.839008526699951 33730.0 78.59043438045252 0.0 - - - - - - - 664.0 67 12 ITGB2 integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) 403 52 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB537589.[MT7]-LNVLANVIR.2y8_1.heavy 578.37 / 898.547 6729.0 41.16964912414551 35 17 9 3 6 3.2342732772583447 30.918846809620497 0.0746002197265625 6 0.9763973600105545 8.017226441381174 6729.0 20.581547797949828 0.0 - - - - - - - 252.05263157894737 13 19 OGDH;OGDHL oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide);oxoglutarate dehydrogenase-like 405 52 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB537589.[MT7]-LNVLANVIR.2y5_1.heavy 578.37 / 572.352 2991.0 41.16964912414551 35 17 9 3 6 3.2342732772583447 30.918846809620497 0.0746002197265625 6 0.9763973600105545 8.017226441381174 2991.0 1.617938630999213 5.0 - - - - - - - 1250.8181818181818 9 11 OGDH;OGDHL oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide);oxoglutarate dehydrogenase-like 407 52 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB537589.[MT7]-LNVLANVIR.2y6_1.heavy 578.37 / 685.435 5982.0 41.16964912414551 35 17 9 3 6 3.2342732772583447 30.918846809620497 0.0746002197265625 6 0.9763973600105545 8.017226441381174 5982.0 17.42079766780534 0.0 - - - - - - - 196.375 11 16 OGDH;OGDHL oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide);oxoglutarate dehydrogenase-like 409 52 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB537589.[MT7]-LNVLANVIR.2y7_1.heavy 578.37 / 784.504 2467.0 41.16964912414551 35 17 9 3 6 3.2342732772583447 30.918846809620497 0.0746002197265625 6 0.9763973600105545 8.017226441381174 2467.0 10.885407110561559 3.0 - - - - - - - 217.54545454545453 15 11 OGDH;OGDHL oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide);oxoglutarate dehydrogenase-like 411 53 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB55289.[MT7]-ARNDEYENLFNMIVEIPR.3b4_1.heavy 789.734 / 601.317 1479.0 48.54279899597168 44 18 10 6 10 12.430574947076673 8.04468018782327 0.034801483154296875 3 0.980695068945742 8.86802865057269 1479.0 1.9922108345534406 4.0 - - - - - - - 318.4 2 10 PPA2 pyrophosphatase (inorganic) 2 413 53 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB55289.[MT7]-ARNDEYENLFNMIVEIPR.3y8_1.heavy 789.734 / 971.534 4607.0 48.54279899597168 44 18 10 6 10 12.430574947076673 8.04468018782327 0.034801483154296875 3 0.980695068945742 8.86802865057269 4607.0 8.808832195111638 0.0 - - - - - - - 658.2857142857143 9 7 PPA2 pyrophosphatase (inorganic) 2 415 53 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB55289.[MT7]-ARNDEYENLFNMIVEIPR.3b7_1.heavy 789.734 / 1022.47 2787.0 48.54279899597168 44 18 10 6 10 12.430574947076673 8.04468018782327 0.034801483154296875 3 0.980695068945742 8.86802865057269 2787.0 1.088671875 0.0 - - - - - - - 755.5714285714286 5 7 PPA2 pyrophosphatase (inorganic) 2 417 53 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB55289.[MT7]-ARNDEYENLFNMIVEIPR.3y5_1.heavy 789.734 / 613.367 6427.0 48.54279899597168 44 18 10 6 10 12.430574947076673 8.04468018782327 0.034801483154296875 3 0.980695068945742 8.86802865057269 6427.0 4.4878291164635105 0.0 - - - - - - - 722.3 12 10 PPA2 pyrophosphatase (inorganic) 2 419 54 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB538248.[MT7]-RQATQMLK[MT7].3y3_1.heavy 421.92 / 535.339 46849.0 21.31100082397461 42 14 10 10 8 2.6770834743839464 37.35408363499465 0.0 4 0.946374683658968 5.305389871829898 46849.0 57.63764858130621 0.0 - - - - - - - 774.9166666666666 93 12 IL2RG interleukin 2 receptor, gamma 421 54 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB538248.[MT7]-RQATQMLK[MT7].3b4_1.heavy 421.92 / 601.354 13310.0 21.31100082397461 42 14 10 10 8 2.6770834743839464 37.35408363499465 0.0 4 0.946374683658968 5.305389871829898 13310.0 26.25328431918607 0.0 - - - - - - - 719.9333333333333 26 15 IL2RG interleukin 2 receptor, gamma 423 54 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB538248.[MT7]-RQATQMLK[MT7].3b5_1.heavy 421.92 / 729.412 14323.0 21.31100082397461 42 14 10 10 8 2.6770834743839464 37.35408363499465 0.0 4 0.946374683658968 5.305389871829898 14323.0 73.63780881932061 1.0 - - - - - - - 780.7142857142857 60 7 IL2RG interleukin 2 receptor, gamma 425 54 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB538248.[MT7]-RQATQMLK[MT7].3b3_1.heavy 421.92 / 500.306 7316.0 21.31100082397461 42 14 10 10 8 2.6770834743839464 37.35408363499465 0.0 4 0.946374683658968 5.305389871829898 7316.0 7.391471911228414 1.0 - - - - - - - 1195.5 14 8 IL2RG interleukin 2 receptor, gamma 427 55 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB537388.[MT7]-VFDPEGK[MT7].2b3_1.heavy 540.302 / 506.273 138959.0 27.781400203704834 42 16 10 6 10 4.721832151813522 21.178219975818674 0.03199958801269531 3 0.9691932742706394 7.013233765875664 138959.0 53.80294610746612 0.0 - - - - - - - 669.3333333333334 277 3 MYL2 myosin, light chain 2, regulatory, cardiac, slow 429 55 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB537388.[MT7]-VFDPEGK[MT7].2y4_1.heavy 540.302 / 574.332 197469.0 27.781400203704834 42 16 10 6 10 4.721832151813522 21.178219975818674 0.03199958801269531 3 0.9691932742706394 7.013233765875664 197469.0 194.865680106075 0.0 - - - - - - - 674.2 394 5 MYL2 myosin, light chain 2, regulatory, cardiac, slow 431 55 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB537388.[MT7]-VFDPEGK[MT7].2y5_1.heavy 540.302 / 689.359 14627.0 27.781400203704834 42 16 10 6 10 4.721832151813522 21.178219975818674 0.03199958801269531 3 0.9691932742706394 7.013233765875664 14627.0 23.59193548387097 0.0 - - - - - - - 1115.4444444444443 29 9 MYL2 myosin, light chain 2, regulatory, cardiac, slow 433 55 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB537388.[MT7]-VFDPEGK[MT7].2y6_1.heavy 540.302 / 836.427 24737.0 27.781400203704834 42 16 10 6 10 4.721832151813522 21.178219975818674 0.03199958801269531 3 0.9691932742706394 7.013233765875664 24737.0 52.669976072822955 0.0 - - - - - - - 143.5 49 4 MYL2 myosin, light chain 2, regulatory, cardiac, slow 435 56 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB538631.[MT7]-GK[MT7]PAEVSVK[MT7].3y7_1.heavy 449.617 / 873.516 2212.0 20.40999984741211 47 17 10 10 10 3.12652534863844 31.98438805031556 0.0 3 0.9717741834510946 7.328452182899569 2212.0 35.877560975609754 0.0 - - - - - - - 107.23076923076923 4 13 RAPGEF1 Rap guanine nucleotide exchange factor (GEF) 1 437 56 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB538631.[MT7]-GK[MT7]PAEVSVK[MT7].3y3_1.heavy 449.617 / 477.315 26828.0 20.40999984741211 47 17 10 10 10 3.12652534863844 31.98438805031556 0.0 3 0.9717741834510946 7.328452182899569 26828.0 44.108617172404244 0.0 - - - - - - - 721.625 53 8 RAPGEF1 Rap guanine nucleotide exchange factor (GEF) 1 439 56 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB538631.[MT7]-GK[MT7]PAEVSVK[MT7].3b5_1.heavy 449.617 / 771.46 4587.0 20.40999984741211 47 17 10 10 10 3.12652534863844 31.98438805031556 0.0 3 0.9717741834510946 7.328452182899569 4587.0 54.89482926829268 0.0 - - - - - - - 209.31578947368422 9 19 RAPGEF1 Rap guanine nucleotide exchange factor (GEF) 1 441 56 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB538631.[MT7]-GK[MT7]PAEVSVK[MT7].3y4_1.heavy 449.617 / 576.384 9748.0 20.40999984741211 47 17 10 10 10 3.12652534863844 31.98438805031556 0.0 3 0.9717741834510946 7.328452182899569 9748.0 29.640735275701743 0.0 - - - - - - - 670.7692307692307 19 13 RAPGEF1 Rap guanine nucleotide exchange factor (GEF) 1 443 57 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54153.[MT7]-MFVDLNPDSDK[MT7].2b3_1.heavy 784.897 / 522.287 N/A N/A - - - - - - - - - 0.0 - - - - - - - GNA11;GNAQ guanine nucleotide binding protein (G protein), alpha 11 (Gq class);guanine nucleotide binding protein (G protein), q polypeptide 445 57 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54153.[MT7]-MFVDLNPDSDK[MT7].2y5_1.heavy 784.897 / 705.354 N/A N/A - - - - - - - - - 0.0 - - - - - - - GNA11;GNAQ guanine nucleotide binding protein (G protein), alpha 11 (Gq class);guanine nucleotide binding protein (G protein), q polypeptide 447 57 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54153.[MT7]-MFVDLNPDSDK[MT7].2b4_1.heavy 784.897 / 637.314 N/A N/A - - - - - - - - - 0.0 - - - - - - - GNA11;GNAQ guanine nucleotide binding protein (G protein), alpha 11 (Gq class);guanine nucleotide binding protein (G protein), q polypeptide 449 57 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54153.[MT7]-MFVDLNPDSDK[MT7].2b6_1.heavy 784.897 / 864.441 N/A N/A - - - - - - - - - 0.0 - - - - - - - GNA11;GNAQ guanine nucleotide binding protein (G protein), alpha 11 (Gq class);guanine nucleotide binding protein (G protein), q polypeptide 451 58 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB541307.[MT7]-EK[MT7]PIC[CAM]VEQGQK[MT7].3b4_1.heavy 583.329 / 756.486 2476.0 21.959999084472656 42 12 10 10 10 0.9723243782753098 61.187471849386036 0.0 3 0.8877328360599118 3.6482668372392055 2476.0 36.72389265242314 0.0 - - - - - - - 138.6086956521739 4 23 RHOQ ras homolog gene family, member Q 453 58 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB541307.[MT7]-EK[MT7]PIC[CAM]VEQGQK[MT7].3y4_1.heavy 583.329 / 604.354 6619.0 21.959999084472656 42 12 10 10 10 0.9723243782753098 61.187471849386036 0.0 3 0.8877328360599118 3.6482668372392055 6619.0 54.347136931084414 0.0 - - - - - - - 173.42857142857142 13 21 RHOQ ras homolog gene family, member Q 455 58 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB541307.[MT7]-EK[MT7]PIC[CAM]VEQGQK[MT7].3y5_1.heavy 583.329 / 733.396 7680.0 21.959999084472656 42 12 10 10 10 0.9723243782753098 61.187471849386036 0.0 3 0.8877328360599118 3.6482668372392055 7680.0 185.52074303405573 0.0 - - - - - - - 110.0 15 23 RHOQ ras homolog gene family, member Q 457 58 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB541307.[MT7]-EK[MT7]PIC[CAM]VEQGQK[MT7].3b7_2.heavy 583.329 / 572.817 8691.0 21.959999084472656 42 12 10 10 10 0.9723243782753098 61.187471849386036 0.0 3 0.8877328360599118 3.6482668372392055 8691.0 54.313280751803994 0.0 - - - - - - - 170.75 17 24 RHOQ ras homolog gene family, member Q 459 59 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB53544.[MT7]-LEEEK[MT7].2b3_1.heavy 468.268 / 516.279 1005.0 22.811800003051758 26 8 10 6 2 0.7303547449188734 92.08787423457537 0.033199310302734375 15 0.7941606754623072 2.6720857323433487 1005.0 0.738970588235294 31.0 - - - - - - - 648.9333333333333 5 15 LOC100286914;LOC100287654;LOC100288646;C9orf174;LOC100507200;COPB1;ANKRD23;CCDC19;SEPT14;KIF3C;NIN;CEP55;STOX2;RBM25;TSC1;MAD1L1;CTTNBP2;NEXN;RAB11FIP3 putative uncharacterized protein C20orf69-like;putative uncharacterized protein C20orf69-like;putative uncharacterized protein C20orf69-like;chromosome 9 open reading frame 174;putative uncharacterized protein C20orf69-like;coatomer protein complex, subunit beta 1;ankyrin repeat domain 23;coiled-coil domain containing 19;septin 14;kinesin family member 3C;ninein (GSK3B interacting protein);centrosomal protein 55kDa;storkhead box 2;RNA binding motif protein 25;tuberous sclerosis 1;MAD1 mitotic arrest deficient-like 1 (yeast);cortactin binding protein 2;nexilin (F actin binding protein);RAB11 family interacting protein 3 (class II) 461 59 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB53544.[MT7]-LEEEK[MT7].2y4_1.heavy 468.268 / 678.343 31369.0 22.811800003051758 26 8 10 6 2 0.7303547449188734 92.08787423457537 0.033199310302734375 15 0.7941606754623072 2.6720857323433487 31369.0 168.88695760122232 0.0 - - - - - - - 740.7142857142857 62 7 LOC100286914;LOC100287654;LOC100288646;C9orf174;LOC100507200;COPB1;ANKRD23;CCDC19;SEPT14;KIF3C;NIN;CEP55;STOX2;RBM25;TSC1;MAD1L1;CTTNBP2;NEXN;RAB11FIP3 putative uncharacterized protein C20orf69-like;putative uncharacterized protein C20orf69-like;putative uncharacterized protein C20orf69-like;chromosome 9 open reading frame 174;putative uncharacterized protein C20orf69-like;coatomer protein complex, subunit beta 1;ankyrin repeat domain 23;coiled-coil domain containing 19;septin 14;kinesin family member 3C;ninein (GSK3B interacting protein);centrosomal protein 55kDa;storkhead box 2;RNA binding motif protein 25;tuberous sclerosis 1;MAD1 mitotic arrest deficient-like 1 (yeast);cortactin binding protein 2;nexilin (F actin binding protein);RAB11 family interacting protein 3 (class II) 463 59 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB53544.[MT7]-LEEEK[MT7].2b4_1.heavy 468.268 / 645.321 3227.0 22.811800003051758 26 8 10 6 2 0.7303547449188734 92.08787423457537 0.033199310302734375 15 0.7941606754623072 2.6720857323433487 3227.0 4.605453102413073 3.0 - - - - - - - 704.1875 6 16 LOC100286914;LOC100287654;LOC100288646;C9orf174;LOC100507200;COPB1;ANKRD23;CCDC19;SEPT14;KIF3C;NIN;CEP55;STOX2;RBM25;TSC1;MAD1L1;CTTNBP2;NEXN;RAB11FIP3 putative uncharacterized protein C20orf69-like;putative uncharacterized protein C20orf69-like;putative uncharacterized protein C20orf69-like;chromosome 9 open reading frame 174;putative uncharacterized protein C20orf69-like;coatomer protein complex, subunit beta 1;ankyrin repeat domain 23;coiled-coil domain containing 19;septin 14;kinesin family member 3C;ninein (GSK3B interacting protein);centrosomal protein 55kDa;storkhead box 2;RNA binding motif protein 25;tuberous sclerosis 1;MAD1 mitotic arrest deficient-like 1 (yeast);cortactin binding protein 2;nexilin (F actin binding protein);RAB11 family interacting protein 3 (class II) 465 59 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB53544.[MT7]-LEEEK[MT7].2y3_1.heavy 468.268 / 549.3 1428.0 22.811800003051758 26 8 10 6 2 0.7303547449188734 92.08787423457537 0.033199310302734375 15 0.7941606754623072 2.6720857323433487 1428.0 2.4795884315906562 20.0 - - - - - - - 1178.857142857143 5 7 LOC100286914;LOC100287654;LOC100288646;C9orf174;LOC100507200;COPB1;ANKRD23;CCDC19;SEPT14;KIF3C;NIN;CEP55;STOX2;RBM25;TSC1;MAD1L1;CTTNBP2;NEXN;RAB11FIP3 putative uncharacterized protein C20orf69-like;putative uncharacterized protein C20orf69-like;putative uncharacterized protein C20orf69-like;chromosome 9 open reading frame 174;putative uncharacterized protein C20orf69-like;coatomer protein complex, subunit beta 1;ankyrin repeat domain 23;coiled-coil domain containing 19;septin 14;kinesin family member 3C;ninein (GSK3B interacting protein);centrosomal protein 55kDa;storkhead box 2;RNA binding motif protein 25;tuberous sclerosis 1;MAD1 mitotic arrest deficient-like 1 (yeast);cortactin binding protein 2;nexilin (F actin binding protein);RAB11 family interacting protein 3 (class II) 467 60 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB540586.[MT7]-ELVPTLPQNRK[MT7].3y7_1.heavy 528.322 / 1000.6 9314.0 29.006049633026123 34 8 10 6 10 1.6221338066996103 45.088555214904275 0.03579902648925781 3 0.7743467843122276 2.547501169786869 9314.0 64.56245647058824 0.0 - - - - - - - 220.125 18 16 ID1 inhibitor of DNA binding 1, dominant negative helix-loop-helix protein 469 60 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB540586.[MT7]-ELVPTLPQNRK[MT7].3y8_1.heavy 528.322 / 1097.65 114.0 29.006049633026123 34 8 10 6 10 1.6221338066996103 45.088555214904275 0.03579902648925781 3 0.7743467843122276 2.547501169786869 114.0 -0.5 7.0 - - - - - - - 0.0 0 0 ID1 inhibitor of DNA binding 1, dominant negative helix-loop-helix protein 471 60 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB540586.[MT7]-ELVPTLPQNRK[MT7].3y8_2.heavy 528.322 / 549.331 124267.0 29.006049633026123 34 8 10 6 10 1.6221338066996103 45.088555214904275 0.03579902648925781 3 0.7743467843122276 2.547501169786869 124267.0 39.62385383364658 0.0 - - - - - - - 766.5 248 2 ID1 inhibitor of DNA binding 1, dominant negative helix-loop-helix protein 473 60 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB540586.[MT7]-ELVPTLPQNRK[MT7].3y5_1.heavy 528.322 / 786.47 55659.0 29.006049633026123 34 8 10 6 10 1.6221338066996103 45.088555214904275 0.03579902648925781 3 0.7743467843122276 2.547501169786869 55659.0 58.16294416315198 0.0 - - - - - - - 397.5 111 4 ID1 inhibitor of DNA binding 1, dominant negative helix-loop-helix protein 475 61 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54909.[MT7]-LRELMGELQR.2b3_1.heavy 694.894 / 543.337 3070.0 36.18360137939453 42 16 10 10 6 1.4041150156277888 45.361559245286855 0.0 6 0.9652890125592993 6.604874674055179 3070.0 1.1998045920859794 3.0 - - - - - - - 341.0 7 6 TRIM32 tripartite motif-containing 32 477 61 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54909.[MT7]-LRELMGELQR.2y6_1.heavy 694.894 / 733.366 2354.0 36.18360137939453 42 16 10 10 6 1.4041150156277888 45.361559245286855 0.0 6 0.9652890125592993 6.604874674055179 2354.0 8.922448340798045 1.0 - - - - - - - 706.3 4 10 TRIM32 tripartite motif-containing 32 479 61 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54909.[MT7]-LRELMGELQR.2b7_1.heavy 694.894 / 973.526 8494.0 36.18360137939453 42 16 10 10 6 1.4041150156277888 45.361559245286855 0.0 6 0.9652890125592993 6.604874674055179 8494.0 24.75315904329609 0.0 - - - - - - - 614.0 16 8 TRIM32 tripartite motif-containing 32 481 61 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54909.[MT7]-LRELMGELQR.2y7_1.heavy 694.894 / 846.45 2661.0 36.18360137939453 42 16 10 10 6 1.4041150156277888 45.361559245286855 0.0 6 0.9652890125592993 6.604874674055179 2661.0 3.7359397791728344 2.0 - - - - - - - 334.72727272727275 10 11 TRIM32 tripartite motif-containing 32 483 62 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB541303.[MT7]-LSESQLELNWNNR.3y6_1.heavy 582.968 / 816.411 17570.0 36.72570037841797 50 20 10 10 10 23.91850149125464 4.180863923961255 0.0 3 0.9978255380050067 26.461090078270594 17570.0 27.372504203250514 0.0 - - - - - - - 239.875 35 8 IL2RG interleukin 2 receptor, gamma 485 62 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB541303.[MT7]-LSESQLELNWNNR.3b5_1.heavy 582.968 / 689.359 27465.0 36.72570037841797 50 20 10 10 10 23.91850149125464 4.180863923961255 0.0 3 0.9978255380050067 26.461090078270594 27465.0 23.095587315697514 0.0 - - - - - - - 707.0 54 2 IL2RG interleukin 2 receptor, gamma 487 62 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB541303.[MT7]-LSESQLELNWNNR.3y4_1.heavy 582.968 / 589.284 18277.0 36.72570037841797 50 20 10 10 10 23.91850149125464 4.180863923961255 0.0 3 0.9978255380050067 26.461090078270594 18277.0 18.99713337932154 0.0 - - - - - - - 336.6666666666667 36 3 IL2RG interleukin 2 receptor, gamma 489 62 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB541303.[MT7]-LSESQLELNWNNR.3y5_1.heavy 582.968 / 703.327 25345.0 36.72570037841797 50 20 10 10 10 23.91850149125464 4.180863923961255 0.0 3 0.9978255380050067 26.461090078270594 25345.0 54.63185849834983 0.0 - - - - - - - 673.3333333333334 50 9 IL2RG interleukin 2 receptor, gamma 491 63 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB537173.[MT7]-VAVLSQNR.2y4_1.heavy 515.81 / 504.253 30282.0 25.68280029296875 46 16 10 10 10 3.2757320272937553 30.527527638643555 0.0 3 0.9612676328692262 6.250482121388533 30282.0 23.042317238087662 0.0 - - - - - - - 1721.857142857143 60 7 ACAT2 acetyl-CoA acetyltransferase 2 493 63 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB537173.[MT7]-VAVLSQNR.2y5_1.heavy 515.81 / 617.336 43526.0 25.68280029296875 46 16 10 10 10 3.2757320272937553 30.527527638643555 0.0 3 0.9612676328692262 6.250482121388533 43526.0 49.98983321566745 0.0 - - - - - - - 734.75 87 8 ACAT2 acetyl-CoA acetyltransferase 2 495 63 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB537173.[MT7]-VAVLSQNR.2y6_1.heavy 515.81 / 716.405 26190.0 25.68280029296875 46 16 10 10 10 3.2757320272937553 30.527527638643555 0.0 3 0.9612676328692262 6.250482121388533 26190.0 69.30845385199021 0.0 - - - - - - - 669.5714285714286 52 7 ACAT2 acetyl-CoA acetyltransferase 2 497 63 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB537173.[MT7]-VAVLSQNR.2y7_1.heavy 515.81 / 787.442 76858.0 25.68280029296875 46 16 10 10 10 3.2757320272937553 30.527527638643555 0.0 3 0.9612676328692262 6.250482121388533 76858.0 214.64133214287767 0.0 - - - - - - - 244.42857142857142 153 7 ACAT2 acetyl-CoA acetyltransferase 2 499 64 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 ODP2_ECOLI.EAAPAAAPAAAAAK.2y7.peptide 590.82 / 599.35 1226810.0 19.671300888061523 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 1226810.0 10342.554803012776 0.0 - - - - - - - 686.0 2453 7 501 64 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 ODP2_ECOLI.EAAPAAAPAAAAAK.2y9.peptide 590.82 / 741.43 683719.0 19.671300888061523 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 683719.0 5868.480609965454 0.0 - - - - - - - 314.75 1367 8 503 64 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 ODP2_ECOLI.EAAPAAAPAAAAAK.2y11.peptide 590.82 / 909.52 674394.0 19.671300888061523 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 674394.0 3769.098221905719 0.0 - - - - - - - 708.1428571428571 1348 7 505 65 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB55026.[MT7]-SMDPFPWQQK[MT7].2y4_1.heavy 776.397 / 733.411 1942.0 38.233076095581055 37 13 10 6 8 1.3888134923160391 59.96463521400342 0.03369903564453125 4 0.9069851547161476 4.014772987260585 1942.0 1.6152735030706507 7.0 - - - - - - - 355.6666666666667 3 9 LIMK2 LIM domain kinase 2 507 65 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB55026.[MT7]-SMDPFPWQQK[MT7].2y5_1.heavy 776.397 / 830.464 2621.0 38.233076095581055 37 13 10 6 8 1.3888134923160391 59.96463521400342 0.03369903564453125 4 0.9069851547161476 4.014772987260585 2621.0 1.2036324217787633 1.0 - - - - - - - 282.1818181818182 5 11 LIMK2 LIM domain kinase 2 509 65 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB55026.[MT7]-SMDPFPWQQK[MT7].2b5_1.heavy 776.397 / 722.33 2330.0 38.233076095581055 37 13 10 6 8 1.3888134923160391 59.96463521400342 0.03369903564453125 4 0.9069851547161476 4.014772987260585 2330.0 1.3705882352941177 2.0 - - - - - - - 669.8 4 10 LIMK2 LIM domain kinase 2 511 65 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB55026.[MT7]-SMDPFPWQQK[MT7].2y7_1.heavy 776.397 / 1074.59 5437.0 38.233076095581055 37 13 10 6 8 1.3888134923160391 59.96463521400342 0.03369903564453125 4 0.9069851547161476 4.014772987260585 5437.0 12.891855670103094 2.0 - - - - - - - 728.25 14 8 LIMK2 LIM domain kinase 2 513 66 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB538255.[MT7]-IDTPRPLVGR.3b3_1.heavy 423.258 / 474.268 57085.0 27.638099670410156 38 12 10 6 10 2.3046622144220694 43.390306559556535 0.03440093994140625 3 0.8975410747923946 3.822149505028457 57085.0 46.37000975601793 0.0 - - - - - - - 1781.75 114 8 MTOR mechanistic target of rapamycin (serine/threonine kinase) 515 66 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB538255.[MT7]-IDTPRPLVGR.3y8_2.heavy 423.258 / 448.277 181807.0 27.638099670410156 38 12 10 6 10 2.3046622144220694 43.390306559556535 0.03440093994140625 3 0.8975410747923946 3.822149505028457 181807.0 223.76730511767346 0.0 - - - - - - - 1742.5714285714287 363 7 MTOR mechanistic target of rapamycin (serine/threonine kinase) 517 66 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB538255.[MT7]-IDTPRPLVGR.3y9_2.heavy 423.258 / 505.791 78603.0 27.638099670410156 38 12 10 6 10 2.3046622144220694 43.390306559556535 0.03440093994140625 3 0.8975410747923946 3.822149505028457 78603.0 100.30625220063844 0.0 - - - - - - - 799.4444444444445 157 9 MTOR mechanistic target of rapamycin (serine/threonine kinase) 519 66 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB538255.[MT7]-IDTPRPLVGR.3y5_1.heavy 423.258 / 541.346 182150.0 27.638099670410156 38 12 10 6 10 2.3046622144220694 43.390306559556535 0.03440093994140625 3 0.8975410747923946 3.822149505028457 182150.0 207.41615129029935 0.0 - - - - - - - 839.375 364 8 MTOR mechanistic target of rapamycin (serine/threonine kinase) 521 67 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB55025.[MT7]-LEPESRPAFSK[MT7].3y3_1.heavy 516.959 / 525.315 10481.0 26.611000061035156 40 10 10 10 10 1.290791829950799 60.08152060587026 0.0 3 0.8336875724000314 2.983242432431566 10481.0 12.337434160133657 0.0 - - - - - - - 765.0 20 11 LIMK2 LIM domain kinase 2 523 67 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB55025.[MT7]-LEPESRPAFSK[MT7].3y4_1.heavy 516.959 / 596.352 6052.0 26.611000061035156 40 10 10 10 10 1.290791829950799 60.08152060587026 0.0 3 0.8336875724000314 2.983242432431566 6052.0 10.644364841986455 0.0 - - - - - - - 728.4 12 15 LIMK2 LIM domain kinase 2 525 67 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB55025.[MT7]-LEPESRPAFSK[MT7].3y9_2.heavy 516.959 / 581.82 39045.0 26.611000061035156 40 10 10 10 10 1.290791829950799 60.08152060587026 0.0 3 0.8336875724000314 2.983242432431566 39045.0 62.24292141610401 0.0 - - - - - - - 316.14285714285717 78 7 LIMK2 LIM domain kinase 2 527 67 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB55025.[MT7]-LEPESRPAFSK[MT7].3y5_1.heavy 516.959 / 693.405 17567.0 26.611000061035156 40 10 10 10 10 1.290791829950799 60.08152060587026 0.0 3 0.8336875724000314 2.983242432431566 17567.0 26.17406880575248 0.0 - - - - - - - 765.75 35 8 LIMK2 LIM domain kinase 2 529 68 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB53920.[MT7]-LEYTEHQGR.2y4_1.heavy 638.824 / 497.258 N/A N/A - - - - - - - - - 0.0 - - - - - - - ARNTL aryl hydrocarbon receptor nuclear translocator-like 531 68 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB53920.[MT7]-LEYTEHQGR.2y8_1.heavy 638.824 / 1019.45 N/A N/A - - - - - - - - - 0.0 - - - - - - - ARNTL aryl hydrocarbon receptor nuclear translocator-like 533 68 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB53920.[MT7]-LEYTEHQGR.2y6_1.heavy 638.824 / 727.348 N/A N/A - - - - - - - - - 0.0 - - - - - - - ARNTL aryl hydrocarbon receptor nuclear translocator-like 535 68 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB53920.[MT7]-LEYTEHQGR.2y7_1.heavy 638.824 / 890.411 N/A N/A - - - - - - - - - 0.0 - - - - - - - ARNTL aryl hydrocarbon receptor nuclear translocator-like 537 69 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB55165.[MT7]-TLLMYTVPAVQGFFR.2y8_1.heavy 944.02 / 921.494 N/A N/A - - - - - - - - - 0.0 - - - - - - - MTOR mechanistic target of rapamycin (serine/threonine kinase) 539 69 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB55165.[MT7]-TLLMYTVPAVQGFFR.2y9_1.heavy 944.02 / 1020.56 N/A N/A - - - - - - - - - 0.0 - - - - - - - MTOR mechanistic target of rapamycin (serine/threonine kinase) 541 69 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB55165.[MT7]-TLLMYTVPAVQGFFR.2b4_1.heavy 944.02 / 603.366 N/A N/A - - - - - - - - - 0.0 - - - - - - - MTOR mechanistic target of rapamycin (serine/threonine kinase) 543 69 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB55165.[MT7]-TLLMYTVPAVQGFFR.2y10_1.heavy 944.02 / 1121.61 N/A N/A - - - - - - - - - 0.0 - - - - - - - MTOR mechanistic target of rapamycin (serine/threonine kinase) 545 70 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB55167.[MT7]-TLLMYTVPAVQGFFR.3y7_1.heavy 629.682 / 824.441 4192.0 51.63362503051758 37 11 10 6 10 1.3967197615303084 58.35496529371884 0.0399017333984375 3 0.8541971089384572 3.1919458488872627 4192.0 78.21583985151796 0.0 - - - - - - - 170.08333333333334 8 12 MTOR mechanistic target of rapamycin (serine/threonine kinase) 547 70 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB55167.[MT7]-TLLMYTVPAVQGFFR.3y6_1.heavy 629.682 / 753.404 2436.0 51.63362503051758 37 11 10 6 10 1.3967197615303084 58.35496529371884 0.0399017333984375 3 0.8541971089384572 3.1919458488872627 2436.0 21.3055552047701 1.0 - - - - - - - 151.11111111111111 5 9 MTOR mechanistic target of rapamycin (serine/threonine kinase) 549 70 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB55167.[MT7]-TLLMYTVPAVQGFFR.3b4_1.heavy 629.682 / 603.366 8044.0 51.63362503051758 37 11 10 6 10 1.3967197615303084 58.35496529371884 0.0399017333984375 3 0.8541971089384572 3.1919458488872627 8044.0 35.49507090926258 0.0 - - - - - - - 226.64285714285714 16 14 MTOR mechanistic target of rapamycin (serine/threonine kinase) 551 70 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB55167.[MT7]-TLLMYTVPAVQGFFR.3y8_1.heavy 629.682 / 921.494 18071.0 51.63362503051758 37 11 10 6 10 1.3967197615303084 58.35496529371884 0.0399017333984375 3 0.8541971089384572 3.1919458488872627 18071.0 62.85301169064724 1.0 - - - - - - - 248.30769230769232 36 13 MTOR mechanistic target of rapamycin (serine/threonine kinase) 553 71 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB538640.[MT7]-AWMAGTLQLGR.2y8_1.heavy 674.37 / 815.473 24303.0 38.79122352600098 34 20 0 6 8 16.78695227829325 5.957007462832147 0.03749847412109375 4 0.9943863363024404 16.46401675395488 24303.0 54.629509225783494 0.0 - - - - - - - 652.0909090909091 48 11 HYAL1 hyaluronoglucosaminidase 1 555 71 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB538640.[MT7]-AWMAGTLQLGR.2y9_1.heavy 674.37 / 946.514 25063.0 38.79122352600098 34 20 0 6 8 16.78695227829325 5.957007462832147 0.03749847412109375 4 0.9943863363024404 16.46401675395488 25063.0 47.882027373232475 0.0 - - - - - - - 562.4166666666666 50 12 HYAL1 hyaluronoglucosaminidase 1 557 71 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB538640.[MT7]-AWMAGTLQLGR.2y10_1.heavy 674.37 / 1132.59 25232.0 38.79122352600098 34 20 0 6 8 16.78695227829325 5.957007462832147 0.03749847412109375 4 0.9943863363024404 16.46401675395488 25232.0 38.63712758405576 1.0 - - - - - - - 309.55555555555554 197 9 HYAL1 hyaluronoglucosaminidase 1 559 71 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB538640.[MT7]-AWMAGTLQLGR.2y7_1.heavy 674.37 / 744.436 21687.0 38.79122352600098 34 20 0 6 8 16.78695227829325 5.957007462832147 0.03749847412109375 4 0.9943863363024404 16.46401675395488 21687.0 25.96739352294332 0.0 - - - - - - - 733.4615384615385 43 13 HYAL1 hyaluronoglucosaminidase 1 561 72 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 OPPA_ECOLI.LAIAASSLWK.2y7.peptide 530.31 / 762.41 669104.0 38.38290023803711 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 669104.0 1086.8383549393534 0.0 - - - - - - - 192.75 1338 8 563 72 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 OPPA_ECOLI.LAIAASSLWK.2y8.peptide 530.31 / 875.5 338864.0 38.38290023803711 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 338864.0 643.0759302617508 0.0 - - - - - - - 171.16666666666666 677 6 565 72 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 OPPA_ECOLI.LAIAASSLWK.2y6.peptide 530.31 / 691.38 496733.0 38.38290023803711 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 496733.0 230.93553016449977 0.0 - - - - - - - 222.6 993 5 567 73 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB53456.[MT7]-GIVTDGR.2y5_1.heavy 431.249 / 547.284 N/A N/A - - - - - - - - - 0.0 - - - - - - - AGRN agrin 569 73 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB53456.[MT7]-GIVTDGR.2y3_2.heavy 431.249 / 174.087 N/A N/A - - - - - - - - - 0.0 - - - - - - - AGRN agrin 571 73 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB53456.[MT7]-GIVTDGR.2y6_1.heavy 431.249 / 660.367 N/A N/A - - - - - - - - - 0.0 - - - - - - - AGRN agrin 573 73 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB53456.[MT7]-GIVTDGR.2b5_1.heavy 431.249 / 630.358 N/A N/A - - - - - - - - - 0.0 - - - - - - - AGRN agrin 575 74 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB537124.[MT7]-LFWEK[MT7].2b3_1.heavy 505.799 / 591.341 6057.0 37.757198333740234 50 20 10 10 10 7.637040967625609 13.094076674973037 0.0 3 0.9972615753186617 23.57831757317165 6057.0 17.19332866592632 0.0 - - - - - - - 705.1 12 10 LIMK2 LIM domain kinase 2 577 74 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB537124.[MT7]-LFWEK[MT7].2y4_1.heavy 505.799 / 753.405 38326.0 37.757198333740234 50 20 10 10 10 7.637040967625609 13.094076674973037 0.0 3 0.9972615753186617 23.57831757317165 38326.0 56.35105780765245 0.0 - - - - - - - 783.2222222222222 76 9 LIMK2 LIM domain kinase 2 579 74 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB537124.[MT7]-LFWEK[MT7].2b4_1.heavy 505.799 / 720.384 3872.0 37.757198333740234 50 20 10 10 10 7.637040967625609 13.094076674973037 0.0 3 0.9972615753186617 23.57831757317165 3872.0 0.1169466633747093 2.0 - - - - - - - 397.0 26 6 LIMK2 LIM domain kinase 2 581 74 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB537124.[MT7]-LFWEK[MT7].2y3_1.heavy 505.799 / 606.337 26213.0 37.757198333740234 50 20 10 10 10 7.637040967625609 13.094076674973037 0.0 3 0.9972615753186617 23.57831757317165 26213.0 41.186039651638026 0.0 - - - - - - - 868.75 52 8 LIMK2 LIM domain kinase 2 583 75 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB55183.[MT7]-GMFEVLEPLHAMMER.3b4_1.heavy 645.32 / 609.282 5595.0 48.08074951171875 38 12 10 6 10 1.0733712524394778 57.876744865565485 0.036102294921875 3 0.8815806107547359 3.550332408208554 5595.0 13.193812264200147 0.0 - - - - - - - 256.46666666666664 11 15 MTOR mechanistic target of rapamycin (serine/threonine kinase) 585 75 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB55183.[MT7]-GMFEVLEPLHAMMER.3b5_1.heavy 645.32 / 708.351 6556.0 48.08074951171875 38 12 10 6 10 1.0733712524394778 57.876744865565485 0.036102294921875 3 0.8815806107547359 3.550332408208554 6556.0 26.688141592920353 0.0 - - - - - - - 169.8125 13 16 MTOR mechanistic target of rapamycin (serine/threonine kinase) 587 75 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB55183.[MT7]-GMFEVLEPLHAMMER.3y8_1.heavy 645.32 / 984.475 4465.0 48.08074951171875 38 12 10 6 10 1.0733712524394778 57.876744865565485 0.036102294921875 3 0.8815806107547359 3.550332408208554 4465.0 24.688823529411764 1.0 - - - - - - - 207.55555555555554 8 18 MTOR mechanistic target of rapamycin (serine/threonine kinase) 589 75 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB55183.[MT7]-GMFEVLEPLHAMMER.3y5_1.heavy 645.32 / 637.28 4521.0 48.08074951171875 38 12 10 6 10 1.0733712524394778 57.876744865565485 0.036102294921875 3 0.8815806107547359 3.550332408208554 4521.0 17.662452926960725 0.0 - - - - - - - 254.5 9 16 MTOR mechanistic target of rapamycin (serine/threonine kinase) 591 76 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB537125.[MT7]-FFTGSLAEVEK[MT7].3y3_1.heavy 505.948 / 519.326 228687.0 38.112823486328125 46 20 10 6 10 7.563391009214073 13.221582736919904 0.0345001220703125 3 0.9934150712200245 15.200162257073634 228687.0 55.87311175945885 0.0 - - - - - - - 188.0 457 1 TRIM32 tripartite motif-containing 32 593 76 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB537125.[MT7]-FFTGSLAEVEK[MT7].3b4_1.heavy 505.948 / 597.315 77232.0 38.112823486328125 46 20 10 6 10 7.563391009214073 13.221582736919904 0.0345001220703125 3 0.9934150712200245 15.200162257073634 77232.0 70.26782437210669 0.0 - - - - - - - 300.8 154 5 TRIM32 tripartite motif-containing 32 595 76 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB537125.[MT7]-FFTGSLAEVEK[MT7].3b5_1.heavy 505.948 / 684.347 209872.0 38.112823486328125 46 20 10 6 10 7.563391009214073 13.221582736919904 0.0345001220703125 3 0.9934150712200245 15.200162257073634 209872.0 127.57286957047953 0.0 - - - - - - - 344.6666666666667 419 6 TRIM32 tripartite motif-containing 32 597 76 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB537125.[MT7]-FFTGSLAEVEK[MT7].3y4_1.heavy 505.948 / 648.369 143835.0 38.112823486328125 46 20 10 6 10 7.563391009214073 13.221582736919904 0.0345001220703125 3 0.9934150712200245 15.200162257073634 143835.0 91.52838760526339 0.0 - - - - - - - 338.4 287 5 TRIM32 tripartite motif-containing 32 599 77 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB53459.[MT7]-TIVDK[MT7].2b3_1.heavy 432.276 / 458.31 7533.0 23.547000885009766 43 13 10 10 10 1.8121702189562428 55.18245413921275 0.0 3 0.9241550050634983 4.452613496930694 7533.0 8.340836236933796 0.0 - - - - - - - 1120.875 15 8 RAPGEF1 Rap guanine nucleotide exchange factor (GEF) 1 601 77 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB53459.[MT7]-TIVDK[MT7].2y4_1.heavy 432.276 / 618.394 7676.0 23.547000885009766 43 13 10 10 10 1.8121702189562428 55.18245413921275 0.0 3 0.9241550050634983 4.452613496930694 7676.0 6.623981182353521 0.0 - - - - - - - 807.125 15 8 RAPGEF1 Rap guanine nucleotide exchange factor (GEF) 1 603 77 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB53459.[MT7]-TIVDK[MT7].2b4_1.heavy 432.276 / 573.336 2870.0 23.547000885009766 43 13 10 10 10 1.8121702189562428 55.18245413921275 0.0 3 0.9241550050634983 4.452613496930694 2870.0 1.8850352202541982 13.0 - - - - - - - 1701.4285714285713 19 7 RAPGEF1 Rap guanine nucleotide exchange factor (GEF) 1 605 77 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB53459.[MT7]-TIVDK[MT7].2y3_1.heavy 432.276 / 505.31 291195.0 23.547000885009766 43 13 10 10 10 1.8121702189562428 55.18245413921275 0.0 3 0.9241550050634983 4.452613496930694 291195.0 198.63221177408576 0.0 - - - - - - - 861.0 582 1 RAPGEF1 Rap guanine nucleotide exchange factor (GEF) 1 607 78 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB540539.[MT7]-MFVDLNPDSDK[MT7].3b4_1.heavy 523.6 / 637.314 70819.0 36.33634948730469 45 20 10 5 10 2.951901426353655 25.866139709718517 0.04489898681640625 3 0.990455601134765 12.622403240565408 70819.0 85.85045284633247 0.0 - - - - - - - 102.0 141 1 GNA11;GNAQ guanine nucleotide binding protein (G protein), alpha 11 (Gq class);guanine nucleotide binding protein (G protein), q polypeptide 609 78 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB540539.[MT7]-MFVDLNPDSDK[MT7].3b3_1.heavy 523.6 / 522.287 16170.0 36.33634948730469 45 20 10 5 10 2.951901426353655 25.866139709718517 0.04489898681640625 3 0.990455601134765 12.622403240565408 16170.0 16.813630111091378 0.0 - - - - - - - 742.125 32 8 GNA11;GNAQ guanine nucleotide binding protein (G protein), alpha 11 (Gq class);guanine nucleotide binding protein (G protein), q polypeptide 611 78 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB540539.[MT7]-MFVDLNPDSDK[MT7].3y4_1.heavy 523.6 / 608.301 17398.0 36.33634948730469 45 20 10 5 10 2.951901426353655 25.866139709718517 0.04489898681640625 3 0.990455601134765 12.622403240565408 17398.0 38.900302183849675 0.0 - - - - - - - 805.875 34 8 GNA11;GNAQ guanine nucleotide binding protein (G protein), alpha 11 (Gq class);guanine nucleotide binding protein (G protein), q polypeptide 613 78 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB540539.[MT7]-MFVDLNPDSDK[MT7].3y5_1.heavy 523.6 / 705.354 30395.0 36.33634948730469 45 20 10 5 10 2.951901426353655 25.866139709718517 0.04489898681640625 3 0.990455601134765 12.622403240565408 30395.0 46.005027144408245 0.0 - - - - - - - 219.14285714285714 60 7 GNA11;GNAQ guanine nucleotide binding protein (G protein), alpha 11 (Gq class);guanine nucleotide binding protein (G protein), q polypeptide 615 79 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB53654.[MT7]-C[CAM]TQEEAR.2y5_1.heavy 519.244 / 632.3 N/A N/A - - - - - - - - - 0.0 - - - - - - - PPA2 pyrophosphatase (inorganic) 2 617 79 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB53654.[MT7]-C[CAM]TQEEAR.2b4_1.heavy 519.244 / 663.289 N/A N/A - - - - - - - - - 0.0 - - - - - - - PPA2 pyrophosphatase (inorganic) 2 619 79 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB53654.[MT7]-C[CAM]TQEEAR.2y6_1.heavy 519.244 / 733.347 N/A N/A - - - - - - - - - 0.0 - - - - - - - PPA2 pyrophosphatase (inorganic) 2 621 79 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB53654.[MT7]-C[CAM]TQEEAR.2b5_1.heavy 519.244 / 792.331 N/A N/A - - - - - - - - - 0.0 - - - - - - - PPA2 pyrophosphatase (inorganic) 2 623 80 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB537424.[MT7]-LTEIIPK[MT7].2b4_1.heavy 551.36 / 601.368 25450.0 34.35540008544922 48 18 10 10 10 3.4504509758459907 28.981718824589805 0.0 3 0.980078443084041 8.729253355202303 25450.0 51.85339513122106 0.0 - - - - - - - 775.7 50 10 ITGB2 integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) 625 80 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB537424.[MT7]-LTEIIPK[MT7].2y3_1.heavy 551.36 / 501.352 19175.0 34.35540008544922 48 18 10 10 10 3.4504509758459907 28.981718824589805 0.0 3 0.980078443084041 8.729253355202303 19175.0 26.253942652329748 0.0 - - - - - - - 1315.3636363636363 38 11 ITGB2 integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) 627 80 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB537424.[MT7]-LTEIIPK[MT7].2y6_1.heavy 551.36 / 844.526 9500.0 34.35540008544922 48 18 10 10 10 3.4504509758459907 28.981718824589805 0.0 3 0.980078443084041 8.729253355202303 9500.0 41.15982432242003 0.0 - - - - - - - 217.9 19 10 ITGB2 integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) 629 80 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB537424.[MT7]-LTEIIPK[MT7].2b5_1.heavy 551.36 / 714.452 13858.0 34.35540008544922 48 18 10 10 10 3.4504509758459907 28.981718824589805 0.0 3 0.980078443084041 8.729253355202303 13858.0 30.600158833606432 0.0 - - - - - - - 722.1428571428571 27 7 ITGB2 integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) 631 81 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB53979.[MT7]-SVPWVPILK[MT7].2y3_1.heavy 663.923 / 517.383 N/A N/A - - - - - - - - - 0.0 - - - - - - - SLC17A5 solute carrier family 17 (anion/sugar transporter), member 5 633 81 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB53979.[MT7]-SVPWVPILK[MT7].2y7_1.heavy 663.923 / 996.636 N/A N/A - - - - - - - - - 0.0 - - - - - - - SLC17A5 solute carrier family 17 (anion/sugar transporter), member 5 635 82 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB53759.[MT7]-EPMNPIK[MT7].2y4_1.heavy 558.82 / 615.395 13981.0 31.534000873565674 28 2 10 6 10 0.5355142540693171 93.85913208441049 0.03240013122558594 3 0.4013567781902033 1.5074549224747156 13981.0 15.890667811338478 0.0 - - - - - - - 740.1 27 10 PPA2 pyrophosphatase (inorganic) 2 637 82 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB53759.[MT7]-EPMNPIK[MT7].2b4_1.heavy 558.82 / 616.288 7566.0 31.534000873565674 28 2 10 6 10 0.5355142540693171 93.85913208441049 0.03240013122558594 3 0.4013567781902033 1.5074549224747156 7566.0 12.69975271484931 0.0 - - - - - - - 736.2857142857143 15 7 PPA2 pyrophosphatase (inorganic) 2 639 82 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB53759.[MT7]-EPMNPIK[MT7].2y3_1.heavy 558.82 / 501.352 1864.0 31.534000873565674 28 2 10 6 10 0.5355142540693171 93.85913208441049 0.03240013122558594 3 0.4013567781902033 1.5074549224747156 1864.0 0.19999999999999996 30.0 - - - - - - - 950.3333333333334 15 6 PPA2 pyrophosphatase (inorganic) 2 641 82 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB53759.[MT7]-EPMNPIK[MT7].2y6_1.heavy 558.82 / 843.488 4715.0 31.534000873565674 28 2 10 6 10 0.5355142540693171 93.85913208441049 0.03240013122558594 3 0.4013567781902033 1.5074549224747156 4715.0 6.900567895235806 1.0 - - - - - - - 383.6666666666667 9 6 PPA2 pyrophosphatase (inorganic) 2 643 83 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB55078.[MT7]-DLTSFAAEAIAMNR.3y6_1.heavy 551.951 / 675.361 9084.0 43.46200180053711 44 14 10 10 10 1.5403898696551963 45.82648050168936 0.0 3 0.9483040488996016 5.404371274945468 9084.0 29.29835014712064 0.0 - - - - - - - 258.0833333333333 18 12 MKNK2 MAP kinase interacting serine/threonine kinase 2 645 83 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB55078.[MT7]-DLTSFAAEAIAMNR.3b6_1.heavy 551.951 / 779.406 7642.0 43.46200180053711 44 14 10 10 10 1.5403898696551963 45.82648050168936 0.0 3 0.9483040488996016 5.404371274945468 7642.0 78.54277777777777 0.0 - - - - - - - 170.1818181818182 15 11 MKNK2 MAP kinase interacting serine/threonine kinase 2 647 83 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB55078.[MT7]-DLTSFAAEAIAMNR.3b4_1.heavy 551.951 / 561.3 6344.0 43.46200180053711 44 14 10 10 10 1.5403898696551963 45.82648050168936 0.0 3 0.9483040488996016 5.404371274945468 6344.0 21.707294350842417 0.0 - - - - - - - 283.0 12 14 MKNK2 MAP kinase interacting serine/threonine kinase 2 649 83 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB55078.[MT7]-DLTSFAAEAIAMNR.3y5_1.heavy 551.951 / 604.323 12328.0 43.46200180053711 44 14 10 10 10 1.5403898696551963 45.82648050168936 0.0 3 0.9483040488996016 5.404371274945468 12328.0 38.35469590597987 0.0 - - - - - - - 268.93333333333334 24 15 MKNK2 MAP kinase interacting serine/threonine kinase 2 651 84 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB542080.[MT7]-YHPQALIYPLTVASK[MT7].4b7_1.heavy 498.041 / 967.548 11067.0 37.846099853515625 42 12 10 10 10 2.185068599037545 45.765153571858974 0.0 3 0.8822868995110431 3.561186765635922 11067.0 246.2096629213483 0.0 - - - - - - - 152.0 22 7 MTOR mechanistic target of rapamycin (serine/threonine kinase) 653 84 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB542080.[MT7]-YHPQALIYPLTVASK[MT7].4b5_1.heavy 498.041 / 741.38 5047.0 37.846099853515625 42 12 10 10 10 2.185068599037545 45.765153571858974 0.0 3 0.8822868995110431 3.561186765635922 5047.0 3.923881091878485 1.0 - - - - - - - 265.9230769230769 13 13 MTOR mechanistic target of rapamycin (serine/threonine kinase) 655 84 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB542080.[MT7]-YHPQALIYPLTVASK[MT7].4y3_1.heavy 498.041 / 449.284 78003.0 37.846099853515625 42 12 10 10 10 2.185068599037545 45.765153571858974 0.0 3 0.8822868995110431 3.561186765635922 78003.0 54.59391683778234 0.0 - - - - - - - 443.0 156 1 MTOR mechanistic target of rapamycin (serine/threonine kinase) 657 84 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB542080.[MT7]-YHPQALIYPLTVASK[MT7].4b6_1.heavy 498.041 / 854.464 9297.0 37.846099853515625 42 12 10 10 10 2.185068599037545 45.765153571858974 0.0 3 0.8822868995110431 3.561186765635922 9297.0 74.32347457627118 0.0 - - - - - - - 212.7 18 10 MTOR mechanistic target of rapamycin (serine/threonine kinase) 659 85 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB542780.[MT7]-ALVQAQHPDWPAPQVEAVAQDQFQGAAR.4y10_1.heavy 793.907 / 1091.52 N/A N/A - - - - - - - - - 0.0 - - - - - - - HYAL1 hyaluronoglucosaminidase 1 661 85 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB542780.[MT7]-ALVQAQHPDWPAPQVEAVAQDQFQGAAR.4b12_2.heavy 793.907 / 729.884 N/A N/A - - - - - - - - - 0.0 - - - - - - - HYAL1 hyaluronoglucosaminidase 1 663 85 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB542780.[MT7]-ALVQAQHPDWPAPQVEAVAQDQFQGAAR.4y7_1.heavy 793.907 / 777.4 N/A N/A - - - - - - - - - 0.0 - - - - - - - HYAL1 hyaluronoglucosaminidase 1 665 85 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB542780.[MT7]-ALVQAQHPDWPAPQVEAVAQDQFQGAAR.4b6_1.heavy 793.907 / 755.453 N/A N/A - - - - - - - - - 0.0 - - - - - - - HYAL1 hyaluronoglucosaminidase 1 667 86 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB53754.[MT7]-FEEFLQR.2b3_1.heavy 556.796 / 550.263 N/A N/A - - - - - - - - - 0.0 - - - - - - - OGDH oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide) 669 86 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB53754.[MT7]-FEEFLQR.2y5_1.heavy 556.796 / 692.373 N/A N/A - - - - - - - - - 0.0 - - - - - - - OGDH oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide) 671 86 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB53754.[MT7]-FEEFLQR.2b4_1.heavy 556.796 / 697.331 N/A N/A - - - - - - - - - 0.0 - - - - - - - OGDH oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide) 673 86 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB53754.[MT7]-FEEFLQR.2y6_1.heavy 556.796 / 821.415 N/A N/A - - - - - - - - - 0.0 - - - - - - - OGDH oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide) 675 87 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB53460.[MT7]-ALLMK[MT7].2b3_1.heavy 432.285 / 442.315 N/A N/A - - - - - - - - - 0.0 - - - - - - - PPA2;MCC pyrophosphatase (inorganic) 2;mutated in colorectal cancers 677 87 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB53460.[MT7]-ALLMK[MT7].2y4_1.heavy 432.285 / 648.424 N/A N/A - - - - - - - - - 0.0 - - - - - - - PPA2;MCC pyrophosphatase (inorganic) 2;mutated in colorectal cancers 679 87 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB53460.[MT7]-ALLMK[MT7].2y3_1.heavy 432.285 / 535.339 N/A N/A - - - - - - - - - 0.0 - - - - - - - PPA2;MCC pyrophosphatase (inorganic) 2;mutated in colorectal cancers 681 88 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB55091.[MT7]-LLDTAFDLDVFK[MT7].3y3_1.heavy 562.318 / 537.352 5312.0 49.18029975891113 39 13 10 6 10 1.1477146406098488 51.25657756687501 0.034000396728515625 3 0.9127930363498541 4.1483840256381885 5312.0 22.80062116312449 0.0 - - - - - - - 189.61904761904762 10 21 OGDH oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide) 683 88 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB55091.[MT7]-LLDTAFDLDVFK[MT7].3b4_1.heavy 562.318 / 587.352 2136.0 49.18029975891113 39 13 10 6 10 1.1477146406098488 51.25657756687501 0.034000396728515625 3 0.9127930363498541 4.1483840256381885 2136.0 23.18120835686053 0.0 - - - - - - - 204.23076923076923 4 13 OGDH oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide) 685 88 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB55091.[MT7]-LLDTAFDLDVFK[MT7].3b5_1.heavy 562.318 / 658.389 5543.0 49.18029975891113 39 13 10 6 10 1.1477146406098488 51.25657756687501 0.034000396728515625 3 0.9127930363498541 4.1483840256381885 5543.0 26.90954608749662 0.0 - - - - - - - 166.0 11 16 OGDH oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide) 687 88 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB55091.[MT7]-LLDTAFDLDVFK[MT7].3b7_1.heavy 562.318 / 920.485 2656.0 49.18029975891113 39 13 10 6 10 1.1477146406098488 51.25657756687501 0.034000396728515625 3 0.9127930363498541 4.1483840256381885 2656.0 64.9903688155922 0.0 - - - - - - - 134.66666666666666 5 9 OGDH oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide) 689 89 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB538652.[MT7]-ILAIHGLISK[MT7].3y3_1.heavy 451.634 / 491.331 39538.0 36.270198822021484 39 17 4 10 8 2.775676642251921 30.715836862547423 0.0 4 0.9754661253752607 7.8629835575746885 39538.0 85.8414103429605 0.0 - - - - - - - 701.1 79 10 CXCR2 chemokine (C-X-C motif) receptor 2 691 89 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB538652.[MT7]-ILAIHGLISK[MT7].3b4_1.heavy 451.634 / 555.399 29171.0 36.270198822021484 39 17 4 10 8 2.775676642251921 30.715836862547423 0.0 4 0.9754661253752607 7.8629835575746885 29171.0 58.1825956284153 0.0 - - - - - - - 621.1111111111111 58 9 CXCR2 chemokine (C-X-C motif) receptor 2 693 89 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB538652.[MT7]-ILAIHGLISK[MT7].3b3_1.heavy 451.634 / 442.315 56004.0 36.270198822021484 39 17 4 10 8 2.775676642251921 30.715836862547423 0.0 4 0.9754661253752607 7.8629835575746885 56004.0 39.837725854236616 1.0 - - - - - - - 881.0 209 3 CXCR2 chemokine (C-X-C motif) receptor 2 695 89 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB538652.[MT7]-ILAIHGLISK[MT7].3y5_1.heavy 451.634 / 661.437 29781.0 36.270198822021484 39 17 4 10 8 2.775676642251921 30.715836862547423 0.0 4 0.9754661253752607 7.8629835575746885 29781.0 50.251517119296906 0.0 - - - - - - - 609.75 59 8 CXCR2 chemokine (C-X-C motif) receptor 2 697 90 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB536947.[MT7]-GPQTLK[MT7].2y4_1.heavy 466.294 / 633.405 1699.0 20.630799293518066 44 20 10 6 8 5.337223505822754 18.73633358072843 0.03380012512207031 4 0.9910514300422625 13.036504495995302 1699.0 0.6460076045627376 1.0 - - - - - - - 702.75 3 8 MTOR mechanistic target of rapamycin (serine/threonine kinase) 699 90 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB536947.[MT7]-GPQTLK[MT7].2y5_1.heavy 466.294 / 730.458 8737.0 20.630799293518066 44 20 10 6 8 5.337223505822754 18.73633358072843 0.03380012512207031 4 0.9910514300422625 13.036504495995302 8737.0 21.380754324513106 0.0 - - - - - - - 326.6923076923077 17 13 MTOR mechanistic target of rapamycin (serine/threonine kinase) 701 90 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB536947.[MT7]-GPQTLK[MT7].2b4_1.heavy 466.294 / 528.29 2023.0 20.630799293518066 44 20 10 6 8 5.337223505822754 18.73633358072843 0.03380012512207031 4 0.9910514300422625 13.036504495995302 2023.0 2.260919881305638 2.0 - - - - - - - 1236.7142857142858 12 7 MTOR mechanistic target of rapamycin (serine/threonine kinase) 703 90 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB536947.[MT7]-GPQTLK[MT7].2y3_1.heavy 466.294 / 505.347 5825.0 20.630799293518066 44 20 10 6 8 5.337223505822754 18.73633358072843 0.03380012512207031 4 0.9910514300422625 13.036504495995302 5825.0 2.7870813397129184 0.0 - - - - - - - 740.0588235294117 11 17 MTOR mechanistic target of rapamycin (serine/threonine kinase) 705 91 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB55093.[MT7]-LVTNLSGQLSELK[MT7].2y4_1.heavy 845.503 / 620.374 8173.0 39.47949981689453 44 14 10 10 10 2.577724737704799 38.793901667343974 0.0 3 0.938536359669823 4.952258292936588 8173.0 14.59195000465506 0.0 - - - - - - - 311.3157894736842 16 19 ITPR1 inositol 1,4,5-triphosphate receptor, type 1 707 91 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB55093.[MT7]-LVTNLSGQLSELK[MT7].2y5_1.heavy 845.503 / 733.458 2024.0 39.47949981689453 44 14 10 10 10 2.577724737704799 38.793901667343974 0.0 3 0.938536359669823 4.952258292936588 2024.0 7.032448696540479 0.0 - - - - - - - 272.625 4 16 ITPR1 inositol 1,4,5-triphosphate receptor, type 1 709 91 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB55093.[MT7]-LVTNLSGQLSELK[MT7].2b4_1.heavy 845.503 / 572.352 8173.0 39.47949981689453 44 14 10 10 10 2.577724737704799 38.793901667343974 0.0 3 0.938536359669823 4.952258292936588 8173.0 13.051433456758096 0.0 - - - - - - - 642.25 16 8 ITPR1 inositol 1,4,5-triphosphate receptor, type 1 711 91 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB55093.[MT7]-LVTNLSGQLSELK[MT7].2y7_1.heavy 845.503 / 918.538 6072.0 39.47949981689453 44 14 10 10 10 2.577724737704799 38.793901667343974 0.0 3 0.938536359669823 4.952258292936588 6072.0 21.95190884623696 0.0 - - - - - - - 257.0 12 20 ITPR1 inositol 1,4,5-triphosphate receptor, type 1 713 92 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB536699.[MT7]-NLSIQR.2b3_1.heavy 437.765 / 459.268 10709.0 23.289000511169434 34 20 2 6 6 10.873252991246071 9.19687972684061 0.034801483154296875 5 0.997573974118264 25.05110083019846 10709.0 9.450387876659807 1.0 - - - - - - - 1771.6 87 10 MTOR mechanistic target of rapamycin (serine/threonine kinase) 715 92 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB536699.[MT7]-NLSIQR.2y4_1.heavy 437.765 / 503.294 15139.0 23.289000511169434 34 20 2 6 6 10.873252991246071 9.19687972684061 0.034801483154296875 5 0.997573974118264 25.05110083019846 15139.0 25.61949734213778 3.0 - - - - - - - 561.0 114 1 MTOR mechanistic target of rapamycin (serine/threonine kinase) 717 92 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB536699.[MT7]-NLSIQR.2y5_1.heavy 437.765 / 616.378 19961.0 23.289000511169434 34 20 2 6 6 10.873252991246071 9.19687972684061 0.034801483154296875 5 0.997573974118264 25.05110083019846 19961.0 9.359898063200816 0.0 - - - - - - - 1224.0833333333333 39 12 MTOR mechanistic target of rapamycin (serine/threonine kinase) 719 92 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB536699.[MT7]-NLSIQR.2b4_1.heavy 437.765 / 572.352 5663.0 23.289000511169434 34 20 2 6 6 10.873252991246071 9.19687972684061 0.034801483154296875 5 0.997573974118264 25.05110083019846 5663.0 6.160321538964655 2.0 - - - - - - - 1219.5 19 8 MTOR mechanistic target of rapamycin (serine/threonine kinase) 721 93 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54230.[MT7]-VLEAILPLVQNDPR.2y8_1.heavy 861.008 / 938.505 N/A N/A - - - - - - - - - 0.0 - - - - - - - RAPGEF1 Rap guanine nucleotide exchange factor (GEF) 1 723 93 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54230.[MT7]-VLEAILPLVQNDPR.2b4_1.heavy 861.008 / 557.341 N/A N/A - - - - - - - - - 0.0 - - - - - - - RAPGEF1 Rap guanine nucleotide exchange factor (GEF) 1 725 93 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54230.[MT7]-VLEAILPLVQNDPR.2y10_1.heavy 861.008 / 1164.67 N/A N/A - - - - - - - - - 0.0 - - - - - - - RAPGEF1 Rap guanine nucleotide exchange factor (GEF) 1 727 93 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54230.[MT7]-VLEAILPLVQNDPR.2b5_1.heavy 861.008 / 670.426 N/A N/A - - - - - - - - - 0.0 - - - - - - - RAPGEF1 Rap guanine nucleotide exchange factor (GEF) 1 729 94 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB539105.[MT7]-YVANIFPYK[MT7].3y3_1.heavy 468.271 / 551.331 206653.0 38.70685005187988 42 16 10 6 10 3.0515679327142706 24.86204806938388 0.037502288818359375 3 0.9620449096443289 6.314573966580269 206653.0 109.43266803427909 0.0 - - - - - - - 1448.0 413 2 PPA2 pyrophosphatase (inorganic) 2 731 94 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB539105.[MT7]-YVANIFPYK[MT7].3b4_1.heavy 468.271 / 592.321 160758.0 38.70685005187988 42 16 10 6 10 3.0515679327142706 24.86204806938388 0.037502288818359375 3 0.9620449096443289 6.314573966580269 160758.0 412.06377705025375 0.0 - - - - - - - 369.1666666666667 321 6 PPA2 pyrophosphatase (inorganic) 2 733 94 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB539105.[MT7]-YVANIFPYK[MT7].3b5_1.heavy 468.271 / 705.405 56964.0 38.70685005187988 42 16 10 6 10 3.0515679327142706 24.86204806938388 0.037502288818359375 3 0.9620449096443289 6.314573966580269 56964.0 212.68515703915122 0.0 - - - - - - - 289.4 113 10 PPA2 pyrophosphatase (inorganic) 2 735 94 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB539105.[MT7]-YVANIFPYK[MT7].3b3_1.heavy 468.271 / 478.278 55261.0 38.70685005187988 42 16 10 6 10 3.0515679327142706 24.86204806938388 0.037502288818359375 3 0.9620449096443289 6.314573966580269 55261.0 46.18224547892165 0.0 - - - - - - - 426.0 110 1 PPA2 pyrophosphatase (inorganic) 2 737 95 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB53466.[MT7]-RTLLAR.2b3_1.heavy 437.291 / 515.342 N/A N/A - - - - - - - - - 0.0 - - - - - - - OGDH;OGDHL oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide);oxoglutarate dehydrogenase-like 739 95 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB53466.[MT7]-RTLLAR.2y4_1.heavy 437.291 / 472.324 N/A N/A - - - - - - - - - 0.0 - - - - - - - OGDH;OGDHL oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide);oxoglutarate dehydrogenase-like 741 95 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB53466.[MT7]-RTLLAR.2y5_1.heavy 437.291 / 573.372 N/A N/A - - - - - - - - - 0.0 - - - - - - - OGDH;OGDHL oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide);oxoglutarate dehydrogenase-like 743 95 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB53466.[MT7]-RTLLAR.2b4_1.heavy 437.291 / 628.426 N/A N/A - - - - - - - - - 0.0 - - - - - - - OGDH;OGDHL oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide);oxoglutarate dehydrogenase-like 745 96 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54424.[MT7]-TIIDK[MT7].2y4_1.heavy 439.283 / 632.41 N/A N/A - - - - - - - - - 0.0 - - - - - - - OGDH;OGDHL oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide);oxoglutarate dehydrogenase-like 747 96 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54424.[MT7]-TIIDK[MT7].2y3_2.heavy 439.283 / 260.167 N/A N/A - - - - - - - - - 0.0 - - - - - - - OGDH;OGDHL oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide);oxoglutarate dehydrogenase-like 749 96 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54424.[MT7]-TIIDK[MT7].2b4_1.heavy 439.283 / 587.352 N/A N/A - - - - - - - - - 0.0 - - - - - - - OGDH;OGDHL oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide);oxoglutarate dehydrogenase-like 751 96 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54424.[MT7]-TIIDK[MT7].2y3_1.heavy 439.283 / 519.326 N/A N/A - - - - - - - - - 0.0 - - - - - - - OGDH;OGDHL oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide);oxoglutarate dehydrogenase-like 753 97 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54040.[MT7]-YVANIFPYK[MT7].2y4_1.heavy 701.902 / 698.399 N/A N/A - - - - - - - - - 0.0 - - - - - - - PPA2 pyrophosphatase (inorganic) 2 755 97 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54040.[MT7]-YVANIFPYK[MT7].2b4_1.heavy 701.902 / 592.321 N/A N/A - - - - - - - - - 0.0 - - - - - - - PPA2 pyrophosphatase (inorganic) 2 757 97 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54040.[MT7]-YVANIFPYK[MT7].2y3_1.heavy 701.902 / 551.331 N/A N/A - - - - - - - - - 0.0 - - - - - - - PPA2 pyrophosphatase (inorganic) 2 759 97 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54040.[MT7]-YVANIFPYK[MT7].2b5_1.heavy 701.902 / 705.405 N/A N/A - - - - - - - - - 0.0 - - - - - - - PPA2 pyrophosphatase (inorganic) 2 761 98 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB538654.[MT7]-WAFNWDTK[MT7].2y4_1.heavy 678.353 / 693.369 2975.0 39.88830089569092 39 15 10 6 8 6.578998844635785 15.199881070284036 0.030002593994140625 4 0.9535971466147648 5.706846335948778 2975.0 -0.47523961661341846 2.0 - - - - - - - 681.1 9 10 HYAL1 hyaluronoglucosaminidase 1 763 98 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB538654.[MT7]-WAFNWDTK[MT7].2b4_1.heavy 678.353 / 663.337 5793.0 39.88830089569092 39 15 10 6 8 6.578998844635785 15.199881070284036 0.030002593994140625 4 0.9535971466147648 5.706846335948778 5793.0 6.716177457064864 2.0 - - - - - - - 1228.3076923076924 14 13 HYAL1 hyaluronoglucosaminidase 1 765 98 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB538654.[MT7]-WAFNWDTK[MT7].2y3_1.heavy 678.353 / 507.289 5245.0 39.88830089569092 39 15 10 6 8 6.578998844635785 15.199881070284036 0.030002593994140625 4 0.9535971466147648 5.706846335948778 5245.0 5.458899056128853 0.0 - - - - - - - 671.0714285714286 10 14 HYAL1 hyaluronoglucosaminidase 1 767 98 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB538654.[MT7]-WAFNWDTK[MT7].2y7_1.heavy 678.353 / 1025.52 10098.0 39.88830089569092 39 15 10 6 8 6.578998844635785 15.199881070284036 0.030002593994140625 4 0.9535971466147648 5.706846335948778 10098.0 23.86809738900518 0.0 - - - - - - - 693.2857142857143 20 7 HYAL1 hyaluronoglucosaminidase 1 769 99 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB55191.[MT7]-IIDTAGLSEAVGLLMC[CAM]R.2b3_1.heavy 982.027 / 486.304 3969.0 51.86984920501709 41 15 10 6 10 2.7483221960302933 36.38583574532895 0.037799835205078125 3 0.9514498452570376 5.578200491094865 3969.0 17.05965497338549 0.0 - - - - - - - 223.53333333333333 7 15 TRIM32 tripartite motif-containing 32 771 99 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB55191.[MT7]-IIDTAGLSEAVGLLMC[CAM]R.2y8_1.heavy 982.027 / 919.485 1006.0 51.86984920501709 41 15 10 6 10 2.7483221960302933 36.38583574532895 0.037799835205078125 3 0.9514498452570376 5.578200491094865 1006.0 2.246540428251838 0.0 - - - - - - - 158.5 2 18 TRIM32 tripartite motif-containing 32 773 99 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB55191.[MT7]-IIDTAGLSEAVGLLMC[CAM]R.2b6_1.heavy 982.027 / 715.411 1565.0 51.86984920501709 41 15 10 6 10 2.7483221960302933 36.38583574532895 0.037799835205078125 3 0.9514498452570376 5.578200491094865 1565.0 30.46994936034115 0.0 - - - - - - - 174.8125 3 16 TRIM32 tripartite motif-containing 32 775 99 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB55191.[MT7]-IIDTAGLSEAVGLLMC[CAM]R.2y10_1.heavy 982.027 / 1135.56 1845.0 51.86984920501709 41 15 10 6 10 2.7483221960302933 36.38583574532895 0.037799835205078125 3 0.9514498452570376 5.578200491094865 1845.0 11.903225806451614 0.0 - - - - - - - 178.93333333333334 3 15 TRIM32 tripartite motif-containing 32 777 100 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB53664.[MT7]-LSGQDVER.2y5_1.heavy 524.281 / 646.315 N/A N/A - - - - - - - - - 0.0 - - - - - - - OGDH;OGDHL oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide);oxoglutarate dehydrogenase-like 779 100 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB53664.[MT7]-LSGQDVER.2y6_1.heavy 524.281 / 703.337 N/A N/A - - - - - - - - - 0.0 - - - - - - - OGDH;OGDHL oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide);oxoglutarate dehydrogenase-like 781 100 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB53664.[MT7]-LSGQDVER.2b5_1.heavy 524.281 / 645.332 N/A N/A - - - - - - - - - 0.0 - - - - - - - OGDH;OGDHL oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide);oxoglutarate dehydrogenase-like 783 100 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB53664.[MT7]-LSGQDVER.2y7_1.heavy 524.281 / 790.369 N/A N/A - - - - - - - - - 0.0 - - - - - - - OGDH;OGDHL oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide);oxoglutarate dehydrogenase-like 785 101 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB53669.[MT7]-DQMTEQR.2y4_1.heavy 526.252 / 533.268 1951.0 16.924574851989746 41 14 10 7 10 8.380943399242874 11.931830968937685 0.021099090576171875 3 0.9326726686377204 4.729327232052277 1951.0 4.183739909814619 0.0 - - - - - - - 188.27027027027026 3 37 ITPR1 inositol 1,4,5-triphosphate receptor, type 1 787 101 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB53669.[MT7]-DQMTEQR.2b3_1.heavy 526.252 / 519.235 1850.0 16.924574851989746 41 14 10 7 10 8.380943399242874 11.931830968937685 0.021099090576171875 3 0.9326726686377204 4.729327232052277 1850.0 8.286897257976236 0.0 - - - - - - - 151.94736842105263 3 38 ITPR1 inositol 1,4,5-triphosphate receptor, type 1 789 101 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB53669.[MT7]-DQMTEQR.2y5_1.heavy 526.252 / 664.308 2230.0 16.924574851989746 41 14 10 7 10 8.380943399242874 11.931830968937685 0.021099090576171875 3 0.9326726686377204 4.729327232052277 2230.0 13.858757062146893 0.0 - - - - - - - 131.74285714285713 4 35 ITPR1 inositol 1,4,5-triphosphate receptor, type 1 791 101 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB53669.[MT7]-DQMTEQR.2y6_1.heavy 526.252 / 792.367 4105.0 16.924574851989746 41 14 10 7 10 8.380943399242874 11.931830968937685 0.021099090576171875 3 0.9326726686377204 4.729327232052277 4105.0 17.501037540086777 0.0 - - - - - - - 115.21212121212122 8 33 ITPR1 inositol 1,4,5-triphosphate receptor, type 1 793 102 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54920.[MT7]-TTC[CAM]FIC[CAM]GLER.2b3_1.heavy 700.843 / 507.235 2523.0 35.2140007019043 36 11 10 5 10 1.1046684765226962 56.73653960509312 0.04180145263671875 3 0.8609154715616372 3.2700606990736842 2523.0 4.800000000000001 0.0 - - - - - - - 677.625 5 8 ITPR1;ITPR2;ITPR3 inositol 1,4,5-triphosphate receptor, type 1;inositol 1,4,5-triphosphate receptor, type 2;inositol 1,4,5-triphosphate receptor, type 3 795 102 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54920.[MT7]-TTC[CAM]FIC[CAM]GLER.2y5_1.heavy 700.843 / 634.298 5700.0 35.2140007019043 36 11 10 5 10 1.1046684765226962 56.73653960509312 0.04180145263671875 3 0.8609154715616372 3.2700606990736842 5700.0 8.847457627118644 0.0 - - - - - - - 701.0 11 12 ITPR1;ITPR2;ITPR3 inositol 1,4,5-triphosphate receptor, type 1;inositol 1,4,5-triphosphate receptor, type 2;inositol 1,4,5-triphosphate receptor, type 3 797 102 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54920.[MT7]-TTC[CAM]FIC[CAM]GLER.2y9_1.heavy 700.843 / 1155.53 11586.0 35.2140007019043 36 11 10 5 10 1.1046684765226962 56.73653960509312 0.04180145263671875 3 0.8609154715616372 3.2700606990736842 11586.0 28.618376768591347 0.0 - - - - - - - 334.75 23 12 ITPR1;ITPR2;ITPR3 inositol 1,4,5-triphosphate receptor, type 1;inositol 1,4,5-triphosphate receptor, type 2;inositol 1,4,5-triphosphate receptor, type 3 799 102 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54920.[MT7]-TTC[CAM]FIC[CAM]GLER.2y6_1.heavy 700.843 / 747.382 3924.0 35.2140007019043 36 11 10 5 10 1.1046684765226962 56.73653960509312 0.04180145263671875 3 0.8609154715616372 3.2700606990736842 3924.0 7.235138415466595 0.0 - - - - - - - 724.375 7 8 ITPR1;ITPR2;ITPR3 inositol 1,4,5-triphosphate receptor, type 1;inositol 1,4,5-triphosphate receptor, type 2;inositol 1,4,5-triphosphate receptor, type 3 801 103 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB53769.[MT7]-FIGVLYK[MT7].2y5_1.heavy 564.357 / 723.452 N/A N/A - - - - - - - - - 0.0 - - - - - - - LIMK1;LIMK2 LIM domain kinase 1;LIM domain kinase 2 803 103 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB53769.[MT7]-FIGVLYK[MT7].2b4_1.heavy 564.357 / 561.352 N/A N/A - - - - - - - - - 0.0 - - - - - - - LIMK1;LIMK2 LIM domain kinase 1;LIM domain kinase 2 805 103 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB53769.[MT7]-FIGVLYK[MT7].2y3_1.heavy 564.357 / 567.362 N/A N/A - - - - - - - - - 0.0 - - - - - - - LIMK1;LIMK2 LIM domain kinase 1;LIM domain kinase 2 807 103 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB53769.[MT7]-FIGVLYK[MT7].2y6_1.heavy 564.357 / 836.536 N/A N/A - - - - - - - - - 0.0 - - - - - - - LIMK1;LIMK2 LIM domain kinase 1;LIM domain kinase 2 809 104 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 EFTU1_ECO24.FESEVYILSK.2y8.peptide 607.82 / 938.52 612823.0 35.51029968261719 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 612823.0 1166.9818958059761 0.0 - - - - - - - 202.0 1225 1 811 104 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 EFTU1_ECO24.FESEVYILSK.2y6.peptide 607.82 / 722.44 107888.0 35.51029968261719 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 107888.0 155.2647967988413 0.0 - - - - - - - 1210.0 215 7 813 104 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 EFTU1_ECO24.FESEVYILSK.2y5.peptide 607.82 / 623.38 189862.0 35.51029968261719 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 189862.0 195.77504805780657 0.0 - - - - - - - 1739.25 379 8 815 105 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB537397.[MT7]-TDITPGPSR.2y8_1.heavy 544.297 / 842.437 10574.0 20.549400329589844 48 18 10 10 10 4.117335198223737 24.28755376612064 0.0 3 0.9855204955612825 10.243776470839556 10574.0 100.05096207380618 0.0 - - - - - - - 182.4375 21 16 ARNTL aryl hydrocarbon receptor nuclear translocator-like 817 105 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB537397.[MT7]-TDITPGPSR.2y5_1.heavy 544.297 / 513.278 25524.0 20.549400329589844 48 18 10 10 10 4.117335198223737 24.28755376612064 0.0 3 0.9855204955612825 10.243776470839556 25524.0 75.85275535625311 0.0 - - - - - - - 678.75 51 8 ARNTL aryl hydrocarbon receptor nuclear translocator-like 819 105 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB537397.[MT7]-TDITPGPSR.2y6_1.heavy 544.297 / 614.326 13896.0 20.549400329589844 48 18 10 10 10 4.117335198223737 24.28755376612064 0.0 3 0.9855204955612825 10.243776470839556 13896.0 49.23086696562032 0.0 - - - - - - - 245.3 27 20 ARNTL aryl hydrocarbon receptor nuclear translocator-like 821 105 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB537397.[MT7]-TDITPGPSR.2y7_1.heavy 544.297 / 727.41 15719.0 20.549400329589844 48 18 10 10 10 4.117335198223737 24.28755376612064 0.0 3 0.9855204955612825 10.243776470839556 15719.0 109.82361704477677 0.0 - - - - - - - 252.85714285714286 31 21 ARNTL aryl hydrocarbon receptor nuclear translocator-like 823 106 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB539261.[MT7]-LIHQLLTDIGR.2y8_1.heavy 711.931 / 915.526 38857.0 43.086100578308105 46 20 10 6 10 9.471910254115327 10.557532463586455 0.038799285888671875 3 0.9967466172841635 21.631018965052718 38857.0 214.3768942501893 0.0 - - - - - - - 655.0 77 7 MTOR mechanistic target of rapamycin (serine/threonine kinase) 825 106 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB539261.[MT7]-LIHQLLTDIGR.2b4_1.heavy 711.931 / 636.395 22770.0 43.086100578308105 46 20 10 6 10 9.471910254115327 10.557532463586455 0.038799285888671875 3 0.9967466172841635 21.631018965052718 22770.0 28.523066335708407 0.0 - - - - - - - 1235.7 45 10 MTOR mechanistic target of rapamycin (serine/threonine kinase) 827 106 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB539261.[MT7]-LIHQLLTDIGR.2y9_1.heavy 711.931 / 1052.58 63415.0 43.086100578308105 46 20 10 6 10 9.471910254115327 10.557532463586455 0.038799285888671875 3 0.9967466172841635 21.631018965052718 63415.0 227.4850192719191 0.0 - - - - - - - 286.9230769230769 126 13 MTOR mechanistic target of rapamycin (serine/threonine kinase) 829 106 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB539261.[MT7]-LIHQLLTDIGR.2y7_1.heavy 711.931 / 787.467 30153.0 43.086100578308105 46 20 10 6 10 9.471910254115327 10.557532463586455 0.038799285888671875 3 0.9967466172841635 21.631018965052718 30153.0 48.55456278439391 0.0 - - - - - - - 683.8 60 10 MTOR mechanistic target of rapamycin (serine/threonine kinase) 831 107 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB53432.[MT7]-QAVTK[MT7].2b3_1.heavy 417.768 / 443.273 5778.0 16.180200576782227 46 20 10 10 6 19.235253404714236 5.198787762031338 0.0 5 0.9997505055878853 78.1309182036225 5778.0 9.902001359249695 0.0 - - - - - - - 1181.6666666666667 11 9 ACAT2 acetyl-CoA acetyltransferase 2 833 107 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB53432.[MT7]-QAVTK[MT7].2y4_1.heavy 417.768 / 562.368 28320.0 16.180200576782227 46 20 10 10 6 19.235253404714236 5.198787762031338 0.0 5 0.9997505055878853 78.1309182036225 28320.0 51.194289307245626 0.0 - - - - - - - 1710.2857142857142 56 7 ACAT2 acetyl-CoA acetyltransferase 2 835 107 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB53432.[MT7]-QAVTK[MT7].2y3_2.heavy 417.768 / 246.169 N/A 16.180200576782227 46 20 10 10 6 19.235253404714236 5.198787762031338 0.0 5 0.9997505055878853 78.1309182036225 35192.0 28.037056494594182 2.0 - - - - - - - 2330.75 70 4 ACAT2 acetyl-CoA acetyltransferase 2 837 107 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB53432.[MT7]-QAVTK[MT7].2y3_1.heavy 417.768 / 491.331 7769.0 16.180200576782227 46 20 10 10 6 19.235253404714236 5.198787762031338 0.0 5 0.9997505055878853 78.1309182036225 7769.0 18.529775398094706 2.0 - - - - - - - 1187.375 58 8 ACAT2 acetyl-CoA acetyltransferase 2 839 108 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB538523.[MT7]-SVPWVPILK[MT7].3y3_1.heavy 442.951 / 517.383 10154.0 42.88759994506836 50 20 10 10 10 13.087711021588618 7.640755502245323 0.0 2 0.991121212361812 13.087710414909935 10154.0 35.37522580645161 0.0 - - - - - - - 260.42857142857144 20 14 SLC17A5 solute carrier family 17 (anion/sugar transporter), member 5 841 108 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB538523.[MT7]-SVPWVPILK[MT7].3b3_1.heavy 442.951 / 428.263 4728.0 42.88759994506836 50 20 10 10 10 13.087711021588618 7.640755502245323 0.0 2 0.991121212361812 13.087710414909935 4728.0 12.449129032258064 0.0 - - - - - - - 254.85714285714286 9 14 SLC17A5 solute carrier family 17 (anion/sugar transporter), member 5 843 109 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54201.[MT7]-DLTSFAAEAIAMNR.2y8_1.heavy 827.423 / 875.44 N/A N/A - - - - - - - - - 0.0 - - - - - - - MKNK2 MAP kinase interacting serine/threonine kinase 2 845 109 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54201.[MT7]-DLTSFAAEAIAMNR.2y9_1.heavy 827.423 / 946.477 N/A N/A - - - - - - - - - 0.0 - - - - - - - MKNK2 MAP kinase interacting serine/threonine kinase 2 847 109 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54201.[MT7]-DLTSFAAEAIAMNR.2y6_1.heavy 827.423 / 675.361 N/A N/A - - - - - - - - - 0.0 - - - - - - - MKNK2 MAP kinase interacting serine/threonine kinase 2 849 109 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54201.[MT7]-DLTSFAAEAIAMNR.2y11_1.heavy 827.423 / 1180.58 N/A N/A - - - - - - - - - 0.0 - - - - - - - MKNK2 MAP kinase interacting serine/threonine kinase 2 851 110 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB542161.[MT7]-TDWDHSWTEQSVDYR.3y7_1.heavy 690.309 / 896.411 16501.0 32.95996602376302 44 18 10 6 10 3.709836770498132 26.95536385730865 0.035198211669921875 3 0.9850554392877535 10.08273709513953 16501.0 30.393284126899136 0.0 - - - - - - - 374.5833333333333 33 12 IL2RG interleukin 2 receptor, gamma 853 110 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB542161.[MT7]-TDWDHSWTEQSVDYR.3b4_1.heavy 690.309 / 662.29 N/A 32.95996602376302 44 18 10 6 10 3.709836770498132 26.95536385730865 0.035198211669921875 3 0.9850554392877535 10.08273709513953 50174.0 9.913251527642533 0.0 - - - - - - - 4226.0 100 1 IL2RG interleukin 2 receptor, gamma 855 110 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB542161.[MT7]-TDWDHSWTEQSVDYR.3y8_1.heavy 690.309 / 997.458 32600.0 32.95996602376302 44 18 10 6 10 3.709836770498132 26.95536385730865 0.035198211669921875 3 0.9850554392877535 10.08273709513953 32600.0 76.1236660320317 0.0 - - - - - - - 678.4444444444445 65 9 IL2RG interleukin 2 receptor, gamma 857 110 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB542161.[MT7]-TDWDHSWTEQSVDYR.3y9_1.heavy 690.309 / 1183.54 8452.0 32.95996602376302 44 18 10 6 10 3.709836770498132 26.95536385730865 0.035198211669921875 3 0.9850554392877535 10.08273709513953 8452.0 52.114851275537205 0.0 - - - - - - - 677.7 16 10 IL2RG interleukin 2 receptor, gamma 859 111 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54418.[MT7]-GLTPLAR.2b3_1.heavy 436.278 / 416.263 N/A 27.72410011291504 43 16 9 10 8 2.6843407381750124 31.79725724352125 0.0 4 0.9691295583212332 7.005954817743021 14690.0 4.704613016599982 1.0 - - - - - - - 2193.6666666666665 29 3 ACAT2 acetyl-CoA acetyltransferase 2 861 111 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54418.[MT7]-GLTPLAR.2y4_1.heavy 436.278 / 456.293 16817.0 27.72410011291504 43 16 9 10 8 2.6843407381750124 31.79725724352125 0.0 4 0.9691295583212332 7.005954817743021 16817.0 15.422815102689684 0.0 - - - - - - - 1766.2857142857142 33 7 ACAT2 acetyl-CoA acetyltransferase 2 863 111 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54418.[MT7]-GLTPLAR.2y5_1.heavy 436.278 / 557.341 7577.0 27.72410011291504 43 16 9 10 8 2.6843407381750124 31.79725724352125 0.0 4 0.9691295583212332 7.005954817743021 7577.0 5.249485422247898 0.0 - - - - - - - 1243.857142857143 15 7 ACAT2 acetyl-CoA acetyltransferase 2 865 111 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54418.[MT7]-GLTPLAR.2b5_1.heavy 436.278 / 626.399 7245.0 27.72410011291504 43 16 9 10 8 2.6843407381750124 31.79725724352125 0.0 4 0.9691295583212332 7.005954817743021 7245.0 15.8484375 1.0 - - - - - - - 797.5714285714286 39 7 ACAT2 acetyl-CoA acetyltransferase 2 867 112 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54003.[MT7]-WAFNWDTK[MT7].3y3_1.heavy 452.571 / 507.289 N/A N/A - - - - - - - - - 0.0 - - - - - - - HYAL1 hyaluronoglucosaminidase 1 869 112 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54003.[MT7]-WAFNWDTK[MT7].3b4_1.heavy 452.571 / 663.337 N/A N/A - - - - - - - - - 0.0 - - - - - - - HYAL1 hyaluronoglucosaminidase 1 871 112 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54003.[MT7]-WAFNWDTK[MT7].3b3_1.heavy 452.571 / 549.294 N/A N/A - - - - - - - - - 0.0 - - - - - - - HYAL1 hyaluronoglucosaminidase 1 873 113 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB53773.[MT7]-RVQDELAR.2b4_1.heavy 565.824 / 643.364 N/A N/A - - - - - - - - - 0.0 - - - - - - - TRIM32 tripartite motif-containing 32 875 113 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB53773.[MT7]-RVQDELAR.2b6_1.heavy 565.824 / 885.491 N/A N/A - - - - - - - - - 0.0 - - - - - - - TRIM32 tripartite motif-containing 32 877 113 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB53773.[MT7]-RVQDELAR.2b5_1.heavy 565.824 / 772.407 N/A N/A - - - - - - - - - 0.0 - - - - - - - TRIM32 tripartite motif-containing 32 879 113 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB53773.[MT7]-RVQDELAR.2y7_1.heavy 565.824 / 830.437 N/A N/A - - - - - - - - - 0.0 - - - - - - - TRIM32 tripartite motif-containing 32 881 114 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB537402.[MT7]-TASGAGEVVR.2y8_1.heavy 545.802 / 774.41 23790.0 19.94315004348755 46 20 10 6 10 16.25235575422472 6.152954163214492 0.03299903869628906 3 0.9971544806778657 23.130156099713563 23790.0 244.92656387503666 0.0 - - - - - - - 176.42857142857142 47 21 ID1 inhibitor of DNA binding 1, dominant negative helix-loop-helix protein 883 114 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB537402.[MT7]-TASGAGEVVR.2y9_1.heavy 545.802 / 845.448 51552.0 19.94315004348755 46 20 10 6 10 16.25235575422472 6.152954163214492 0.03299903869628906 3 0.9971544806778657 23.130156099713563 51552.0 737.6911244353182 0.0 - - - - - - - 248.94117647058823 103 17 ID1 inhibitor of DNA binding 1, dominant negative helix-loop-helix protein 885 114 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB537402.[MT7]-TASGAGEVVR.2b7_1.heavy 545.802 / 718.349 21355.0 19.94315004348755 46 20 10 6 10 16.25235575422472 6.152954163214492 0.03299903869628906 3 0.9971544806778657 23.130156099713563 21355.0 189.6324 0.0 - - - - - - - 200.9090909090909 42 22 ID1 inhibitor of DNA binding 1, dominant negative helix-loop-helix protein 887 114 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB537402.[MT7]-TASGAGEVVR.2y7_1.heavy 545.802 / 687.378 18620.0 19.94315004348755 46 20 10 6 10 16.25235575422472 6.152954163214492 0.03299903869628906 3 0.9971544806778657 23.130156099713563 18620.0 69.04588153902577 0.0 - - - - - - - 234.1 37 20 ID1 inhibitor of DNA binding 1, dominant negative helix-loop-helix protein 889 115 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54000.[MT7]-K[MT7]VTEDLSK[MT7].2y4_1.heavy 676.411 / 606.358 N/A N/A - - - - - - - - - 0.0 - - - - - - - MTOR mechanistic target of rapamycin (serine/threonine kinase) 891 115 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54000.[MT7]-K[MT7]VTEDLSK[MT7].2b4_1.heavy 676.411 / 746.465 N/A N/A - - - - - - - - - 0.0 - - - - - - - MTOR mechanistic target of rapamycin (serine/threonine kinase) 893 115 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54000.[MT7]-K[MT7]VTEDLSK[MT7].2b5_1.heavy 676.411 / 861.492 N/A N/A - - - - - - - - - 0.0 - - - - - - - MTOR mechanistic target of rapamycin (serine/threonine kinase) 895 115 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54000.[MT7]-K[MT7]VTEDLSK[MT7].2y7_1.heavy 676.411 / 935.517 N/A N/A - - - - - - - - - 0.0 - - - - - - - MTOR mechanistic target of rapamycin (serine/threonine kinase) 897 116 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB537543.[MT7]-ELMGELQR.2y5_1.heavy 560.301 / 602.326 10817.0 31.113800525665283 46 20 10 6 10 7.253513166523387 13.786422896634798 0.030401229858398438 3 0.995816649563603 19.074305303701195 10817.0 13.017725606517882 0.0 - - - - - - - 709.6875 21 16 TRIM32 tripartite motif-containing 32 899 116 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB537543.[MT7]-ELMGELQR.2y6_1.heavy 560.301 / 733.366 10925.0 31.113800525665283 46 20 10 6 10 7.253513166523387 13.786422896634798 0.030401229858398438 3 0.995816649563603 19.074305303701195 10925.0 28.186510976589975 0.0 - - - - - - - 787.0 21 8 TRIM32 tripartite motif-containing 32 901 116 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB537543.[MT7]-ELMGELQR.2b5_1.heavy 560.301 / 704.341 8449.0 31.113800525665283 46 20 10 6 10 7.253513166523387 13.786422896634798 0.030401229858398438 3 0.995816649563603 19.074305303701195 8449.0 22.076398434101783 1.0 - - - - - - - 319.8235294117647 20 17 TRIM32 tripartite motif-containing 32 903 116 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB537543.[MT7]-ELMGELQR.2y7_1.heavy 560.301 / 846.45 18406.0 31.113800525665283 46 20 10 6 10 7.253513166523387 13.786422896634798 0.030401229858398438 3 0.995816649563603 19.074305303701195 18406.0 59.169632856468745 0.0 - - - - - - - 281.7647058823529 36 17 TRIM32 tripartite motif-containing 32 905 117 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB536973.[MT7]-GLIEVK[MT7].2y4_1.heavy 473.812 / 632.41 31230.0 29.54867458343506 36 20 2 6 8 49.75640397850835 2.0097915444852834 0.030498504638671875 4 0.9978783676231971 26.78862903987573 31230.0 40.66923656454043 1.0 - - - - - - - 788.7058823529412 175 17 ACAT2 acetyl-CoA acetyltransferase 2 907 117 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB536973.[MT7]-GLIEVK[MT7].2y5_1.heavy 473.812 / 745.494 10127.0 29.54867458343506 36 20 2 6 8 49.75640397850835 2.0097915444852834 0.030498504638671875 4 0.9978783676231971 26.78862903987573 10127.0 15.66251867325225 1.0 - - - - - - - 763.5833333333334 46 12 ACAT2 acetyl-CoA acetyltransferase 2 909 117 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB536973.[MT7]-GLIEVK[MT7].2b4_1.heavy 473.812 / 557.341 36491.0 29.54867458343506 36 20 2 6 8 49.75640397850835 2.0097915444852834 0.030498504638671875 4 0.9978783676231971 26.78862903987573 36491.0 29.70287791503062 0.0 - - - - - - - 1753.8 72 10 ACAT2 acetyl-CoA acetyltransferase 2 911 117 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB536973.[MT7]-GLIEVK[MT7].2y3_1.heavy 473.812 / 519.326 39659.0 29.54867458343506 36 20 2 6 8 49.75640397850835 2.0097915444852834 0.030498504638671875 4 0.9978783676231971 26.78862903987573 39659.0 41.99063758771553 0.0 - - - - - - - 1230.5833333333333 79 12 ACAT2 acetyl-CoA acetyltransferase 2 913 118 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 SUCC_ECO24.LVQQFTK.2y4.peptide 432.25 / 523.29 515125.0 23.547000885009766 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 515125.0 834.3538306317787 0.0 - - - - - - - 818.2727272727273 1030 11 915 118 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 SUCC_ECO24.LVQQFTK.2y6.peptide 432.25 / 750.41 793138.0 23.547000885009766 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 793138.0 2515.20843975169 0.0 - - - - - - - 228.6875 1586 16 917 118 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 SUCC_ECO24.LVQQFTK.2y5.peptide 432.25 / 651.35 2413770.0 23.547000885009766 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 2413770.0 4060.362727540328 0.0 - - - - - - - 696.7777777777778 4827 9 919 119 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB539270.[MT7]-LIHQLLTDIGR.3y7_1.heavy 474.956 / 787.467 34337.0 43.10550022125244 39 13 10 6 10 1.006263892675025 58.684808690150454 0.038799285888671875 3 0.9160255050323282 4.228648913743294 34337.0 127.98702369364187 0.0 - - - - - - - 289.54545454545456 68 11 MTOR mechanistic target of rapamycin (serine/threonine kinase) 921 119 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB539270.[MT7]-LIHQLLTDIGR.3y6_1.heavy 474.956 / 674.383 47000.0 43.10550022125244 39 13 10 6 10 1.006263892675025 58.684808690150454 0.038799285888671875 3 0.9160255050323282 4.228648913743294 47000.0 663.2084296247385 0.0 - - - - - - - 203.15384615384616 94 13 MTOR mechanistic target of rapamycin (serine/threonine kinase) 923 119 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB539270.[MT7]-LIHQLLTDIGR.3b3_1.heavy 474.956 / 508.336 93535.0 43.10550022125244 39 13 10 6 10 1.006263892675025 58.684808690150454 0.038799285888671875 3 0.9160255050323282 4.228648913743294 93535.0 1218.9244569589703 0.0 - - - - - - - 699.4285714285714 187 7 MTOR mechanistic target of rapamycin (serine/threonine kinase) 925 119 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB539270.[MT7]-LIHQLLTDIGR.3y5_1.heavy 474.956 / 561.299 137738.0 43.10550022125244 39 13 10 6 10 1.006263892675025 58.684808690150454 0.038799285888671875 3 0.9160255050323282 4.228648913743294 137738.0 365.74660942196954 0.0 - - - - - - - 794.2222222222222 275 9 MTOR mechanistic target of rapamycin (serine/threonine kinase) 927 120 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB53955.[MT7]-NLSWLEEK[MT7].2y4_1.heavy 653.866 / 662.384 N/A N/A - - - - - - - - - 0.0 - - - - - - - RAPGEF1 Rap guanine nucleotide exchange factor (GEF) 1 929 120 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB53955.[MT7]-NLSWLEEK[MT7].2y3_1.heavy 653.866 / 549.3 N/A N/A - - - - - - - - - 0.0 - - - - - - - RAPGEF1 Rap guanine nucleotide exchange factor (GEF) 1 931 120 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB53955.[MT7]-NLSWLEEK[MT7].2y6_1.heavy 653.866 / 935.495 N/A N/A - - - - - - - - - 0.0 - - - - - - - RAPGEF1 Rap guanine nucleotide exchange factor (GEF) 1 933 120 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB53955.[MT7]-NLSWLEEK[MT7].2y7_1.heavy 653.866 / 1048.58 N/A N/A - - - - - - - - - 0.0 - - - - - - - RAPGEF1 Rap guanine nucleotide exchange factor (GEF) 1 935 121 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB55056.[MT7]-IEIPEVLLWAK[MT7].3b6_1.heavy 533.664 / 825.484 5699.0 49.58462429046631 40 14 10 6 10 1.2933728978477195 45.582105416417555 0.035701751708984375 3 0.932555333771898 4.72516421079337 5699.0 28.65793397345992 0.0 - - - - - - - 155.5 11 10 RAPGEF1 Rap guanine nucleotide exchange factor (GEF) 1 937 121 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB55056.[MT7]-IEIPEVLLWAK[MT7].3y3_1.heavy 533.664 / 548.331 15254.0 49.58462429046631 40 14 10 6 10 1.2933728978477195 45.582105416417555 0.035701751708984375 3 0.932555333771898 4.72516421079337 15254.0 58.43901465705471 0.0 - - - - - - - 234.6153846153846 30 13 RAPGEF1 Rap guanine nucleotide exchange factor (GEF) 1 939 121 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB55056.[MT7]-IEIPEVLLWAK[MT7].3b5_1.heavy 533.664 / 726.415 8001.0 49.58462429046631 40 14 10 6 10 1.2933728978477195 45.582105416417555 0.035701751708984375 3 0.932555333771898 4.72516421079337 8001.0 82.56104347826087 0.0 - - - - - - - 126.86666666666666 16 15 RAPGEF1 Rap guanine nucleotide exchange factor (GEF) 1 941 121 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB55056.[MT7]-IEIPEVLLWAK[MT7].3b3_1.heavy 533.664 / 500.32 13470.0 49.58462429046631 40 14 10 6 10 1.2933728978477195 45.582105416417555 0.035701751708984375 3 0.932555333771898 4.72516421079337 13470.0 66.45525362318841 0.0 - - - - - - - 207.26666666666668 26 15 RAPGEF1 Rap guanine nucleotide exchange factor (GEF) 1 943 122 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54953.[MT7]-ILVTLLHTLER.3y6_1.heavy 484.64 / 768.436 24128.0 49.349700927734375 43 17 10 6 10 3.269717924657847 30.583677951505337 0.03260040283203125 3 0.9778803077924202 8.282644574866046 24128.0 594.5182608695652 0.0 - - - - - - - 125.08333333333333 48 12 ACAT2 acetyl-CoA acetyltransferase 2 945 122 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54953.[MT7]-ILVTLLHTLER.3b4_1.heavy 484.64 / 571.394 74289.0 49.349700927734375 43 17 10 6 10 3.269717924657847 30.583677951505337 0.03260040283203125 3 0.9778803077924202 8.282644574866046 74289.0 142.8163118811881 0.0 - - - - - - - 194.0909090909091 148 11 ACAT2 acetyl-CoA acetyltransferase 2 947 122 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54953.[MT7]-ILVTLLHTLER.3b5_1.heavy 484.64 / 684.478 33364.0 49.349700927734375 43 17 10 6 10 3.269717924657847 30.583677951505337 0.03260040283203125 3 0.9778803077924202 8.282644574866046 33364.0 599.8003512643679 0.0 - - - - - - - 196.2 66 10 ACAT2 acetyl-CoA acetyltransferase 2 949 122 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54953.[MT7]-ILVTLLHTLER.3y5_1.heavy 484.64 / 655.352 116369.0 49.349700927734375 43 17 10 6 10 3.269717924657847 30.583677951505337 0.03260040283203125 3 0.9778803077924202 8.282644574866046 116369.0 1077.1743685300207 0.0 - - - - - - - 230.88888888888889 232 9 ACAT2 acetyl-CoA acetyltransferase 2 951 123 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB540544.[MT7]-AADGFLFVVGC[CAM]DR.3y7_1.heavy 524.265 / 852.403 4382.0 42.93327522277832 39 13 10 6 10 1.8174951268306438 43.55567186728053 0.03749847412109375 3 0.9256100578730176 4.4965094290242416 4382.0 13.98427936682015 0.0 - - - - - - - 197.125 8 16 ARNTL aryl hydrocarbon receptor nuclear translocator-like 953 123 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB540544.[MT7]-AADGFLFVVGC[CAM]DR.3y6_1.heavy 524.265 / 705.335 9764.0 42.93327522277832 39 13 10 6 10 1.8174951268306438 43.55567186728053 0.03749847412109375 3 0.9256100578730176 4.4965094290242416 9764.0 35.05150487588652 0.0 - - - - - - - 226.0 19 16 ARNTL aryl hydrocarbon receptor nuclear translocator-like 955 123 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB540544.[MT7]-AADGFLFVVGC[CAM]DR.3b6_1.heavy 524.265 / 719.385 12532.0 42.93327522277832 39 13 10 6 10 1.8174951268306438 43.55567186728053 0.03749847412109375 3 0.9256100578730176 4.4965094290242416 12532.0 53.061623038771835 0.0 - - - - - - - 274.7857142857143 25 14 ARNTL aryl hydrocarbon receptor nuclear translocator-like 957 123 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB540544.[MT7]-AADGFLFVVGC[CAM]DR.3y4_1.heavy 524.265 / 507.198 26678.0 42.93327522277832 39 13 10 6 10 1.8174951268306438 43.55567186728053 0.03749847412109375 3 0.9256100578730176 4.4965094290242416 26678.0 47.18688270530251 0.0 - - - - - - - 725.0 53 7 ARNTL aryl hydrocarbon receptor nuclear translocator-like 959 124 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54305.[MT7]-YHPQALIYPLTVASK[MT7].3y7_1.heavy 663.719 / 859.537 N/A N/A - - - - - - - - - 0.0 - - - - - - - MTOR mechanistic target of rapamycin (serine/threonine kinase) 961 124 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54305.[MT7]-YHPQALIYPLTVASK[MT7].3b6_1.heavy 663.719 / 854.464 N/A N/A - - - - - - - - - 0.0 - - - - - - - MTOR mechanistic target of rapamycin (serine/threonine kinase) 963 124 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54305.[MT7]-YHPQALIYPLTVASK[MT7].3b5_1.heavy 663.719 / 741.38 N/A N/A - - - - - - - - - 0.0 - - - - - - - MTOR mechanistic target of rapamycin (serine/threonine kinase) 965 124 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54305.[MT7]-YHPQALIYPLTVASK[MT7].3y5_1.heavy 663.719 / 649.4 N/A N/A - - - - - - - - - 0.0 - - - - - - - MTOR mechanistic target of rapamycin (serine/threonine kinase) 967 125 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54219.[MT7]-VGHVGPLQIGQAVK[MT7].3y6_1.heavy 564.345 / 759.484 N/A N/A - - - - - - - - - 0.0 - - - - - - - TRIM32 tripartite motif-containing 32 969 125 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54219.[MT7]-VGHVGPLQIGQAVK[MT7].3b4_1.heavy 564.345 / 537.326 N/A N/A - - - - - - - - - 0.0 - - - - - - - TRIM32 tripartite motif-containing 32 971 125 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54219.[MT7]-VGHVGPLQIGQAVK[MT7].3b5_1.heavy 564.345 / 594.348 N/A N/A - - - - - - - - - 0.0 - - - - - - - TRIM32 tripartite motif-containing 32 973 125 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54219.[MT7]-VGHVGPLQIGQAVK[MT7].3y5_1.heavy 564.345 / 646.4 N/A N/A - - - - - - - - - 0.0 - - - - - - - TRIM32 tripartite motif-containing 32 975 126 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB539251.[MT7]-VLEMLPGSASK[MT7].3y6_1.heavy 473.942 / 690.39 8529.0 35.777700424194336 42 17 10 5 10 2.8952279160483054 27.227670085018783 0.042400360107421875 3 0.9702170230910666 7.13336589798676 8529.0 13.591423455684872 0.0 - - - - - - - 631.8888888888889 17 9 RAPGEF1 Rap guanine nucleotide exchange factor (GEF) 1 977 126 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB539251.[MT7]-VLEMLPGSASK[MT7].3b4_1.heavy 473.942 / 617.345 20713.0 35.777700424194336 42 17 10 5 10 2.8952279160483054 27.227670085018783 0.042400360107421875 3 0.9702170230910666 7.13336589798676 20713.0 27.712455900966262 0.0 - - - - - - - 319.14285714285717 41 7 RAPGEF1 Rap guanine nucleotide exchange factor (GEF) 1 979 126 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB539251.[MT7]-VLEMLPGSASK[MT7].3y4_1.heavy 473.942 / 536.316 6295.0 35.777700424194336 42 17 10 5 10 2.8952279160483054 27.227670085018783 0.042400360107421875 3 0.9702170230910666 7.13336589798676 6295.0 9.245634423048216 0.0 - - - - - - - 1189.2857142857142 12 7 RAPGEF1 Rap guanine nucleotide exchange factor (GEF) 1 981 126 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB539251.[MT7]-VLEMLPGSASK[MT7].3y5_1.heavy 473.942 / 593.338 12387.0 35.777700424194336 42 17 10 5 10 2.8952279160483054 27.227670085018783 0.042400360107421875 3 0.9702170230910666 7.13336589798676 12387.0 23.516349475856778 0.0 - - - - - - - 741.2 24 10 RAPGEF1 Rap guanine nucleotide exchange factor (GEF) 1 983 127 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB538538.[MT7]-DTILQLNLK[MT7].3y3_1.heavy 449.281 / 518.342 133421.0 38.65997505187988 38 12 10 6 10 1.1089671096162974 62.99601579624117 0.03749847412109375 3 0.8926040989383162 3.7316667560051693 133421.0 178.78749314923317 0.0 - - - - - - - 254.33333333333334 266 3 GNA11;GNAQ guanine nucleotide binding protein (G protein), alpha 11 (Gq class);guanine nucleotide binding protein (G protein), q polypeptide 985 127 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB538538.[MT7]-DTILQLNLK[MT7].3b4_1.heavy 449.281 / 587.352 111297.0 38.65997505187988 38 12 10 6 10 1.1089671096162974 62.99601579624117 0.03749847412109375 3 0.8926040989383162 3.7316667560051693 111297.0 95.09212381840601 0.0 - - - - - - - 339.0 222 5 GNA11;GNAQ guanine nucleotide binding protein (G protein), alpha 11 (Gq class);guanine nucleotide binding protein (G protein), q polypeptide 987 127 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB538538.[MT7]-DTILQLNLK[MT7].3b5_1.heavy 449.281 / 715.411 47723.0 38.65997505187988 38 12 10 6 10 1.1089671096162974 62.99601579624117 0.03749847412109375 3 0.8926040989383162 3.7316667560051693 47723.0 91.89859741340942 0.0 - - - - - - - 109.28571428571429 95 7 GNA11;GNAQ guanine nucleotide binding protein (G protein), alpha 11 (Gq class);guanine nucleotide binding protein (G protein), q polypeptide 989 127 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB538538.[MT7]-DTILQLNLK[MT7].3b3_1.heavy 449.281 / 474.268 82138.0 38.65997505187988 38 12 10 6 10 1.1089671096162974 62.99601579624117 0.03749847412109375 3 0.8926040989383162 3.7316667560051693 82138.0 141.34765433220252 0.0 - - - - - - - 826.25 164 4 GNA11;GNAQ guanine nucleotide binding protein (G protein), alpha 11 (Gq class);guanine nucleotide binding protein (G protein), q polypeptide 991 128 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB538532.[MT7]-EQLSSSDTAPR.2b3_1.heavy 667.837 / 515.295 7579.0 20.235700607299805 50 20 10 10 10 6.7164122445112655 14.888901449091549 0.0 3 0.9902144312031455 12.46563894590826 7579.0 14.231644001604359 0.0 - - - - - - - 613.2727272727273 15 11 ARNTL aryl hydrocarbon receptor nuclear translocator-like 993 128 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB538532.[MT7]-EQLSSSDTAPR.2y8_1.heavy 667.837 / 820.38 11547.0 20.235700607299805 50 20 10 10 10 6.7164122445112655 14.888901449091549 0.0 3 0.9902144312031455 12.46563894590826 11547.0 30.43081932773109 0.0 - - - - - - - 209.71428571428572 23 14 ARNTL aryl hydrocarbon receptor nuclear translocator-like 995 128 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB538532.[MT7]-EQLSSSDTAPR.2y9_1.heavy 667.837 / 933.464 8452.0 20.235700607299805 50 20 10 10 10 6.7164122445112655 14.888901449091549 0.0 3 0.9902144312031455 12.46563894590826 8452.0 20.2580938580223 0.0 - - - - - - - 246.31578947368422 16 19 ARNTL aryl hydrocarbon receptor nuclear translocator-like 997 128 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB538532.[MT7]-EQLSSSDTAPR.2y10_1.heavy 667.837 / 1061.52 13531.0 20.235700607299805 50 20 10 10 10 6.7164122445112655 14.888901449091549 0.0 3 0.9902144312031455 12.46563894590826 13531.0 10.53703240158381 0.0 - - - - - - - 286.9230769230769 27 13 ARNTL aryl hydrocarbon receptor nuclear translocator-like 999 129 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB537823.[MT7]-AFALEVIK[MT7].2y4_1.heavy 589.873 / 632.41 28118.0 38.43844985961914 44 18 10 6 10 3.4795296329925214 22.92667263718605 0.03710174560546875 3 0.9864781018031887 10.601149212027673 28118.0 83.88894402035623 0.0 - - - - - - - 724.8 56 10 PPA2 pyrophosphatase (inorganic) 2 1001 129 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB537823.[MT7]-AFALEVIK[MT7].2y5_1.heavy 589.873 / 745.494 17290.0 38.43844985961914 44 18 10 6 10 3.4795296329925214 22.92667263718605 0.03710174560546875 3 0.9864781018031887 10.601149212027673 17290.0 46.11473120025987 0.0 - - - - - - - 267.4375 34 16 PPA2 pyrophosphatase (inorganic) 2 1003 129 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB537823.[MT7]-AFALEVIK[MT7].2y3_1.heavy 589.873 / 503.367 18076.0 38.43844985961914 44 18 10 6 10 3.4795296329925214 22.92667263718605 0.03710174560546875 3 0.9864781018031887 10.601149212027673 18076.0 22.40637103418574 0.0 - - - - - - - 746.2727272727273 36 11 PPA2 pyrophosphatase (inorganic) 2 1005 129 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB537823.[MT7]-AFALEVIK[MT7].2b5_1.heavy 589.873 / 676.379 20171.0 38.43844985961914 44 18 10 6 10 3.4795296329925214 22.92667263718605 0.03710174560546875 3 0.9864781018031887 10.601149212027673 20171.0 35.15259727637083 0.0 - - - - - - - 725.5384615384615 40 13 PPA2 pyrophosphatase (inorganic) 2 1007 130 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB541090.[MT7]-GADPEETILNAFK[MT7].3y3_1.heavy 564.973 / 509.32 51783.0 43.55380058288574 42 16 10 6 10 6.374384160284935 15.687789986527891 0.036800384521484375 3 0.9608564875602595 6.217353270346895 51783.0 115.0027675042561 0.0 - - - - - - - 358.625 103 8 MYL2 myosin, light chain 2, regulatory, cardiac, slow 1009 130 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB541090.[MT7]-GADPEETILNAFK[MT7].3b5_1.heavy 564.973 / 614.29 42093.0 43.55380058288574 42 16 10 6 10 6.374384160284935 15.687789986527891 0.036800384521484375 3 0.9608564875602595 6.217353270346895 42093.0 164.99215690607733 0.0 - - - - - - - 275.09090909090907 84 11 MYL2 myosin, light chain 2, regulatory, cardiac, slow 1011 130 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB541090.[MT7]-GADPEETILNAFK[MT7].3y4_1.heavy 564.973 / 623.363 31240.0 43.55380058288574 42 16 10 6 10 6.374384160284935 15.687789986527891 0.036800384521484375 3 0.9608564875602595 6.217353270346895 31240.0 226.13210023535927 0.0 - - - - - - - 201.8 62 10 MYL2 myosin, light chain 2, regulatory, cardiac, slow 1013 130 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB541090.[MT7]-GADPEETILNAFK[MT7].3y5_1.heavy 564.973 / 736.447 47674.0 43.55380058288574 42 16 10 6 10 6.374384160284935 15.687789986527891 0.036800384521484375 3 0.9608564875602595 6.217353270346895 47674.0 321.33701937967345 0.0 - - - - - - - 246.8181818181818 95 11 MYL2 myosin, light chain 2, regulatory, cardiac, slow 1015 131 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54213.[MT7]-NLVHIITHGEEK[MT7].3y6_1.heavy 559.989 / 844.428 N/A N/A - - - - - - - - - 0.0 - - - - - - - MYL2 myosin, light chain 2, regulatory, cardiac, slow 1017 131 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54213.[MT7]-NLVHIITHGEEK[MT7].3b4_1.heavy 559.989 / 608.364 N/A N/A - - - - - - - - - 0.0 - - - - - - - MYL2 myosin, light chain 2, regulatory, cardiac, slow 1019 131 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54213.[MT7]-NLVHIITHGEEK[MT7].3b5_1.heavy 559.989 / 721.448 N/A N/A - - - - - - - - - 0.0 - - - - - - - MYL2 myosin, light chain 2, regulatory, cardiac, slow 1021 131 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54213.[MT7]-NLVHIITHGEEK[MT7].3y5_1.heavy 559.989 / 743.38 N/A N/A - - - - - - - - - 0.0 - - - - - - - MYL2 myosin, light chain 2, regulatory, cardiac, slow 1023 132 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54407.[MT7]-EAAEER.2y4_1.heavy 424.715 / 504.241 509.0 14.31470012664795 40 12 10 10 8 1.1773324195545913 73.95891189968884 0.0 4 0.8812759901234675 3.545680658823787 509.0 2.1475602379272107 7.0 - - - - - - - 0.0 1 0 TRIM32 tripartite motif-containing 32 1025 132 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54407.[MT7]-EAAEER.2b5_1.heavy 424.715 / 674.311 1091.0 14.31470012664795 40 12 10 10 8 1.1773324195545913 73.95891189968884 0.0 4 0.8812759901234675 3.545680658823787 1091.0 8.763229844589068 0.0 - - - - - - - 155.96153846153845 2 26 TRIM32 tripartite motif-containing 32 1027 132 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54407.[MT7]-EAAEER.2y5_1.heavy 424.715 / 575.278 1200.0 14.31470012664795 40 12 10 10 8 1.1773324195545913 73.95891189968884 0.0 4 0.8812759901234675 3.545680658823787 1200.0 5.025364274150027 1.0 - - - - - - - 212.85185185185185 2 27 TRIM32 tripartite motif-containing 32 1029 132 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54407.[MT7]-EAAEER.2b4_1.heavy 424.715 / 545.269 1764.0 14.31470012664795 40 12 10 10 8 1.1773324195545913 73.95891189968884 0.0 4 0.8812759901234675 3.545680658823787 1764.0 23.64923076923077 0.0 - - - - - - - 133.40740740740742 3 27 TRIM32 tripartite motif-containing 32 1031 133 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54807.[MT7]-IGFGSFVDK[MT7].2y8_1.heavy 629.358 / 1000.52 5093.0 37.88959884643555 36 14 10 10 2 6.470166531671443 15.45555272967092 0.0 11 0.9406586441831555 5.04094835110344 5093.0 10.682596371882084 0.0 - - - - - - - 771.75 10 8 ITGB2;ITGB7 integrin, beta 2 (complement component 3 receptor 3 and 4 subunit);integrin, beta 7 1033 133 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54807.[MT7]-IGFGSFVDK[MT7].2b6_1.heavy 629.358 / 753.405 1175.0 37.88959884643555 36 14 10 10 2 6.470166531671443 15.45555272967092 0.0 11 0.9406586441831555 5.04094835110344 1175.0 1.0276967930029155 9.0 - - - - - - - 744.7 4 10 ITGB2;ITGB7 integrin, beta 2 (complement component 3 receptor 3 and 4 subunit);integrin, beta 7 1035 133 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54807.[MT7]-IGFGSFVDK[MT7].2y3_1.heavy 629.358 / 505.31 1077.0 37.88959884643555 36 14 10 10 2 6.470166531671443 15.45555272967092 0.0 11 0.9406586441831555 5.04094835110344 1077.0 -0.1466303607896528 26.0 - - - - - - - 769.7142857142857 7 7 ITGB2;ITGB7 integrin, beta 2 (complement component 3 receptor 3 and 4 subunit);integrin, beta 7 1037 133 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54807.[MT7]-IGFGSFVDK[MT7].2y6_1.heavy 629.358 / 796.432 1665.0 37.88959884643555 36 14 10 10 2 6.470166531671443 15.45555272967092 0.0 11 0.9406586441831555 5.04094835110344 1665.0 0.19999999999999996 3.0 - - - - - - - 240.54545454545453 4 11 ITGB2;ITGB7 integrin, beta 2 (complement component 3 receptor 3 and 4 subunit);integrin, beta 7 1039 134 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB53446.[MT7]-LIDAK[MT7].2b3_1.heavy 424.278 / 486.304 N/A N/A - - - - - - - - - 0.0 - - - - - - - ARNTL;ARNTL2 aryl hydrocarbon receptor nuclear translocator-like;aryl hydrocarbon receptor nuclear translocator-like 2 1041 134 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB53446.[MT7]-LIDAK[MT7].2y4_1.heavy 424.278 / 590.363 N/A N/A - - - - - - - - - 0.0 - - - - - - - ARNTL;ARNTL2 aryl hydrocarbon receptor nuclear translocator-like;aryl hydrocarbon receptor nuclear translocator-like 2 1043 134 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB53446.[MT7]-LIDAK[MT7].2y3_1.heavy 424.278 / 477.279 N/A N/A - - - - - - - - - 0.0 - - - - - - - ARNTL;ARNTL2 aryl hydrocarbon receptor nuclear translocator-like;aryl hydrocarbon receptor nuclear translocator-like 2 1045 135 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54014.[MT7]-FSLPSVDGQK[MT7].2y4_1.heavy 683.384 / 591.322 N/A N/A - - - - - - - - - 0.0 - - - - - - - IL2RG interleukin 2 receptor, gamma 1047 135 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54014.[MT7]-FSLPSVDGQK[MT7].2y5_1.heavy 683.384 / 690.39 N/A N/A - - - - - - - - - 0.0 - - - - - - - IL2RG interleukin 2 receptor, gamma 1049 135 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54014.[MT7]-FSLPSVDGQK[MT7].2y9_1.heavy 683.384 / 1074.59 N/A N/A - - - - - - - - - 0.0 - - - - - - - IL2RG interleukin 2 receptor, gamma 1051 135 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54014.[MT7]-FSLPSVDGQK[MT7].2y7_1.heavy 683.384 / 874.475 N/A N/A - - - - - - - - - 0.0 - - - - - - - IL2RG interleukin 2 receptor, gamma 1053 136 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB53962.[MT7]-SLDHPNVLK[MT7].2y5_1.heavy 655.887 / 714.463 N/A N/A - - - - - - - - - 0.0 - - - - - - - LIMK2 LIM domain kinase 2 1055 136 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB53962.[MT7]-SLDHPNVLK[MT7].2b4_1.heavy 655.887 / 597.311 N/A N/A - - - - - - - - - 0.0 - - - - - - - LIMK2 LIM domain kinase 2 1057 136 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB53962.[MT7]-SLDHPNVLK[MT7].2y3_1.heavy 655.887 / 503.367 N/A N/A - - - - - - - - - 0.0 - - - - - - - LIMK2 LIM domain kinase 2 1059 136 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB53962.[MT7]-SLDHPNVLK[MT7].2y6_1.heavy 655.887 / 851.522 N/A N/A - - - - - - - - - 0.0 - - - - - - - LIMK2 LIM domain kinase 2 1061 137 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TNAA_ECO24.GLTFTYEPK.2y7.peptide 528.27 / 885.44 408773.0 32.83929951985677 23 -3 10 6 10 null 0.0 0.03569793701171875 3 0.0 0.0 408773.0 645.0383632308565 0.0 - - - - - - - 730.5555555555555 817 9 1063 137 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TNAA_ECO24.GLTFTYEPK.2y6.peptide 528.27 / 784.39 403004.0 32.83929951985677 23 -3 10 6 10 null 0.0 0.03569793701171875 3 0.0 0.0 403004.0 610.5989962451073 0.0 - - - - - - - 738.0 806 8 1065 137 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TNAA_ECO24.GLTFTYEPK.2y5.peptide 528.27 / 637.32 765346.0 32.83929951985677 23 -3 10 6 10 null 0.0 0.03569793701171875 3 0.0 0.0 765346.0 497.25148128359604 0.0 - - - - - - - 738.0 1530 3 1067 138 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB55069.[MT7]-WFSFMNPWTK[MT7].3b6_1.heavy 544.614 / 957.441 3346.0 49.13892364501953 42 18 10 6 8 4.743401249386694 21.081918805188508 0.032501220703125 4 0.9866534813522314 10.670730661629186 3346.0 81.86412893553224 0.0 - - - - - - - 120.25 6 12 ARNTL aryl hydrocarbon receptor nuclear translocator-like 1069 138 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB55069.[MT7]-WFSFMNPWTK[MT7].3y3_1.heavy 544.614 / 578.342 7095.0 49.13892364501953 42 18 10 6 8 4.743401249386694 21.081918805188508 0.032501220703125 4 0.9866534813522314 10.670730661629186 7095.0 116.9324446880606 0.0 - - - - - - - 193.64285714285714 14 14 ARNTL aryl hydrocarbon receptor nuclear translocator-like 1071 138 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB55069.[MT7]-WFSFMNPWTK[MT7].3b3_1.heavy 544.614 / 565.289 5307.0 49.13892364501953 42 18 10 6 8 4.743401249386694 21.081918805188508 0.032501220703125 4 0.9866534813522314 10.670730661629186 5307.0 29.353796410891086 1.0 - - - - - - - 203.52941176470588 10 17 ARNTL aryl hydrocarbon receptor nuclear translocator-like 1073 138 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB55069.[MT7]-WFSFMNPWTK[MT7].3y4_1.heavy 544.614 / 675.395 8364.0 49.13892364501953 42 18 10 6 8 4.743401249386694 21.081918805188508 0.032501220703125 4 0.9866534813522314 10.670730661629186 8364.0 65.26820809248555 0.0 - - - - - - - 176.6875 16 16 ARNTL aryl hydrocarbon receptor nuclear translocator-like 1075 139 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB53968.[MT7]-ETSFNQAYGR.2y9_1.heavy 658.821 / 1043.49 N/A N/A - - - - - - - - - 0.0 - - - - - - - MTOR mechanistic target of rapamycin (serine/threonine kinase) 1077 139 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB53968.[MT7]-ETSFNQAYGR.2y6_1.heavy 658.821 / 708.342 N/A N/A - - - - - - - - - 0.0 - - - - - - - MTOR mechanistic target of rapamycin (serine/threonine kinase) 1079 139 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB53968.[MT7]-ETSFNQAYGR.2b5_1.heavy 658.821 / 723.343 N/A N/A - - - - - - - - - 0.0 - - - - - - - MTOR mechanistic target of rapamycin (serine/threonine kinase) 1081 139 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB53968.[MT7]-ETSFNQAYGR.2y7_1.heavy 658.821 / 855.411 N/A N/A - - - - - - - - - 0.0 - - - - - - - MTOR mechanistic target of rapamycin (serine/threonine kinase) 1083 140 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54017.[MT7]-EAFTIMDQNR.2y5_1.heavy 684.839 / 663.288 N/A N/A - - - - - - - - - 0.0 - - - - - - - MYL2 myosin, light chain 2, regulatory, cardiac, slow 1085 140 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54017.[MT7]-EAFTIMDQNR.2y9_1.heavy 684.839 / 1095.53 N/A N/A - - - - - - - - - 0.0 - - - - - - - MYL2 myosin, light chain 2, regulatory, cardiac, slow 1087 140 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54017.[MT7]-EAFTIMDQNR.2y6_1.heavy 684.839 / 776.372 N/A N/A - - - - - - - - - 0.0 - - - - - - - MYL2 myosin, light chain 2, regulatory, cardiac, slow 1089 140 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54017.[MT7]-EAFTIMDQNR.2y7_1.heavy 684.839 / 877.42 N/A N/A - - - - - - - - - 0.0 - - - - - - - MYL2 myosin, light chain 2, regulatory, cardiac, slow 1091 141 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB538492.[MT7]-VYQSLANLIR.2b3_1.heavy 660.891 / 535.3 10207.0 42.206298828125 48 18 10 10 10 6.271224143417137 15.945850078563902 0.0 3 0.9894912741236673 12.028356176650208 10207.0 22.617022890743947 0.0 - - - - - - - 778.6 20 10 RAPGEF1 Rap guanine nucleotide exchange factor (GEF) 1 1093 141 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB538492.[MT7]-VYQSLANLIR.2y8_1.heavy 660.891 / 914.542 14592.0 42.206298828125 48 18 10 10 10 6.271224143417137 15.945850078563902 0.0 3 0.9894912741236673 12.028356176650208 14592.0 49.048670530706616 0.0 - - - - - - - 604.75 29 8 RAPGEF1 Rap guanine nucleotide exchange factor (GEF) 1 1095 141 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB538492.[MT7]-VYQSLANLIR.2y9_1.heavy 660.891 / 1077.61 51109.0 42.206298828125 48 18 10 10 10 6.271224143417137 15.945850078563902 0.0 3 0.9894912741236673 12.028356176650208 51109.0 147.20922507765462 0.0 - - - - - - - 680.25 102 8 RAPGEF1 Rap guanine nucleotide exchange factor (GEF) 1 1097 141 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB538492.[MT7]-VYQSLANLIR.2y7_1.heavy 660.891 / 786.483 14063.0 42.206298828125 48 18 10 10 10 6.271224143417137 15.945850078563902 0.0 3 0.9894912741236673 12.028356176650208 14063.0 56.68566079295154 0.0 - - - - - - - 287.4 28 15 RAPGEF1 Rap guanine nucleotide exchange factor (GEF) 1 1099 142 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB55310.[MT7]-ALLLLNPASFSIQLTPGGGPLSLR.3b6_1.heavy 860.506 / 782.526 16661.0 53.458600997924805 44 18 10 6 10 8.56769131684766 11.671755704288532 0.03440093994140625 3 0.9884077127945026 11.45136796911118 16661.0 -0.6033861475780897 0.0 - - - - - - - 232.0 33 6 HYAL1 hyaluronoglucosaminidase 1 1101 142 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB55310.[MT7]-ALLLLNPASFSIQLTPGGGPLSLR.3b4_1.heavy 860.506 / 555.399 19158.0 53.458600997924805 44 18 10 6 10 8.56769131684766 11.671755704288532 0.03440093994140625 3 0.9884077127945026 11.45136796911118 19158.0 -0.30701923076923165 0.0 - - - - - - - 216.0 38 8 HYAL1 hyaluronoglucosaminidase 1 1103 142 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB55310.[MT7]-ALLLLNPASFSIQLTPGGGPLSLR.3y10_1.heavy 860.506 / 954.537 12772.0 53.458600997924805 44 18 10 6 10 8.56769131684766 11.671755704288532 0.03440093994140625 3 0.9884077127945026 11.45136796911118 12772.0 55.955759803921566 0.0 - - - - - - - 264.0 25 8 HYAL1 hyaluronoglucosaminidase 1 1105 142 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB55310.[MT7]-ALLLLNPASFSIQLTPGGGPLSLR.3y9_1.heavy 860.506 / 853.489 23864.0 53.458600997924805 44 18 10 6 10 8.56769131684766 11.671755704288532 0.03440093994140625 3 0.9884077127945026 11.45136796911118 23864.0 0.0 0.0 - - - - - - - 168.0 47 4 HYAL1 hyaluronoglucosaminidase 1 1107 143 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB538990.[MT7]-AC[CAM]PEHSAPIK[MT7].3y3_1.heavy 466.586 / 501.352 84727.0 19.473499298095703 47 17 10 10 10 3.9282143171838997 25.456859510580134 0.0 3 0.9744436762816084 7.70342574978505 84727.0 57.196318701334874 0.0 - - - - - - - 1225.0 169 7 SLC17A5 solute carrier family 17 (anion/sugar transporter), member 5 1109 143 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB538990.[MT7]-AC[CAM]PEHSAPIK[MT7].3b4_1.heavy 466.586 / 602.273 45502.0 19.473499298095703 47 17 10 10 10 3.9282143171838997 25.456859510580134 0.0 3 0.9744436762816084 7.70342574978505 45502.0 118.46495742592904 1.0 - - - - - - - 342.93333333333334 91 15 SLC17A5 solute carrier family 17 (anion/sugar transporter), member 5 1111 143 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB538990.[MT7]-AC[CAM]PEHSAPIK[MT7].3y4_1.heavy 466.586 / 572.389 20507.0 19.473499298095703 47 17 10 10 10 3.9282143171838997 25.456859510580134 0.0 3 0.9744436762816084 7.70342574978505 20507.0 41.418739527054434 0.0 - - - - - - - 751.6 41 10 SLC17A5 solute carrier family 17 (anion/sugar transporter), member 5 1113 143 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB538990.[MT7]-AC[CAM]PEHSAPIK[MT7].3y5_1.heavy 466.586 / 659.421 16201.0 19.473499298095703 47 17 10 10 10 3.9282143171838997 25.456859510580134 0.0 3 0.9744436762816084 7.70342574978505 16201.0 12.473623912429936 1.0 - - - - - - - 766.2222222222222 37 9 SLC17A5 solute carrier family 17 (anion/sugar transporter), member 5 1115 144 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 CH10_ECO24.SAGGIVLTGSAAAK.2y7.peptide 601.84 / 605.33 390871.0 27.361767450968426 23 -3 10 6 10 null 0.0 0.034099578857421875 3 0.0 0.0 390871.0 364.24992493102695 0.0 - - - - - - - 4255.0 781 1 1117 144 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 CH10_ECO24.SAGGIVLTGSAAAK.2y8.peptide 601.84 / 718.41 500097.0 27.361767450968426 23 -3 10 6 10 null 0.0 0.034099578857421875 3 0.0 0.0 500097.0 1419.553470154537 0.0 - - - - - - - 4673.0 1000 1 1119 144 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 CH10_ECO24.SAGGIVLTGSAAAK.2y9.peptide 601.84 / 817.48 668229.0 27.361767450968426 23 -3 10 6 10 null 0.0 0.034099578857421875 3 0.0 0.0 668229.0 700.3254430709794 0.0 - - - - - - - 5719.0 1336 1 1121 145 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54078.[MT7]-ILFVSESVFK[MT7].2y4_1.heavy 728.936 / 624.384 N/A N/A - - - - - - - - - 0.0 - - - - - - - ARNTL aryl hydrocarbon receptor nuclear translocator-like 1123 145 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54078.[MT7]-ILFVSESVFK[MT7].2b3_1.heavy 728.936 / 518.346 N/A N/A - - - - - - - - - 0.0 - - - - - - - ARNTL aryl hydrocarbon receptor nuclear translocator-like 1125 145 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54078.[MT7]-ILFVSESVFK[MT7].2y9_1.heavy 728.936 / 1199.68 N/A N/A - - - - - - - - - 0.0 - - - - - - - ARNTL aryl hydrocarbon receptor nuclear translocator-like 1127 145 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54078.[MT7]-ILFVSESVFK[MT7].2y6_1.heavy 728.936 / 840.458 N/A N/A - - - - - - - - - 0.0 - - - - - - - ARNTL aryl hydrocarbon receptor nuclear translocator-like 1129 146 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB55315.[MT7]-VMQLFGLVNTLLANDPTSLRK[MT7].4y9_2.heavy 655.379 / 573.323 N/A N/A - - - - - - - - - 0.0 - - - - - - - MTOR mechanistic target of rapamycin (serine/threonine kinase) 1131 146 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB55315.[MT7]-VMQLFGLVNTLLANDPTSLRK[MT7].4b4_1.heavy 655.379 / 616.361 N/A N/A - - - - - - - - - 0.0 - - - - - - - MTOR mechanistic target of rapamycin (serine/threonine kinase) 1133 146 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB55315.[MT7]-VMQLFGLVNTLLANDPTSLRK[MT7].4b6_1.heavy 655.379 / 820.451 N/A N/A - - - - - - - - - 0.0 - - - - - - - MTOR mechanistic target of rapamycin (serine/threonine kinase) 1135 146 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB55315.[MT7]-VMQLFGLVNTLLANDPTSLRK[MT7].4b3_1.heavy 655.379 / 503.277 N/A N/A - - - - - - - - - 0.0 - - - - - - - MTOR mechanistic target of rapamycin (serine/threonine kinase) 1137 147 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54840.[MT7]-TLDFGLNVK[MT7].2y5_1.heavy 647.884 / 674.432 12074.0 37.59505081176758 36 11 10 5 10 1.2983259371452183 61.37235891255189 0.04470062255859375 3 0.8570615314819403 3.2245827367496314 12074.0 20.288849927849927 0.0 - - - - - - - 803.0 24 9 LIMK2 LIM domain kinase 2 1139 147 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54840.[MT7]-TLDFGLNVK[MT7].2b6_1.heavy 647.884 / 791.442 3365.0 37.59505081176758 36 11 10 5 10 1.2983259371452183 61.37235891255189 0.04470062255859375 3 0.8570615314819403 3.2245827367496314 3365.0 15.975252525252525 0.0 - - - - - - - 841.5 6 8 LIMK2 LIM domain kinase 2 1141 147 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54840.[MT7]-TLDFGLNVK[MT7].2y6_1.heavy 647.884 / 821.5 22367.0 37.59505081176758 36 11 10 5 10 1.2983259371452183 61.37235891255189 0.04470062255859375 3 0.8570615314819403 3.2245827367496314 22367.0 98.40475869809202 0.0 - - - - - - - 297.0 44 10 LIMK2 LIM domain kinase 2 1143 147 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54840.[MT7]-TLDFGLNVK[MT7].2b5_1.heavy 647.884 / 678.358 13955.0 37.59505081176758 36 11 10 5 10 1.2983259371452183 61.37235891255189 0.04470062255859375 3 0.8570615314819403 3.2245827367496314 13955.0 26.483318028772572 0.0 - - - - - - - 841.5 27 8 LIMK2 LIM domain kinase 2 1145 148 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB55319.[MT7]-IVSWSQVGVEPSIMGIGPIPAIK[MT7].3y6_1.heavy 889.511 / 782.526 7575.0 48.65187358856201 46 20 10 6 10 15.069737802587094 6.635815520481884 0.033298492431640625 3 0.9914084620870456 13.30501857667246 7575.0 25.074041811846687 0.0 - - - - - - - 729.5714285714286 15 7 ACAT2 acetyl-CoA acetyltransferase 2 1147 148 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB55319.[MT7]-IVSWSQVGVEPSIMGIGPIPAIK[MT7].3b5_1.heavy 889.511 / 717.405 2066.0 48.65187358856201 46 20 10 6 10 15.069737802587094 6.635815520481884 0.033298492431640625 3 0.9914084620870456 13.30501857667246 2066.0 4.882711262266317 0.0 - - - - - - - 249.7 4 20 ACAT2 acetyl-CoA acetyltransferase 2 1149 148 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB55319.[MT7]-IVSWSQVGVEPSIMGIGPIPAIK[MT7].3y4_1.heavy 889.511 / 572.389 37704.0 48.65187358856201 46 20 10 6 10 15.069737802587094 6.635815520481884 0.033298492431640625 3 0.9914084620870456 13.30501857667246 37704.0 49.82044321761862 0.0 - - - - - - - 811.7142857142857 75 7 ACAT2 acetyl-CoA acetyltransferase 2 1151 148 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB55319.[MT7]-IVSWSQVGVEPSIMGIGPIPAIK[MT7].3b8_1.heavy 889.511 / 1001.55 6600.0 48.65187358856201 46 20 10 6 10 15.069737802587094 6.635815520481884 0.033298492431640625 3 0.9914084620870456 13.30501857667246 6600.0 15.41991774718684 0.0 - - - - - - - 729.5714285714286 13 7 ACAT2 acetyl-CoA acetyltransferase 2 1153 149 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54748.[MT7]-C[CAM]DEETQK[MT7].2b3_1.heavy 599.287 / 549.209 N/A N/A - - - - - - - - - 0.0 - - - - - - - LIMK2 LIM domain kinase 2 1155 149 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54748.[MT7]-C[CAM]DEETQK[MT7].2b4_1.heavy 599.287 / 678.252 N/A N/A - - - - - - - - - 0.0 - - - - - - - LIMK2 LIM domain kinase 2 1157 149 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54748.[MT7]-C[CAM]DEETQK[MT7].2b6_1.heavy 599.287 / 907.358 N/A N/A - - - - - - - - - 0.0 - - - - - - - LIMK2 LIM domain kinase 2 1159 149 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54748.[MT7]-C[CAM]DEETQK[MT7].2y3_1.heavy 599.287 / 520.321 N/A N/A - - - - - - - - - 0.0 - - - - - - - LIMK2 LIM domain kinase 2 1161 150 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB53595.[MT7]-DGFIDK[MT7].2b3_1.heavy 491.776 / 464.226 N/A N/A - - - - - - - - - 0.0 - - - - - - - MYL12B;MYL9;MYL12A;MYL2;MYL5;MYL10 myosin, light chain 12B, regulatory;myosin, light chain 9, regulatory;myosin, light chain 12A, regulatory, non-sarcomeric;myosin, light chain 2, regulatory, cardiac, slow;myosin, light chain 5, regulatory;myosin, light chain 10, regulatory 1163 150 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB53595.[MT7]-DGFIDK[MT7].2y5_1.heavy 491.776 / 723.416 N/A N/A - - - - - - - - - 0.0 - - - - - - - MYL12B;MYL9;MYL12A;MYL2;MYL5;MYL10 myosin, light chain 12B, regulatory;myosin, light chain 9, regulatory;myosin, light chain 12A, regulatory, non-sarcomeric;myosin, light chain 2, regulatory, cardiac, slow;myosin, light chain 5, regulatory;myosin, light chain 10, regulatory 1165 150 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB53595.[MT7]-DGFIDK[MT7].2y3_1.heavy 491.776 / 519.326 N/A N/A - - - - - - - - - 0.0 - - - - - - - MYL12B;MYL9;MYL12A;MYL2;MYL5;MYL10 myosin, light chain 12B, regulatory;myosin, light chain 9, regulatory;myosin, light chain 12A, regulatory, non-sarcomeric;myosin, light chain 2, regulatory, cardiac, slow;myosin, light chain 5, regulatory;myosin, light chain 10, regulatory 1167 150 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB53595.[MT7]-DGFIDK[MT7].2b5_1.heavy 491.776 / 692.337 N/A N/A - - - - - - - - - 0.0 - - - - - - - MYL12B;MYL9;MYL12A;MYL2;MYL5;MYL10 myosin, light chain 12B, regulatory;myosin, light chain 9, regulatory;myosin, light chain 12A, regulatory, non-sarcomeric;myosin, light chain 2, regulatory, cardiac, slow;myosin, light chain 5, regulatory;myosin, light chain 10, regulatory 1169 151 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54330.[MT7]-DLELAVPGTYDPNQPIIR.2b4_1.heavy 1078.08 / 615.347 N/A N/A - - - - - - - - - 0.0 - - - - - - - MTOR mechanistic target of rapamycin (serine/threonine kinase) 1171 151 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54330.[MT7]-DLELAVPGTYDPNQPIIR.2b6_1.heavy 1078.08 / 785.453 N/A N/A - - - - - - - - - 0.0 - - - - - - - MTOR mechanistic target of rapamycin (serine/threonine kinase) 1173 151 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54330.[MT7]-DLELAVPGTYDPNQPIIR.2b5_1.heavy 1078.08 / 686.384 N/A N/A - - - - - - - - - 0.0 - - - - - - - MTOR mechanistic target of rapamycin (serine/threonine kinase) 1175 151 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54330.[MT7]-DLELAVPGTYDPNQPIIR.2y7_1.heavy 1078.08 / 837.494 N/A N/A - - - - - - - - - 0.0 - - - - - - - MTOR mechanistic target of rapamycin (serine/threonine kinase) 1177 152 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54708.[MT7]-K[MT7]LGGDLLR.2b6_1.heavy 580.374 / 872.544 2412.0 28.553524494171143 35 18 10 3 4 6.104528521742018 16.381281477158783 0.07570075988769531 7 0.9850104633043225 10.067561204152955 2412.0 6.14957507082153 0.0 - - - - - - - 264.77272727272725 4 22 ITGB2 integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) 1179 152 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54708.[MT7]-K[MT7]LGGDLLR.2y6_1.heavy 580.374 / 630.357 3059.0 28.553524494171143 35 18 10 3 4 6.104528521742018 16.381281477158783 0.07570075988769531 7 0.9850104633043225 10.067561204152955 3059.0 8.433158932362755 5.0 - - - - - - - 823.2857142857143 8 7 ITGB2 integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) 1181 152 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54708.[MT7]-K[MT7]LGGDLLR.2b5_1.heavy 580.374 / 759.46 8411.0 28.553524494171143 35 18 10 3 4 6.104528521742018 16.381281477158783 0.07570075988769531 7 0.9850104633043225 10.067561204152955 8411.0 38.70781021634399 0.0 - - - - - - - 269.94117647058823 16 17 ITGB2 integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) 1183 152 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54708.[MT7]-K[MT7]LGGDLLR.2y7_1.heavy 580.374 / 743.441 4117.0 28.553524494171143 35 18 10 3 4 6.104528521742018 16.381281477158783 0.07570075988769531 7 0.9850104633043225 10.067561204152955 4117.0 17.33492666914023 0.0 - - - - - - - 285.7142857142857 8 21 ITGB2 integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) 1185 153 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB538062.[MT7]-ALNEITESGR.2y8_1.heavy 617.331 / 905.432 45317.0 27.72410011291504 48 18 10 10 10 6.292400642585328 15.892185777750077 0.0 3 0.9875948477683416 11.069075219653877 45317.0 334.76211834674996 0.0 - - - - - - - 839.0 90 7 ITGB2 integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) 1187 153 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB538062.[MT7]-ALNEITESGR.2b4_1.heavy 617.331 / 572.316 39792.0 27.72410011291504 48 18 10 10 10 6.292400642585328 15.892185777750077 0.0 3 0.9875948477683416 11.069075219653877 39792.0 48.84103413439767 0.0 - - - - - - - 1181.2222222222222 79 9 ITGB2 integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) 1189 153 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB538062.[MT7]-ALNEITESGR.2y9_1.heavy 617.331 / 1018.52 67206.0 27.72410011291504 48 18 10 10 10 6.292400642585328 15.892185777750077 0.0 3 0.9875948477683416 11.069075219653877 67206.0 290.73492885008363 0.0 - - - - - - - 739.0 134 7 ITGB2 integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) 1191 153 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB538062.[MT7]-ALNEITESGR.2y6_1.heavy 617.331 / 662.347 30072.0 27.72410011291504 48 18 10 10 10 6.292400642585328 15.892185777750077 0.0 3 0.9875948477683416 11.069075219653877 30072.0 88.56426527958388 0.0 - - - - - - - 745.6666666666666 60 9 ITGB2 integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) 1193 154 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB542235.[MT7]-VQTC[CAM]INLITSQEYAVK[MT7].3b6_1.heavy 719.061 / 860.442 25778.0 37.757198333740234 50 20 10 10 10 5.329208207667415 18.764513620639683 0.0 3 0.9914411665631945 13.330450934709189 25778.0 60.17859923220216 0.0 - - - - - - - 766.0 51 8 MKNK2 MAP kinase interacting serine/threonine kinase 2 1195 154 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB542235.[MT7]-VQTC[CAM]INLITSQEYAVK[MT7].3b4_1.heavy 719.061 / 633.315 14601.0 37.757198333740234 50 20 10 10 10 5.329208207667415 18.764513620639683 0.0 3 0.9914411665631945 13.330450934709189 14601.0 32.05822018863716 0.0 - - - - - - - 773.5 29 12 MKNK2 MAP kinase interacting serine/threonine kinase 2 1197 154 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB542235.[MT7]-VQTC[CAM]INLITSQEYAVK[MT7].3y4_1.heavy 719.061 / 624.384 17215.0 37.757198333740234 50 20 10 10 10 5.329208207667415 18.764513620639683 0.0 3 0.9914411665631945 13.330450934709189 17215.0 23.49768111249498 0.0 - - - - - - - 1262.0 34 7 MKNK2 MAP kinase interacting serine/threonine kinase 2 1199 154 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB542235.[MT7]-VQTC[CAM]INLITSQEYAVK[MT7].3b7_1.heavy 719.061 / 973.526 19288.0 37.757198333740234 50 20 10 10 10 5.329208207667415 18.764513620639683 0.0 3 0.9914411665631945 13.330450934709189 19288.0 31.63136868064118 0.0 - - - - - - - 766.0 38 8 MKNK2 MAP kinase interacting serine/threonine kinase 2 1201 155 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB536430.[MT7]-SISLSR.2b3_1.heavy 403.746 / 432.258 N/A N/A - - - - - - - - - 0.0 - - - - - - - MTOR mechanistic target of rapamycin (serine/threonine kinase) 1203 155 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB536430.[MT7]-SISLSR.2y4_1.heavy 403.746 / 462.267 N/A N/A - - - - - - - - - 0.0 - - - - - - - MTOR mechanistic target of rapamycin (serine/threonine kinase) 1205 155 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB536430.[MT7]-SISLSR.2y5_1.heavy 403.746 / 575.351 N/A N/A - - - - - - - - - 0.0 - - - - - - - MTOR mechanistic target of rapamycin (serine/threonine kinase) 1207 155 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB536430.[MT7]-SISLSR.2b5_1.heavy 403.746 / 632.374 N/A N/A - - - - - - - - - 0.0 - - - - - - - MTOR mechanistic target of rapamycin (serine/threonine kinase) 1209 156 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB539347.[MT7]-GDLIVADSSRK[MT7].3y7_1.heavy 483.615 / 906.513 7491.0 24.650800704956055 47 17 10 10 10 4.48536606717988 22.294724332918 0.0 3 0.9736659949643729 7.5883301587261105 7491.0 51.09075140204682 0.0 - - - - - - - 172.75 14 12 TRIM32 tripartite motif-containing 32 1211 156 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB539347.[MT7]-GDLIVADSSRK[MT7].3y6_1.heavy 483.615 / 807.444 9419.0 24.650800704956055 47 17 10 10 10 4.48536606717988 22.294724332918 0.0 3 0.9736659949643729 7.5883301587261105 9419.0 21.58933262138202 0.0 - - - - - - - 265.6666666666667 18 12 TRIM32 tripartite motif-containing 32 1213 156 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB539347.[MT7]-GDLIVADSSRK[MT7].3b4_1.heavy 483.615 / 543.326 28034.0 24.650800704956055 47 17 10 10 10 4.48536606717988 22.294724332918 0.0 3 0.9736659949643729 7.5883301587261105 28034.0 25.66635417875377 0.0 - - - - - - - 1197.2857142857142 56 7 TRIM32 tripartite motif-containing 32 1215 156 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB539347.[MT7]-GDLIVADSSRK[MT7].3y4_1.heavy 483.615 / 621.38 6675.0 24.650800704956055 47 17 10 10 10 4.48536606717988 22.294724332918 0.0 3 0.9736659949643729 7.5883301587261105 6675.0 8.706896551724139 3.0 - - - - - - - 1307.0 13 8 TRIM32 tripartite motif-containing 32 1217 157 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB542230.[MT7]-DLELAVPGTYDPNQPIIR.3y7_1.heavy 719.055 / 837.494 129132.0 40.29899978637695 45 15 10 10 10 2.5104537405633 31.69986895541348 0.0 3 0.95871857232045 6.053123756987365 129132.0 164.36272397536214 0.0 - - - - - - - 720.8 258 10 MTOR mechanistic target of rapamycin (serine/threonine kinase) 1219 157 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB542230.[MT7]-DLELAVPGTYDPNQPIIR.3b6_1.heavy 719.055 / 785.453 46433.0 40.29899978637695 45 15 10 10 10 2.5104537405633 31.69986895541348 0.0 3 0.95871857232045 6.053123756987365 46433.0 193.89604395604397 0.0 - - - - - - - 672.0 92 7 MTOR mechanistic target of rapamycin (serine/threonine kinase) 1221 157 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB542230.[MT7]-DLELAVPGTYDPNQPIIR.3b4_1.heavy 719.055 / 615.347 82320.0 40.29899978637695 45 15 10 10 10 2.5104537405633 31.69986895541348 0.0 3 0.95871857232045 6.053123756987365 82320.0 86.07814192432681 0.0 - - - - - - - 750.3333333333334 164 9 MTOR mechanistic target of rapamycin (serine/threonine kinase) 1223 157 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB542230.[MT7]-DLELAVPGTYDPNQPIIR.3b5_1.heavy 719.055 / 686.384 152197.0 40.29899978637695 45 15 10 10 10 2.5104537405633 31.69986895541348 0.0 3 0.95871857232045 6.053123756987365 152197.0 141.26214719346282 0.0 - - - - - - - 769.5714285714286 304 7 MTOR mechanistic target of rapamycin (serine/threonine kinase) 1225 158 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB53991.[MT7]-DTILQLNLK[MT7].2y4_1.heavy 673.418 / 631.426 1537.0 43.723201751708984 35 5 10 10 10 0.4466517686683027 103.31232199509594 0.0 3 0.6100463014301114 1.9081366146400072 1537.0 0.35702671312427403 1.0 - - - - - - - 377.42857142857144 3 7 GNA11;GNAQ guanine nucleotide binding protein (G protein), alpha 11 (Gq class);guanine nucleotide binding protein (G protein), q polypeptide 1227 158 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB53991.[MT7]-DTILQLNLK[MT7].2y3_1.heavy 673.418 / 518.342 1045.0 43.723201751708984 35 5 10 10 10 0.4466517686683027 103.31232199509594 0.0 3 0.6100463014301114 1.9081366146400072 1045.0 1.1166085946573752 13.0 - - - - - - - 377.7142857142857 2 7 GNA11;GNAQ guanine nucleotide binding protein (G protein), alpha 11 (Gq class);guanine nucleotide binding protein (G protein), q polypeptide 1229 158 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB53991.[MT7]-DTILQLNLK[MT7].2y6_1.heavy 673.418 / 872.569 430.0 43.723201751708984 35 5 10 10 10 0.4466517686683027 103.31232199509594 0.0 3 0.6100463014301114 1.9081366146400072 430.0 0.5088757396449705 36.0 - - - - - - - 0.0 1 0 GNA11;GNAQ guanine nucleotide binding protein (G protein), alpha 11 (Gq class);guanine nucleotide binding protein (G protein), q polypeptide 1231 158 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB53991.[MT7]-DTILQLNLK[MT7].2b5_1.heavy 673.418 / 715.411 5656.0 43.723201751708984 35 5 10 10 10 0.4466517686683027 103.31232199509594 0.0 3 0.6100463014301114 1.9081366146400072 5656.0 3.448780487804878 0.0 - - - - - - - 330.25 11 8 GNA11;GNAQ guanine nucleotide binding protein (G protein), alpha 11 (Gq class);guanine nucleotide binding protein (G protein), q polypeptide 1233 159 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB55320.[MT7]-IVSWSQVGVEPSIMGIGPIPAIK[MT7].4y4_1.heavy 667.385 / 572.389 39239.0 48.62687397003174 40 17 10 3 10 2.621726054113219 38.142810475225005 0.06669998168945312 3 0.972980588110913 7.491032450697048 39239.0 21.269319258652125 0.0 - - - - - - - 739.625 78 8 ACAT2 acetyl-CoA acetyltransferase 2 1235 159 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB55320.[MT7]-IVSWSQVGVEPSIMGIGPIPAIK[MT7].4b5_1.heavy 667.385 / 717.405 2241.0 48.62687397003174 40 17 10 3 10 2.621726054113219 38.142810475225005 0.06669998168945312 3 0.972980588110913 7.491032450697048 2241.0 4.459701492537314 2.0 - - - - - - - 212.8235294117647 6 17 ACAT2 acetyl-CoA acetyltransferase 2 1237 159 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB55320.[MT7]-IVSWSQVGVEPSIMGIGPIPAIK[MT7].4y3_1.heavy 667.385 / 475.336 5171.0 48.62687397003174 40 17 10 3 10 2.621726054113219 38.142810475225005 0.06669998168945312 3 0.972980588110913 7.491032450697048 5171.0 9.363723858380286 0.0 - - - - - - - 651.1111111111111 10 9 ACAT2 acetyl-CoA acetyltransferase 2 1239 159 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB55320.[MT7]-IVSWSQVGVEPSIMGIGPIPAIK[MT7].4b6_1.heavy 667.385 / 845.464 4366.0 48.62687397003174 40 17 10 3 10 2.621726054113219 38.142810475225005 0.06669998168945312 3 0.972980588110913 7.491032450697048 4366.0 1.9157950650248134 1.0 - - - - - - - 246.28571428571428 8 14 ACAT2 acetyl-CoA acetyltransferase 2 1241 160 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54857.[MT7]-ELVPTLPQNR.2y4_1.heavy 655.881 / 514.273 9730.0 32.142699241638184 46 20 10 6 10 5.019737893762067 14.882081631643114 0.030399322509765625 3 0.9977614720973763 26.079548318012122 9730.0 25.86700623851252 0.0 - - - - - - - 734.4615384615385 19 13 ID1 inhibitor of DNA binding 1, dominant negative helix-loop-helix protein 1243 160 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54857.[MT7]-ELVPTLPQNR.2y8_1.heavy 655.881 / 924.526 8445.0 32.142699241638184 46 20 10 6 10 5.019737893762067 14.882081631643114 0.030399322509765625 3 0.9977614720973763 26.079548318012122 8445.0 16.37295918367347 1.0 - - - - - - - 260.89473684210526 17 19 ID1 inhibitor of DNA binding 1, dominant negative helix-loop-helix protein 1245 160 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54857.[MT7]-ELVPTLPQNR.2y9_1.heavy 655.881 / 1037.61 13891.0 32.142699241638184 46 20 10 6 10 5.019737893762067 14.882081631643114 0.030399322509765625 3 0.9977614720973763 26.079548318012122 13891.0 53.30494835218888 0.0 - - - - - - - 309.6875 27 16 ID1 inhibitor of DNA binding 1, dominant negative helix-loop-helix protein 1247 160 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54857.[MT7]-ELVPTLPQNR.2y7_1.heavy 655.881 / 825.458 94792.0 32.142699241638184 46 20 10 6 10 5.019737893762067 14.882081631643114 0.030399322509765625 3 0.9977614720973763 26.079548318012122 94792.0 115.83343452593093 0.0 - - - - - - - 752.8 189 10 ID1 inhibitor of DNA binding 1, dominant negative helix-loop-helix protein 1249 161 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB536854.[MT7]-TDEFPR.2b3_1.heavy 454.733 / 490.227 26220.0 23.900850296020508 42 18 10 6 8 10.433381517047199 9.58462027259418 0.039501190185546875 4 0.9854478668022445 10.218119305581489 26220.0 35.848676010634136 0.0 - - - - - - - 481.0 52 1 ACAT2 acetyl-CoA acetyltransferase 2 1251 161 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB536854.[MT7]-TDEFPR.2y4_1.heavy 454.733 / 548.283 38848.0 23.900850296020508 42 18 10 6 8 10.433381517047199 9.58462027259418 0.039501190185546875 4 0.9854478668022445 10.218119305581489 38848.0 67.23263078997569 0.0 - - - - - - - 481.0 77 1 ACAT2 acetyl-CoA acetyltransferase 2 1253 161 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB536854.[MT7]-TDEFPR.2y5_1.heavy 454.733 / 663.31 19905.0 23.900850296020508 42 18 10 6 8 10.433381517047199 9.58462027259418 0.039501190185546875 4 0.9854478668022445 10.218119305581489 19905.0 4.080751708428246 1.0 - - - - - - - 765.5454545454545 40 11 ACAT2 acetyl-CoA acetyltransferase 2 1255 161 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB536854.[MT7]-TDEFPR.2b4_1.heavy 454.733 / 637.295 19665.0 23.900850296020508 42 18 10 6 8 10.433381517047199 9.58462027259418 0.039501190185546875 4 0.9854478668022445 10.218119305581489 19665.0 21.156406391502934 0.0 - - - - - - - 704.4285714285714 39 7 ACAT2 acetyl-CoA acetyltransferase 2 1257 162 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB538486.[MT7]-ELVPTLPQNR.3y3_1.heavy 437.59 / 417.22 35096.0 32.142699241638184 46 20 10 6 10 42.79524319782835 2.336708300446684 0.030399322509765625 3 0.9995718387945068 59.64076639939906 35096.0 19.036751153902856 0.0 - - - - - - - 1304.142857142857 70 7 ID1 inhibitor of DNA binding 1, dominant negative helix-loop-helix protein 1259 162 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB538486.[MT7]-ELVPTLPQNR.3b5_1.heavy 437.59 / 684.405 14556.0 32.142699241638184 46 20 10 6 10 42.79524319782835 2.336708300446684 0.030399322509765625 3 0.9995718387945068 59.64076639939906 14556.0 45.85008332876487 0.0 - - - - - - - 274.4 29 20 ID1 inhibitor of DNA binding 1, dominant negative helix-loop-helix protein 1261 162 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB538486.[MT7]-ELVPTLPQNR.3b3_1.heavy 437.59 / 486.304 152286.0 32.142699241638184 46 20 10 6 10 42.79524319782835 2.336708300446684 0.030399322509765625 3 0.9995718387945068 59.64076639939906 152286.0 119.12818850810217 0.0 - - - - - - - 740.0 304 1 ID1 inhibitor of DNA binding 1, dominant negative helix-loop-helix protein 1263 162 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB538486.[MT7]-ELVPTLPQNR.3y4_1.heavy 437.59 / 514.273 174738.0 32.142699241638184 46 20 10 6 10 42.79524319782835 2.336708300446684 0.030399322509765625 3 0.9995718387945068 59.64076639939906 174738.0 223.4508988310564 0.0 - - - - - - - 2228.0 349 8 ID1 inhibitor of DNA binding 1, dominant negative helix-loop-helix protein 1265 163 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TPX_ECO57.DLSDVTLGQFAGK.2y7.peptide 675.85 / 720.4 219153.0 37.757198333740234 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 219153.0 136.4727241962775 0.0 - - - - - - - 746.2857142857143 438 7 1267 163 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TPX_ECO57.DLSDVTLGQFAGK.2y8.peptide 675.85 / 821.45 639051.0 37.757198333740234 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 639051.0 213.48485183384634 0.0 - - - - - - - 264.3333333333333 1278 6 1269 163 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TPX_ECO57.DLSDVTLGQFAGK.2y6.peptide 675.85 / 607.32 560910.0 37.757198333740234 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 560910.0 90.05422026471415 0.0 - - - - - - - 1239.5714285714287 1121 7 1271 164 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB540693.[MT7]-LIAINANDPEASK[MT7].3b4_1.heavy 548.645 / 555.399 31260.0 32.302398681640625 50 20 10 10 10 11.429560133379676 8.749243088362876 0.0 3 0.9974907302415534 24.631895769875918 31260.0 33.558314891930415 0.0 - - - - - - - 381.0 62 1 PPA2 pyrophosphatase (inorganic) 2 1273 164 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB540693.[MT7]-LIAINANDPEASK[MT7].3b5_1.heavy 548.645 / 669.442 22937.0 32.302398681640625 50 20 10 10 10 11.429560133379676 8.749243088362876 0.0 3 0.9974907302415534 24.631895769875918 22937.0 27.85452773613193 0.0 - - - - - - - 1278.625 45 8 PPA2 pyrophosphatase (inorganic) 2 1275 164 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB540693.[MT7]-LIAINANDPEASK[MT7].3y4_1.heavy 548.645 / 578.327 28909.0 32.302398681640625 50 20 10 10 10 11.429560133379676 8.749243088362876 0.0 3 0.9974907302415534 24.631895769875918 28909.0 21.839035415899097 0.0 - - - - - - - 1271.0 57 1 PPA2 pyrophosphatase (inorganic) 2 1277 164 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB540693.[MT7]-LIAINANDPEASK[MT7].3y5_1.heavy 548.645 / 675.379 55340.0 32.302398681640625 50 20 10 10 10 11.429560133379676 8.749243088362876 0.0 3 0.9974907302415534 24.631895769875918 55340.0 35.10813010870223 0.0 - - - - - - - 445.0 110 1 PPA2 pyrophosphatase (inorganic) 2 1279 165 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB536719.[MT7]-QDLPK[MT7].2y4_1.heavy 444.773 / 616.379 N/A N/A - - - - - - - - - 0.0 - - - - - - - ARL4C;NDUFS1;PRKAA1 ADP-ribosylation factor-like 4C;NADH dehydrogenase (ubiquinone) Fe-S protein 1, 75kDa (NADH-coenzyme Q reductase);protein kinase, AMP-activated, alpha 1 catalytic subunit 1281 166 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54323.[MT7]-ALYPSIYMPAVLEGTGK[MT7].2b3_1.heavy 1049.58 / 492.294 N/A N/A - - - - - - - - - 0.0 - - - - - - - HYAL1 hyaluronoglucosaminidase 1 1283 166 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54323.[MT7]-ALYPSIYMPAVLEGTGK[MT7].2y4_1.heavy 1049.58 / 506.306 N/A N/A - - - - - - - - - 0.0 - - - - - - - HYAL1 hyaluronoglucosaminidase 1 1285 166 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54323.[MT7]-ALYPSIYMPAVLEGTGK[MT7].2y9_1.heavy 1049.58 / 1015.59 N/A N/A - - - - - - - - - 0.0 - - - - - - - HYAL1 hyaluronoglucosaminidase 1 1287 166 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54323.[MT7]-ALYPSIYMPAVLEGTGK[MT7].2y6_1.heavy 1049.58 / 748.432 N/A N/A - - - - - - - - - 0.0 - - - - - - - HYAL1 hyaluronoglucosaminidase 1 1289 167 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB536715.[MT7]-DFGEK[MT7].2b3_1.heavy 442.242 / 464.226 4741.0 21.02669906616211 50 20 10 10 10 5.966262663007143 16.760911419477726 0.0 3 0.9949918825527754 17.431858852930624 4741.0 10.834295691592878 0.0 - - - - - - - 761.6363636363636 9 11 TRIM32 tripartite motif-containing 32 1291 167 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB536715.[MT7]-DFGEK[MT7].2y4_1.heavy 442.242 / 624.347 58614.0 21.02669906616211 50 20 10 10 10 5.966262663007143 16.760911419477726 0.0 3 0.9949918825527754 17.431858852930624 58614.0 78.88555728197254 0.0 - - - - - - - 1159.75 117 8 TRIM32 tripartite motif-containing 32 1293 167 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB536715.[MT7]-DFGEK[MT7].2b4_1.heavy 442.242 / 593.269 10832.0 21.02669906616211 50 20 10 10 10 5.966262663007143 16.760911419477726 0.0 3 0.9949918825527754 17.431858852930624 10832.0 19.2623001470165 0.0 - - - - - - - 745.8125 21 16 TRIM32 tripartite motif-containing 32 1295 167 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB536715.[MT7]-DFGEK[MT7].2y3_1.heavy 442.242 / 477.279 24320.0 21.02669906616211 50 20 10 10 10 5.966262663007143 16.760911419477726 0.0 3 0.9949918825527754 17.431858852930624 24320.0 37.59234988592787 0.0 - - - - - - - 841.25 48 12 TRIM32 tripartite motif-containing 32 1297 168 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB542222.[MT7]-QLPQLTSLELQYVSPK[MT7].3b9_1.heavy 711.412 / 1154.65 5520.0 42.206298828125 44 14 10 10 10 1.4896103813803816 44.5796698376014 0.0 3 0.9419235994856744 5.096099801615284 5520.0 15.559999999999999 0.0 - - - - - - - 229.91666666666666 11 12 MTOR mechanistic target of rapamycin (serine/threonine kinase) 1299 168 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB542222.[MT7]-QLPQLTSLELQYVSPK[MT7].3b4_1.heavy 711.412 / 611.363 9737.0 42.206298828125 44 14 10 10 10 1.4896103813803816 44.5796698376014 0.0 3 0.9419235994856744 5.096099801615284 9737.0 24.558693640724123 0.0 - - - - - - - 291.2 19 10 MTOR mechanistic target of rapamycin (serine/threonine kinase) 1301 168 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB542222.[MT7]-QLPQLTSLELQYVSPK[MT7].3b5_1.heavy 711.412 / 724.447 5827.0 42.206298828125 44 14 10 10 10 1.4896103813803816 44.5796698376014 0.0 3 0.9419235994856744 5.096099801615284 5827.0 5.6399382773351405 1.0 - - - - - - - 366.85714285714283 15 14 MTOR mechanistic target of rapamycin (serine/threonine kinase) 1303 168 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB542222.[MT7]-QLPQLTSLELQYVSPK[MT7].3y5_1.heavy 711.412 / 737.431 10734.0 42.206298828125 44 14 10 10 10 1.4896103813803816 44.5796698376014 0.0 3 0.9419235994856744 5.096099801615284 10734.0 21.652242002978934 0.0 - - - - - - - 736.0 21 10 MTOR mechanistic target of rapamycin (serine/threonine kinase) 1305 169 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB53838.[MT7]-SQMYVQHR.2y5_1.heavy 596.804 / 702.368 N/A N/A - - - - - - - - - 0.0 - - - - - - - HYAL1 hyaluronoglucosaminidase 1 1307 169 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB53838.[MT7]-SQMYVQHR.2b4_1.heavy 596.804 / 654.304 N/A N/A - - - - - - - - - 0.0 - - - - - - - HYAL1 hyaluronoglucosaminidase 1 1309 169 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB53838.[MT7]-SQMYVQHR.2b5_1.heavy 596.804 / 753.372 N/A N/A - - - - - - - - - 0.0 - - - - - - - HYAL1 hyaluronoglucosaminidase 1 1311 169 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB53838.[MT7]-SQMYVQHR.2y7_1.heavy 596.804 / 961.467 N/A N/A - - - - - - - - - 0.0 - - - - - - - HYAL1 hyaluronoglucosaminidase 1 1313 170 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB538783.[MT7]-LRELMGELQR.3y6_1.heavy 463.598 / 733.366 23538.0 36.18360137939453 50 20 10 10 10 9.368658652159894 10.67388659495514 0.0 3 0.996246423976541 20.13741969693378 23538.0 134.22978280419676 0.0 - - - - - - - 214.8 47 10 TRIM32 tripartite motif-containing 32 1315 170 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB538783.[MT7]-LRELMGELQR.3b4_1.heavy 463.598 / 656.421 16170.0 36.18360137939453 50 20 10 10 10 9.368658652159894 10.67388659495514 0.0 3 0.996246423976541 20.13741969693378 16170.0 54.155840365959456 0.0 - - - - - - - 281.4166666666667 32 12 TRIM32 tripartite motif-containing 32 1317 170 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB538783.[MT7]-LRELMGELQR.3b7_1.heavy 463.598 / 973.526 N/A 36.18360137939453 50 20 10 10 10 9.368658652159894 10.67388659495514 0.0 3 0.996246423976541 20.13741969693378 0.0 0.0 9.0 - - - - - - - 0.0 0 0 TRIM32 tripartite motif-containing 32 1319 170 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB538783.[MT7]-LRELMGELQR.3y5_1.heavy 463.598 / 602.326 92208.0 36.18360137939453 50 20 10 10 10 9.368658652159894 10.67388659495514 0.0 3 0.996246423976541 20.13741969693378 92208.0 223.78997659690316 0.0 - - - - - - - 585.0 184 7 TRIM32 tripartite motif-containing 32 1321 171 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB539339.[MT7]-QYLLGLYDTAGQEDYDR.3y7_1.heavy 722.015 / 882.359 82086.0 40.86180114746094 46 16 10 10 10 4.066353479203895 24.59205785021372 0.0 3 0.9691868431612369 7.012498049629055 82086.0 70.0106808929695 0.0 - - - - - - - 328.6666666666667 164 3 RHOQ ras homolog gene family, member Q 1323 171 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB539339.[MT7]-QYLLGLYDTAGQEDYDR.3b6_1.heavy 722.015 / 832.505 53739.0 40.86180114746094 46 16 10 10 10 4.066353479203895 24.59205785021372 0.0 3 0.9691868431612369 7.012498049629055 53739.0 64.6045576799573 0.0 - - - - - - - 1234.4285714285713 107 7 RHOQ ras homolog gene family, member Q 1325 171 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB539339.[MT7]-QYLLGLYDTAGQEDYDR.3b5_1.heavy 722.015 / 719.421 87619.0 40.86180114746094 46 16 10 10 10 4.066353479203895 24.59205785021372 0.0 3 0.9691868431612369 7.012498049629055 87619.0 76.74027699443725 0.0 - - - - - - - 1245.2857142857142 175 7 RHOQ ras homolog gene family, member Q 1327 171 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB539339.[MT7]-QYLLGLYDTAGQEDYDR.3b3_1.heavy 722.015 / 549.315 51692.0 40.86180114746094 46 16 10 10 10 4.066353479203895 24.59205785021372 0.0 3 0.9691868431612369 7.012498049629055 51692.0 34.10059413780208 0.0 - - - - - - - 1355.888888888889 103 9 RHOQ ras homolog gene family, member Q 1329 172 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54324.[MT7]-VSK[MT7]VEILQHVIDYIR.4y4_1.heavy 525.816 / 566.293 N/A N/A - - - - - - - - - 0.0 - - - - - - - ID1 inhibitor of DNA binding 1, dominant negative helix-loop-helix protein 1331 172 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54324.[MT7]-VSK[MT7]VEILQHVIDYIR.4y5_1.heavy 525.816 / 679.377 N/A N/A - - - - - - - - - 0.0 - - - - - - - ID1 inhibitor of DNA binding 1, dominant negative helix-loop-helix protein 1333 172 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54324.[MT7]-VSK[MT7]VEILQHVIDYIR.4b5_1.heavy 525.816 / 831.518 N/A N/A - - - - - - - - - 0.0 - - - - - - - ID1 inhibitor of DNA binding 1, dominant negative helix-loop-helix protein 1335 172 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54324.[MT7]-VSK[MT7]VEILQHVIDYIR.4y6_1.heavy 525.816 / 778.446 N/A N/A - - - - - - - - - 0.0 - - - - - - - ID1 inhibitor of DNA binding 1, dominant negative helix-loop-helix protein 1337 173 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54464.[MT7]-EDQDK[MT7].2b3_1.heavy 461.74 / 517.237 N/A N/A - - - - - - - - - 0.0 - - - - - - - ACAT2;SMC1A acetyl-CoA acetyltransferase 2;structural maintenance of chromosomes 1A 1339 173 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54464.[MT7]-EDQDK[MT7].2y4_1.heavy 461.74 / 649.327 N/A N/A - - - - - - - - - 0.0 - - - - - - - ACAT2;SMC1A acetyl-CoA acetyltransferase 2;structural maintenance of chromosomes 1A 1341 173 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54464.[MT7]-EDQDK[MT7].2b4_1.heavy 461.74 / 632.264 N/A N/A - - - - - - - - - 0.0 - - - - - - - ACAT2;SMC1A acetyl-CoA acetyltransferase 2;structural maintenance of chromosomes 1A 1343 173 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54464.[MT7]-EDQDK[MT7].2y3_1.heavy 461.74 / 534.3 N/A N/A - - - - - - - - - 0.0 - - - - - - - ACAT2;SMC1A acetyl-CoA acetyltransferase 2;structural maintenance of chromosomes 1A 1345 174 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB539851.[MT7]-LRPLTASQTVK[MT7].3b6_1.heavy 501.315 / 796.516 8036.0 26.328800201416016 42 20 2 10 10 30.006553349115165 3.332605342457594 0.0 3 0.9996737410281605 68.32337790766417 8036.0 33.45303167420814 0.0 - - - - - - - 240.8 16 15 OGDH oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide) 1347 174 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB539851.[MT7]-LRPLTASQTVK[MT7].3b5_1.heavy 501.315 / 725.479 6340.0 26.328800201416016 42 20 2 10 10 30.006553349115165 3.332605342457594 0.0 3 0.9996737410281605 68.32337790766417 6340.0 15.380752317274528 1.0 - - - - - - - 706.75 12 12 OGDH oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide) 1349 174 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB539851.[MT7]-LRPLTASQTVK[MT7].3b7_1.heavy 501.315 / 883.548 6266.0 26.328800201416016 42 20 2 10 10 30.006553349115165 3.332605342457594 0.0 3 0.9996737410281605 68.32337790766417 6266.0 38.10723210214318 0.0 - - - - - - - 174.1818181818182 12 11 OGDH oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide) 1351 174 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB539851.[MT7]-LRPLTASQTVK[MT7].3b8_2.heavy 501.315 / 506.307 N/A 26.328800201416016 42 20 2 10 10 30.006553349115165 3.332605342457594 0.0 3 0.9996737410281605 68.32337790766417 23444.0 16.01324122379072 1.0 - - - - - - - 369.0 99 1 OGDH oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide) 1353 175 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54327.[MT7]-K[MT7]LNLLTEYIEGGTLK[MT7].3y6_1.heavy 708.76 / 748.432 16042.0 48.38639831542969 40 10 10 10 10 1.962890465689946 33.96351851107172 0.0 2 0.8293934637917288 2.9443357770798 16042.0 88.81223188405797 0.0 - - - - - - - 217.0 32 9 LIMK2 LIM domain kinase 2 1355 175 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54327.[MT7]-K[MT7]LNLLTEYIEGGTLK[MT7].3b5_1.heavy 708.76 / 870.602 N/A 48.38639831542969 40 10 10 10 10 1.962890465689946 33.96351851107172 0.0 2 0.8293934637917288 2.9443357770798 287.0 1.1665722952477249 27.0 - - - - - - - 0.0 1 0 LIMK2 LIM domain kinase 2 1357 175 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54327.[MT7]-K[MT7]LNLLTEYIEGGTLK[MT7].3b3_1.heavy 708.76 / 644.433 6612.0 48.38639831542969 40 10 10 10 10 1.962890465689946 33.96351851107172 0.0 2 0.8293934637917288 2.9443357770798 6612.0 21.339060903204107 0.0 - - - - - - - 325.55555555555554 13 9 LIMK2 LIM domain kinase 2 1359 175 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54327.[MT7]-K[MT7]LNLLTEYIEGGTLK[MT7].3y5_1.heavy 708.76 / 619.39 N/A 48.38639831542969 40 10 10 10 10 1.962890465689946 33.96351851107172 0.0 2 0.8293934637917288 2.9443357770798 747.0 0.5196521739130435 18.0 - - - - - - - 236.11111111111111 12 9 LIMK2 LIM domain kinase 2 1361 176 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB538490.[MT7]-EEWVPELK[MT7].2b3_1.heavy 659.368 / 589.274 26608.0 36.313899993896484 48 18 10 10 10 3.4343497847472033 29.117593217826773 0.0 3 0.9846552930538951 9.950070503041582 26608.0 58.003650936169535 0.0 - - - - - - - 409.0 53 2 LOC100510206;RHOQ rho-related GTP-binding protein RhoQ-like;ras homolog gene family, member Q 1363 176 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB538490.[MT7]-EEWVPELK[MT7].2y4_1.heavy 659.368 / 630.394 60790.0 36.313899993896484 48 18 10 10 10 3.4343497847472033 29.117593217826773 0.0 3 0.9846552930538951 9.950070503041582 60790.0 104.96754175324651 0.0 - - - - - - - 672.4285714285714 121 7 LOC100510206;RHOQ rho-related GTP-binding protein RhoQ-like;ras homolog gene family, member Q 1365 176 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB538490.[MT7]-EEWVPELK[MT7].2y5_1.heavy 659.368 / 729.463 9415.0 36.313899993896484 48 18 10 10 10 3.4343497847472033 29.117593217826773 0.0 3 0.9846552930538951 9.950070503041582 9415.0 20.548629647637853 0.0 - - - - - - - 599.5714285714286 18 7 LOC100510206;RHOQ rho-related GTP-binding protein RhoQ-like;ras homolog gene family, member Q 1367 176 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB538490.[MT7]-EEWVPELK[MT7].2b4_1.heavy 659.368 / 688.342 23947.0 36.313899993896484 48 18 10 10 10 3.4343497847472033 29.117593217826773 0.0 3 0.9846552930538951 9.950070503041582 23947.0 14.262394820997777 1.0 - - - - - - - 340.8333333333333 67 6 LOC100510206;RHOQ rho-related GTP-binding protein RhoQ-like;ras homolog gene family, member Q 1369 177 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB53868.[MT7]-EAHSQIEK[MT7].2y5_1.heavy 615.34 / 748.432 2804.0 17.260374546051025 45 18 10 7 10 5.7437701996760655 17.41016728100295 0.025499343872070312 3 0.9856552630202803 10.291899836719992 2804.0 48.068571428571424 0.0 - - - - - - - 81.66666666666667 5 6 ARNTL aryl hydrocarbon receptor nuclear translocator-like 1371 177 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB53868.[MT7]-EAHSQIEK[MT7].2y3_1.heavy 615.34 / 533.341 1577.0 17.260374546051025 45 18 10 7 10 5.7437701996760655 17.41016728100295 0.025499343872070312 3 0.9856552630202803 10.291899836719992 1577.0 15.77 0.0 - - - - - - - 146.6875 3 16 ARNTL aryl hydrocarbon receptor nuclear translocator-like 1373 177 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB53868.[MT7]-EAHSQIEK[MT7].2y6_1.heavy 615.34 / 885.491 1157.0 17.260374546051025 45 18 10 7 10 5.7437701996760655 17.41016728100295 0.025499343872070312 3 0.9856552630202803 10.291899836719992 1157.0 9.917142857142856 0.0 - - - - - - - 91.53846153846153 2 13 ARNTL aryl hydrocarbon receptor nuclear translocator-like 1375 177 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB53868.[MT7]-EAHSQIEK[MT7].2y7_1.heavy 615.34 / 956.528 1823.0 17.260374546051025 45 18 10 7 10 5.7437701996760655 17.41016728100295 0.025499343872070312 3 0.9856552630202803 10.291899836719992 1823.0 7.291999999999999 0.0 - - - - - - - 162.36363636363637 3 11 ARNTL aryl hydrocarbon receptor nuclear translocator-like 1377 178 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB53720.[MT7]-APHLAYLR.2y4_1.heavy 542.823 / 522.304 N/A N/A - - - - - - - - - 0.0 - - - - - - - ACAT2 acetyl-CoA acetyltransferase 2 1379 178 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB53720.[MT7]-APHLAYLR.2y5_1.heavy 542.823 / 635.388 N/A N/A - - - - - - - - - 0.0 - - - - - - - ACAT2 acetyl-CoA acetyltransferase 2 1381 178 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB53720.[MT7]-APHLAYLR.2y6_1.heavy 542.823 / 772.446 N/A N/A - - - - - - - - - 0.0 - - - - - - - ACAT2 acetyl-CoA acetyltransferase 2 1383 178 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB53720.[MT7]-APHLAYLR.2y7_1.heavy 542.823 / 869.499 N/A N/A - - - - - - - - - 0.0 - - - - - - - ACAT2 acetyl-CoA acetyltransferase 2 1385 179 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB53880.[MT7]-SSPYPTDVAR.2y8_1.heavy 618.821 / 918.468 N/A N/A - - - - - - - - - 0.0 - - - - - - - OGDH;OGDHL oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide);oxoglutarate dehydrogenase-like 1387 179 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB53880.[MT7]-SSPYPTDVAR.2y9_1.heavy 618.821 / 1005.5 N/A N/A - - - - - - - - - 0.0 - - - - - - - OGDH;OGDHL oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide);oxoglutarate dehydrogenase-like 1389 179 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB53880.[MT7]-SSPYPTDVAR.2y6_1.heavy 618.821 / 658.352 N/A N/A - - - - - - - - - 0.0 - - - - - - - OGDH;OGDHL oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide);oxoglutarate dehydrogenase-like 1391 179 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB53880.[MT7]-SSPYPTDVAR.2y7_1.heavy 618.821 / 821.415 N/A N/A - - - - - - - - - 0.0 - - - - - - - OGDH;OGDHL oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide);oxoglutarate dehydrogenase-like 1393 180 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54727.[MT7]-EILHFPK[MT7].2b3_1.heavy 586.357 / 500.32 9235.0 31.995375633239746 41 14 10 7 10 2.6016757664596764 38.43676498400821 0.029300689697265625 3 0.9337424821331132 4.767790643755025 9235.0 7.720886327652892 0.0 - - - - - - - 1150.3333333333333 18 9 TRIM32 tripartite motif-containing 32 1395 180 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54727.[MT7]-EILHFPK[MT7].2b4_1.heavy 586.357 / 637.379 6059.0 31.995375633239746 41 14 10 7 10 2.6016757664596764 38.43676498400821 0.029300689697265625 3 0.9337424821331132 4.767790643755025 6059.0 13.101112062948157 0.0 - - - - - - - 742.0 12 18 TRIM32 tripartite motif-containing 32 1397 180 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54727.[MT7]-EILHFPK[MT7].2y3_1.heavy 586.357 / 535.336 8118.0 31.995375633239746 41 14 10 7 10 2.6016757664596764 38.43676498400821 0.029300689697265625 3 0.9337424821331132 4.767790643755025 8118.0 16.48130311614731 0.0 - - - - - - - 1159.857142857143 16 7 TRIM32 tripartite motif-containing 32 1399 180 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54727.[MT7]-EILHFPK[MT7].2b5_1.heavy 586.357 / 784.447 3765.0 31.995375633239746 41 14 10 7 10 2.6016757664596764 38.43676498400821 0.029300689697265625 3 0.9337424821331132 4.767790643755025 3765.0 4.482142857142857 1.0 - - - - - - - 684.5454545454545 7 11 TRIM32 tripartite motif-containing 32 1401 181 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54862.[MT7]-EEWVPELK[MT7].3y3_1.heavy 439.915 / 533.341 68335.0 36.313899993896484 43 13 10 10 10 1.6269797512580915 49.03736647044579 0.0 3 0.9155108323467193 4.21556306586287 68335.0 88.13832705500592 0.0 - - - - - - - 410.0 136 1 LOC100510206;RHOQ rho-related GTP-binding protein RhoQ-like;ras homolog gene family, member Q 1403 181 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54862.[MT7]-EEWVPELK[MT7].3b4_1.heavy 439.915 / 688.342 35756.0 36.313899993896484 43 13 10 10 10 1.6269797512580915 49.03736647044579 0.0 3 0.9155108323467193 4.21556306586287 35756.0 47.200513211984386 1.0 - - - - - - - 658.7142857142857 81 7 LOC100510206;RHOQ rho-related GTP-binding protein RhoQ-like;ras homolog gene family, member Q 1405 181 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54862.[MT7]-EEWVPELK[MT7].3b3_1.heavy 439.915 / 589.274 123454.0 36.313899993896484 43 13 10 10 10 1.6269797512580915 49.03736647044579 0.0 3 0.9155108323467193 4.21556306586287 123454.0 300.9724750033894 0.0 - - - - - - - 102.0 246 1 LOC100510206;RHOQ rho-related GTP-binding protein RhoQ-like;ras homolog gene family, member Q 1407 181 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54862.[MT7]-EEWVPELK[MT7].3y4_1.heavy 439.915 / 630.394 69462.0 36.313899993896484 43 13 10 10 10 1.6269797512580915 49.03736647044579 0.0 3 0.9155108323467193 4.21556306586287 69462.0 139.5641846658374 0.0 - - - - - - - 322.14285714285717 138 7 LOC100510206;RHOQ rho-related GTP-binding protein RhoQ-like;ras homolog gene family, member Q 1409 182 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 ENO_ECO24.IQLVGDDLFVTNTK.2y8.peptide 781.92 / 937.5 550403.0 40.7057991027832 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 550403.0 222.12755202551836 0.0 - - - - - - - 975.0 1100 1 1411 182 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 ENO_ECO24.IQLVGDDLFVTNTK.2y6.peptide 781.92 / 709.39 884440.0 40.7057991027832 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 884440.0 606.4733410836294 0.0 - - - - - - - 1312.5 1768 2 1413 182 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 ENO_ECO24.IQLVGDDLFVTNTK.2y5.peptide 781.92 / 562.32 1030180.0 40.7057991027832 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 1030180.0 746.7809770498047 0.0 - - - - - - - 2231.25 2060 4 1415 183 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54351.[MT7]-LQNLVIPWAPENLTLHK[MT7].3b4_1.heavy 758.779 / 613.379 N/A N/A - - - - - - - - - 0.0 - - - - - - - IL2RG interleukin 2 receptor, gamma 1417 183 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54351.[MT7]-LQNLVIPWAPENLTLHK[MT7].3b5_1.heavy 758.779 / 712.447 N/A N/A - - - - - - - - - 0.0 - - - - - - - IL2RG interleukin 2 receptor, gamma 1419 183 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54351.[MT7]-LQNLVIPWAPENLTLHK[MT7].3b3_1.heavy 758.779 / 500.295 N/A N/A - - - - - - - - - 0.0 - - - - - - - IL2RG interleukin 2 receptor, gamma 1421 183 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54351.[MT7]-LQNLVIPWAPENLTLHK[MT7].3y8_1.heavy 758.779 / 1095.63 N/A N/A - - - - - - - - - 0.0 - - - - - - - IL2RG interleukin 2 receptor, gamma 1423 184 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB536522.[MT7]-ILEINGTPVR.3b4_1.heavy 419.255 / 613.404 16161.0 34.69135093688965 44 18 10 6 10 7.804121482447414 12.813742100877633 0.038700103759765625 3 0.9898625806823057 12.247038840354838 16161.0 32.43720992046453 0.0 - - - - - - - 301.57142857142856 32 7 LIMK2 LIM domain kinase 2 1425 184 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB536522.[MT7]-ILEINGTPVR.3y4_1.heavy 419.255 / 472.288 32414.0 34.69135093688965 44 18 10 6 10 7.804121482447414 12.813742100877633 0.038700103759765625 3 0.9898625806823057 12.247038840354838 32414.0 12.0035538953687 0.0 - - - - - - - 275.0 64 1 LIMK2 LIM domain kinase 2 1427 184 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB536522.[MT7]-ILEINGTPVR.3b3_1.heavy 419.255 / 500.32 78785.0 34.69135093688965 44 18 10 6 10 7.804121482447414 12.813742100877633 0.038700103759765625 3 0.9898625806823057 12.247038840354838 78785.0 139.92004112871047 0.0 - - - - - - - 390.0 157 4 LIMK2 LIM domain kinase 2 1429 184 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB536522.[MT7]-ILEINGTPVR.3y5_1.heavy 419.255 / 529.309 34709.0 34.69135093688965 44 18 10 6 10 7.804121482447414 12.813742100877633 0.038700103759765625 3 0.9898625806823057 12.247038840354838 34709.0 20.774419036594395 0.0 - - - - - - - 367.0 69 1 LIMK2 LIM domain kinase 2 1431 185 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB542393.[MT7]-K[MT7]FK[MT7]PGYLEATLNWFR.4y5_1.heavy 576.332 / 735.394 10245.0 42.79590034484863 44 18 10 6 10 29.25235757594651 3.4185278824236556 0.036998748779296875 3 0.9822264710594387 9.243366754168514 10245.0 65.88807408964203 0.0 - - - - - - - 232.92307692307693 20 13 PPA2 pyrophosphatase (inorganic) 2 1433 185 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB542393.[MT7]-K[MT7]FK[MT7]PGYLEATLNWFR.4y4_1.heavy 576.332 / 622.31 34926.0 42.79590034484863 44 18 10 6 10 29.25235757594651 3.4185278824236556 0.036998748779296875 3 0.9822264710594387 9.243366754168514 34926.0 119.63602209944752 0.0 - - - - - - - 188.57142857142858 69 14 PPA2 pyrophosphatase (inorganic) 2 1435 185 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB542393.[MT7]-K[MT7]FK[MT7]PGYLEATLNWFR.4b8_2.heavy 576.332 / 698.422 17541.0 42.79590034484863 44 18 10 6 10 29.25235757594651 3.4185278824236556 0.036998748779296875 3 0.9822264710594387 9.243366754168514 17541.0 74.56535440909695 0.0 - - - - - - - 302.1578947368421 35 19 PPA2 pyrophosphatase (inorganic) 2 1437 185 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB542393.[MT7]-K[MT7]FK[MT7]PGYLEATLNWFR.4y3_1.heavy 576.332 / 508.267 13505.0 42.79590034484863 44 18 10 6 10 29.25235757594651 3.4185278824236556 0.036998748779296875 3 0.9822264710594387 9.243366754168514 13505.0 53.91491463322505 0.0 - - - - - - - 274.06666666666666 27 15 PPA2 pyrophosphatase (inorganic) 2 1439 186 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB53729.[MT7]-NLDWFPR.2y4_1.heavy 546.291 / 605.319 N/A N/A - - - - - - - - - 0.0 - - - - - - - ITPR1;ITPR2;ITPR3 inositol 1,4,5-triphosphate receptor, type 1;inositol 1,4,5-triphosphate receptor, type 2;inositol 1,4,5-triphosphate receptor, type 3 1441 186 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB53729.[MT7]-NLDWFPR.2y5_1.heavy 546.291 / 720.346 N/A N/A - - - - - - - - - 0.0 - - - - - - - ITPR1;ITPR2;ITPR3 inositol 1,4,5-triphosphate receptor, type 1;inositol 1,4,5-triphosphate receptor, type 2;inositol 1,4,5-triphosphate receptor, type 3 1443 186 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB53729.[MT7]-NLDWFPR.2b4_1.heavy 546.291 / 673.343 N/A N/A - - - - - - - - - 0.0 - - - - - - - ITPR1;ITPR2;ITPR3 inositol 1,4,5-triphosphate receptor, type 1;inositol 1,4,5-triphosphate receptor, type 2;inositol 1,4,5-triphosphate receptor, type 3 1445 186 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB53729.[MT7]-NLDWFPR.2y6_1.heavy 546.291 / 833.43 N/A N/A - - - - - - - - - 0.0 - - - - - - - ITPR1;ITPR2;ITPR3 inositol 1,4,5-triphosphate receptor, type 1;inositol 1,4,5-triphosphate receptor, type 2;inositol 1,4,5-triphosphate receptor, type 3 1447 187 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54459.[MT7]-EVVSALR.2y4_1.heavy 459.28 / 446.272 17964.0 26.88930034637451 41 15 10 6 10 2.276477994518871 34.6840444282778 0.03479957580566406 3 0.9513335919094956 5.571479003029702 17964.0 9.589039573029183 0.0 - - - - - - - 876.0 35 1 RAPGEF1 Rap guanine nucleotide exchange factor (GEF) 1 1449 187 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54459.[MT7]-EVVSALR.2y5_1.heavy 459.28 / 545.341 23221.0 26.88930034637451 41 15 10 6 10 2.276477994518871 34.6840444282778 0.03479957580566406 3 0.9513335919094956 5.571479003029702 23221.0 22.694954287925796 0.0 - - - - - - - 1272.2857142857142 46 7 RAPGEF1 Rap guanine nucleotide exchange factor (GEF) 1 1451 187 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54459.[MT7]-EVVSALR.2b4_1.heavy 459.28 / 559.321 7083.0 26.88930034637451 41 15 10 6 10 2.276477994518871 34.6840444282778 0.03479957580566406 3 0.9513335919094956 5.571479003029702 7083.0 5.299261613691931 4.0 - - - - - - - 1726.1818181818182 18 11 RAPGEF1 Rap guanine nucleotide exchange factor (GEF) 1 1453 187 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54459.[MT7]-EVVSALR.2y6_1.heavy 459.28 / 644.409 35343.0 26.88930034637451 41 15 10 6 10 2.276477994518871 34.6840444282778 0.03479957580566406 3 0.9513335919094956 5.571479003029702 35343.0 10.117763980703948 0.0 - - - - - - - 292.0 70 1 RAPGEF1 Rap guanine nucleotide exchange factor (GEF) 1 1455 188 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54354.[MT7]-K[MT7]FK[MT7]PGYLEATLNWFR.3b6_2.heavy 768.107 / 577.358 N/A N/A - - - - - - - - - 0.0 - - - - - - - PPA2 pyrophosphatase (inorganic) 2 1457 188 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54354.[MT7]-K[MT7]FK[MT7]PGYLEATLNWFR.3y7_1.heavy 768.107 / 907.479 N/A N/A - - - - - - - - - 0.0 - - - - - - - PPA2 pyrophosphatase (inorganic) 2 1459 188 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54354.[MT7]-K[MT7]FK[MT7]PGYLEATLNWFR.3y4_1.heavy 768.107 / 622.31 N/A N/A - - - - - - - - - 0.0 - - - - - - - PPA2 pyrophosphatase (inorganic) 2 1461 188 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54354.[MT7]-K[MT7]FK[MT7]PGYLEATLNWFR.3y8_1.heavy 768.107 / 1036.52 N/A N/A - - - - - - - - - 0.0 - - - - - - - PPA2 pyrophosphatase (inorganic) 2 1463 189 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 RBSB_ECOLI.LAATIAQLPDQIGAK.3y7.peptide 503.96 / 728.39 335548.0 35.79890060424805 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 335548.0 879.8058483483484 0.0 - - - - - - - 727.5 671 10 1465 189 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 RBSB_ECOLI.LAATIAQLPDQIGAK.3y6.peptide 503.96 / 631.34 71310.0 35.79890060424805 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 71310.0 174.39063414634145 0.0 - - - - - - - 746.4285714285714 142 7 1467 189 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 RBSB_ECOLI.LAATIAQLPDQIGAK.3y5.peptide 503.96 / 516.31 60552.0 35.79890060424805 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 60552.0 55.764854441644395 0.0 - - - - - - - 764.4615384615385 121 13 1469 190 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB542764.[MT7]-GATNPYTEANYK[MT7]PTFLSDDELK[MT7].4y4_1.heavy 727.375 / 648.369 16676.0 36.097801208496094 50 20 10 10 10 5.7237109729766935 17.471182677135364 0.0 3 0.9915084104561273 13.383203216346496 16676.0 20.851479312807157 0.0 - - - - - - - 1278.7 33 10 ARNTL aryl hydrocarbon receptor nuclear translocator-like 1471 190 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB542764.[MT7]-GATNPYTEANYK[MT7]PTFLSDDELK[MT7].4y3_1.heavy 727.375 / 533.341 18824.0 36.097801208496094 50 20 10 10 10 5.7237109729766935 17.471182677135364 0.0 3 0.9915084104561273 13.383203216346496 18824.0 22.590072836049067 0.0 - - - - - - - 1140.0 37 7 ARNTL aryl hydrocarbon receptor nuclear translocator-like 1473 190 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB542764.[MT7]-GATNPYTEANYK[MT7]PTFLSDDELK[MT7].4y6_1.heavy 727.375 / 850.427 24144.0 36.097801208496094 50 20 10 10 10 5.7237109729766935 17.471182677135364 0.0 3 0.9915084104561273 13.383203216346496 24144.0 33.35160942619427 0.0 - - - - - - - 760.0 48 7 ARNTL aryl hydrocarbon receptor nuclear translocator-like 1475 190 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB542764.[MT7]-GATNPYTEANYK[MT7]PTFLSDDELK[MT7].4b6_1.heavy 727.375 / 748.375 8901.0 36.097801208496094 50 20 10 10 10 5.7237109729766935 17.471182677135364 0.0 3 0.9915084104561273 13.383203216346496 8901.0 13.574431286735937 0.0 - - - - - - - 699.1666666666666 17 12 ARNTL aryl hydrocarbon receptor nuclear translocator-like 1477 191 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB53873.[MT7]-K[MT7]LEAAEER.3y7_1.heavy 411.906 / 817.405 N/A N/A - - - - - - - - - 0.0 - - - - - - - STMN2;STMN1;STMN4 stathmin-like 2;stathmin 1;stathmin-like 4 1479 191 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB53873.[MT7]-K[MT7]LEAAEER.3y6_1.heavy 411.906 / 704.321 N/A N/A - - - - - - - - - 0.0 - - - - - - - STMN2;STMN1;STMN4 stathmin-like 2;stathmin 1;stathmin-like 4 1481 191 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB53873.[MT7]-K[MT7]LEAAEER.3y4_1.heavy 411.906 / 504.241 N/A N/A - - - - - - - - - 0.0 - - - - - - - STMN2;STMN1;STMN4 stathmin-like 2;stathmin 1;stathmin-like 4 1483 191 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB53873.[MT7]-K[MT7]LEAAEER.3y5_1.heavy 411.906 / 575.278 N/A N/A - - - - - - - - - 0.0 - - - - - - - STMN2;STMN1;STMN4 stathmin-like 2;stathmin 1;stathmin-like 4 1485 192 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54043.[MT7]-NEEIDEMIK[MT7].2b3_1.heavy 704.865 / 517.237 N/A N/A - - - - - - - - - 0.0 - - - - - - - MYL2 myosin, light chain 2, regulatory, cardiac, slow 1487 192 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54043.[MT7]-NEEIDEMIK[MT7].2y3_1.heavy 704.865 / 535.339 N/A N/A - - - - - - - - - 0.0 - - - - - - - MYL2 myosin, light chain 2, regulatory, cardiac, slow 1489 192 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54043.[MT7]-NEEIDEMIK[MT7].2b6_1.heavy 704.865 / 874.391 N/A N/A - - - - - - - - - 0.0 - - - - - - - MYL2 myosin, light chain 2, regulatory, cardiac, slow 1491 192 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54043.[MT7]-NEEIDEMIK[MT7].2b5_1.heavy 704.865 / 745.349 N/A N/A - - - - - - - - - 0.0 - - - - - - - MYL2 myosin, light chain 2, regulatory, cardiac, slow 1493 193 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB55307.[MT7]-TIITYPWFQNSSVILFLNK[MT7].3y6_1.heavy 858.152 / 891.578 2551.0 52.76919937133789 43 18 10 5 10 7.974905151032266 12.539334086883285 0.04199981689453125 3 0.9898740732795113 12.25399864430754 2551.0 3.596544838844592 1.0 - - - - - - - 280.3636363636364 5 11 GNA11;GNAQ guanine nucleotide binding protein (G protein), alpha 11 (Gq class);guanine nucleotide binding protein (G protein), q polypeptide 1495 193 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB55307.[MT7]-TIITYPWFQNSSVILFLNK[MT7].3y3_1.heavy 858.152 / 518.342 3986.0 52.76919937133789 43 18 10 5 10 7.974905151032266 12.539334086883285 0.04199981689453125 3 0.9898740732795113 12.25399864430754 3986.0 3.702510670515937 1.0 - - - - - - - 697.5 7 8 GNA11;GNAQ guanine nucleotide binding protein (G protein), alpha 11 (Gq class);guanine nucleotide binding protein (G protein), q polypeptide 1497 193 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB55307.[MT7]-TIITYPWFQNSSVILFLNK[MT7].3y4_1.heavy 858.152 / 665.41 5048.0 52.76919937133789 43 18 10 5 10 7.974905151032266 12.539334086883285 0.04199981689453125 3 0.9898740732795113 12.25399864430754 5048.0 4.798993237835449 0.0 - - - - - - - 332.25 10 8 GNA11;GNAQ guanine nucleotide binding protein (G protein), alpha 11 (Gq class);guanine nucleotide binding protein (G protein), q polypeptide 1499 193 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB55307.[MT7]-TIITYPWFQNSSVILFLNK[MT7].3y5_1.heavy 858.152 / 778.494 3401.0 52.76919937133789 43 18 10 5 10 7.974905151032266 12.539334086883285 0.04199981689453125 3 0.9898740732795113 12.25399864430754 3401.0 5.189908111977344 0.0 - - - - - - - 377.3 6 10 GNA11;GNAQ guanine nucleotide binding protein (G protein), alpha 11 (Gq class);guanine nucleotide binding protein (G protein), q polypeptide 1501 194 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB53714.[MT7]-VTEDLSK[MT7].2y4_1.heavy 540.313 / 606.358 N/A N/A - - - - - - - - - 0.0 - - - - - - - MTOR mechanistic target of rapamycin (serine/threonine kinase) 1503 194 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB53714.[MT7]-VTEDLSK[MT7].2y5_1.heavy 540.313 / 735.401 N/A N/A - - - - - - - - - 0.0 - - - - - - - MTOR mechanistic target of rapamycin (serine/threonine kinase) 1505 194 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB53714.[MT7]-VTEDLSK[MT7].2b4_1.heavy 540.313 / 589.295 N/A N/A - - - - - - - - - 0.0 - - - - - - - MTOR mechanistic target of rapamycin (serine/threonine kinase) 1507 194 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB53714.[MT7]-VTEDLSK[MT7].2y6_1.heavy 540.313 / 836.448 N/A N/A - - - - - - - - - 0.0 - - - - - - - MTOR mechanistic target of rapamycin (serine/threonine kinase) 1509 195 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB536734.[MT7]-ALQLFR.2y4_1.heavy 446.28 / 563.33 20153.0 36.58340072631836 47 17 10 10 10 3.1363104847862897 31.884598315467507 0.0 3 0.979929663130551 8.696729887060469 20153.0 15.083044100000137 0.0 - - - - - - - 730.5714285714286 40 7 MDN1;SPHK1 MDN1, midasin homolog (yeast);sphingosine kinase 1 1511 195 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB536734.[MT7]-ALQLFR.2b3_1.heavy 446.28 / 457.289 49103.0 36.58340072631836 47 17 10 10 10 3.1363104847862897 31.884598315467507 0.0 3 0.979929663130551 8.696729887060469 49103.0 66.3194472556881 0.0 - - - - - - - 805.75 98 8 MDN1;SPHK1 MDN1, midasin homolog (yeast);sphingosine kinase 1 1513 195 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB536734.[MT7]-ALQLFR.2y5_1.heavy 446.28 / 676.414 52581.0 36.58340072631836 47 17 10 10 10 3.1363104847862897 31.884598315467507 0.0 3 0.979929663130551 8.696729887060469 52581.0 25.782398477795763 0.0 - - - - - - - 221.66666666666666 105 6 MDN1;SPHK1 MDN1, midasin homolog (yeast);sphingosine kinase 1 1515 195 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB536734.[MT7]-ALQLFR.2b4_1.heavy 446.28 / 570.373 32019.0 36.58340072631836 47 17 10 10 10 3.1363104847862897 31.884598315467507 0.0 3 0.979929663130551 8.696729887060469 32019.0 99.21877647739942 0.0 - - - - - - - 266.2 64 10 MDN1;SPHK1 MDN1, midasin homolog (yeast);sphingosine kinase 1 1517 196 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB542385.[MT7]-LQNLVIPWAPENLTLHK[MT7].4y8_1.heavy 569.336 / 1095.63 25349.0 45.10634994506836 41 15 10 6 10 1.6835884167444244 41.71065300129458 0.0330963134765625 3 0.9574695137694647 5.96294524981491 25349.0 59.228139682539684 0.0 - - - - - - - 307.27272727272725 50 11 IL2RG interleukin 2 receptor, gamma 1519 196 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB542385.[MT7]-LQNLVIPWAPENLTLHK[MT7].4b4_1.heavy 569.336 / 613.379 70457.0 45.10634994506836 41 15 10 6 10 1.6835884167444244 41.71065300129458 0.0330963134765625 3 0.9574695137694647 5.96294524981491 70457.0 57.41444144361387 0.0 - - - - - - - 832.0 140 10 IL2RG interleukin 2 receptor, gamma 1521 196 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB542385.[MT7]-LQNLVIPWAPENLTLHK[MT7].4b5_1.heavy 569.336 / 712.447 77867.0 45.10634994506836 41 15 10 6 10 1.6835884167444244 41.71065300129458 0.0330963134765625 3 0.9574695137694647 5.96294524981491 77867.0 9.810828912466842 1.0 - - - - - - - 733.5714285714286 155 7 IL2RG interleukin 2 receptor, gamma 1523 196 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB542385.[MT7]-LQNLVIPWAPENLTLHK[MT7].4b3_1.heavy 569.336 / 500.295 104061.0 45.10634994506836 41 15 10 6 10 1.6835884167444244 41.71065300129458 0.0330963134765625 3 0.9574695137694647 5.96294524981491 104061.0 64.09852659340659 0.0 - - - - - - - 390.0 208 1 IL2RG interleukin 2 receptor, gamma 1525 197 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB537309.[MT7]-IQQIEK[MT7].2y4_1.heavy 523.826 / 661.4 12534.0 24.439300537109375 39 17 4 10 8 3.9242775236774574 20.51130722439796 0.0 4 0.975028620578381 7.793511714395537 12534.0 21.438187283294674 0.0 - - - - - - - 690.0 25 12 APC;UBE4A adenomatous polyposis coli;ubiquitination factor E4A (UFD2 homolog, yeast) 1527 197 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB537309.[MT7]-IQQIEK[MT7].2b3_1.heavy 523.826 / 514.311 10949.0 24.439300537109375 39 17 4 10 8 3.9242775236774574 20.51130722439796 0.0 4 0.975028620578381 7.793511714395537 10949.0 11.881564668769716 0.0 - - - - - - - 1657.0 21 7 APC;UBE4A adenomatous polyposis coli;ubiquitination factor E4A (UFD2 homolog, yeast) 1529 197 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB537309.[MT7]-IQQIEK[MT7].2y5_1.heavy 523.826 / 789.459 18945.0 24.439300537109375 39 17 4 10 8 3.9242775236774574 20.51130722439796 0.0 4 0.975028620578381 7.793511714395537 18945.0 39.04398283418554 1.0 - - - - - - - 666.0 70 12 APC;UBE4A adenomatous polyposis coli;ubiquitination factor E4A (UFD2 homolog, yeast) 1531 197 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB537309.[MT7]-IQQIEK[MT7].2y3_1.heavy 523.826 / 533.341 14335.0 24.439300537109375 39 17 4 10 8 3.9242775236774574 20.51130722439796 0.0 4 0.975028620578381 7.793511714395537 14335.0 19.217084694625598 0.0 - - - - - - - 792.0 28 11 APC;UBE4A adenomatous polyposis coli;ubiquitination factor E4A (UFD2 homolog, yeast) 1533 198 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB536736.[MT7]-LTIEK[MT7].2y4_1.heavy 446.291 / 634.389 32984.0 27.53499984741211 40 20 10 6 4 51.55397606589654 1.9397145987766204 0.03440093994140625 7 0.9992819932665873 46.05450536867868 32984.0 9.730854051538504 1.0 - - - - - - - 750.0 65 2 RAPGEF1 Rap guanine nucleotide exchange factor (GEF) 1 1535 198 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB536736.[MT7]-LTIEK[MT7].2b4_1.heavy 446.291 / 601.368 3927.0 27.53499984741211 40 20 10 6 4 51.55397606589654 1.9397145987766204 0.03440093994140625 7 0.9992819932665873 46.05450536867868 3927.0 1.6345926837202762 6.0 - - - - - - - 1213.4285714285713 18 7 RAPGEF1 Rap guanine nucleotide exchange factor (GEF) 1 1537 198 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB536736.[MT7]-LTIEK[MT7].2b4_2.heavy 446.291 / 301.188 3855.0 27.53499984741211 40 20 10 6 4 51.55397606589654 1.9397145987766204 0.03440093994140625 7 0.9992819932665873 46.05450536867868 3855.0 1.0110389659116612 21.0 - - - - - - - 1214.0 51 2 RAPGEF1 Rap guanine nucleotide exchange factor (GEF) 1 1539 198 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB536736.[MT7]-LTIEK[MT7].2y3_1.heavy 446.291 / 533.341 12994.0 27.53499984741211 40 20 10 6 4 51.55397606589654 1.9397145987766204 0.03440093994140625 7 0.9992819932665873 46.05450536867868 12994.0 9.57737195847716 0.0 - - - - - - - 1820.75 25 8 RAPGEF1 Rap guanine nucleotide exchange factor (GEF) 1 1541 199 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54441.[MT7]-VMVMK[MT7].2b3_1.heavy 448.271 / 474.287 N/A N/A - - - - - - - - - 0.0 - - - - - - - LIMK2 LIM domain kinase 2 1543 199 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54441.[MT7]-VMVMK[MT7].2y4_1.heavy 448.271 / 652.364 N/A N/A - - - - - - - - - 0.0 - - - - - - - LIMK2 LIM domain kinase 2 1545 199 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54441.[MT7]-VMVMK[MT7].2y3_1.heavy 448.271 / 521.324 N/A N/A - - - - - - - - - 0.0 - - - - - - - LIMK2 LIM domain kinase 2 1547 200 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB538762.[MT7]-FSLPSVDGQK[MT7].3b5_1.heavy 455.925 / 676.379 22937.0 34.26327419281006 43 18 10 5 10 5.8833684168398666 16.997065781869395 0.040897369384765625 3 0.985470308649853 10.226026690248105 22937.0 22.998003791419464 1.0 - - - - - - - 891.0 45 3 IL2RG interleukin 2 receptor, gamma 1549 200 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB538762.[MT7]-FSLPSVDGQK[MT7].3y4_1.heavy 455.925 / 591.322 55273.0 34.26327419281006 43 18 10 5 10 5.8833684168398666 16.997065781869395 0.040897369384765625 3 0.985470308649853 10.226026690248105 55273.0 10.775718725101095 0.0 - - - - - - - 2846.0 110 1 IL2RG interleukin 2 receptor, gamma 1551 200 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB538762.[MT7]-FSLPSVDGQK[MT7].3b3_1.heavy 455.925 / 492.294 72692.0 34.26327419281006 43 18 10 5 10 5.8833684168398666 16.997065781869395 0.040897369384765625 3 0.985470308649853 10.226026690248105 72692.0 10.868647594523065 0.0 - - - - - - - 3363.0 145 1 IL2RG interleukin 2 receptor, gamma 1553 200 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB538762.[MT7]-FSLPSVDGQK[MT7].3y5_1.heavy 455.925 / 690.39 4139.0 34.26327419281006 43 18 10 5 10 5.8833684168398666 16.997065781869395 0.040897369384765625 3 0.985470308649853 10.226026690248105 4139.0 0.4790862901011991 1.0 - - - - - - - 763.8571428571429 8 7 IL2RG interleukin 2 receptor, gamma 1555 201 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54444.[MT7]-NAYNK[MT7].2b3_1.heavy 449.255 / 493.253 1517.0 16.566933314005535 39 14 10 7 8 2.4136095468866428 31.404811327535207 0.021099090576171875 4 0.9407872529938426 5.046475087253154 1517.0 0.9776746500777601 4.0 - - - - - - - 284.1666666666667 5 30 ITGB2 integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) 1557 201 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54444.[MT7]-NAYNK[MT7].2y4_1.heavy 449.255 / 639.358 6201.0 16.566933314005535 39 14 10 7 8 2.4136095468866428 31.404811327535207 0.021099090576171875 4 0.9407872529938426 5.046475087253154 6201.0 9.651504119563135 0.0 - - - - - - - 765.6666666666666 12 9 ITGB2 integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) 1559 201 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54444.[MT7]-NAYNK[MT7].2y3_1.heavy 449.255 / 568.321 3667.0 16.566933314005535 39 14 10 7 8 2.4136095468866428 31.404811327535207 0.021099090576171875 4 0.9407872529938426 5.046475087253154 3667.0 7.468868418369082 0.0 - - - - - - - 755.1111111111111 7 9 ITGB2 integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) 1561 202 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB538054.[MT7]-EAHSQIEK[MT7].3y3_1.heavy 410.562 / 533.341 170044.0 17.253999710083008 50 20 10 10 10 3.463923054900107 22.355123584710626 0.0 3 0.9902893453788577 12.513708905569768 170044.0 51.101665107897716 0.0 - - - - - - - 778.7 340 10 ARNTL aryl hydrocarbon receptor nuclear translocator-like 1563 202 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB538054.[MT7]-EAHSQIEK[MT7].3b4_1.heavy 410.562 / 569.28 23005.0 17.253999710083008 50 20 10 10 10 3.463923054900107 22.355123584710626 0.0 3 0.9902893453788577 12.513708905569768 23005.0 21.758715159962474 0.0 - - - - - - - 699.7142857142857 46 7 ARNTL aryl hydrocarbon receptor nuclear translocator-like 1565 202 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB538054.[MT7]-EAHSQIEK[MT7].3b3_2.heavy 410.562 / 241.628 84969.0 17.253999710083008 50 20 10 10 10 3.463923054900107 22.355123584710626 0.0 3 0.9902893453788577 12.513708905569768 84969.0 83.28253119614838 0.0 - - - - - - - 795.8571428571429 169 7 ARNTL aryl hydrocarbon receptor nuclear translocator-like 1567 202 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB538054.[MT7]-EAHSQIEK[MT7].3b3_1.heavy 410.562 / 482.248 69035.0 17.253999710083008 50 20 10 10 10 3.463923054900107 22.355123584710626 0.0 3 0.9902893453788577 12.513708905569768 69035.0 47.5575556395735 0.0 - - - - - - - 1248.0 138 7 ARNTL aryl hydrocarbon receptor nuclear translocator-like 1569 203 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB53483.[MT7]-QVLQTR.2b3_1.heavy 444.773 / 485.32 N/A N/A - - - - - - - - - 0.0 - - - - - - - ARNTL aryl hydrocarbon receptor nuclear translocator-like 1571 203 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB53483.[MT7]-QVLQTR.2y4_1.heavy 444.773 / 517.309 N/A N/A - - - - - - - - - 0.0 - - - - - - - ARNTL aryl hydrocarbon receptor nuclear translocator-like 1573 203 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB53483.[MT7]-QVLQTR.2y4_2.heavy 444.773 / 259.158 N/A N/A - - - - - - - - - 0.0 - - - - - - - ARNTL aryl hydrocarbon receptor nuclear translocator-like 1575 203 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB53483.[MT7]-QVLQTR.2y5_1.heavy 444.773 / 616.378 N/A N/A - - - - - - - - - 0.0 - - - - - - - ARNTL aryl hydrocarbon receptor nuclear translocator-like 1577 204 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB538457.[MT7]-NLSWLEEK[MT7].3y3_1.heavy 436.246 / 549.3 21084.0 36.58340072631836 43 13 10 10 10 1.9158605545915421 40.737353010379486 0.0 3 0.9273084509718456 4.54939696428289 21084.0 59.46840554655796 0.0 - - - - - - - 272.8888888888889 42 9 RAPGEF1 Rap guanine nucleotide exchange factor (GEF) 1 1579 204 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB538457.[MT7]-NLSWLEEK[MT7].3b4_1.heavy 436.246 / 645.348 13612.0 36.58340072631836 43 13 10 10 10 1.9158605545915421 40.737353010379486 0.0 3 0.9273084509718456 4.54939696428289 13612.0 17.9622951065184 0.0 - - - - - - - 306.8888888888889 27 9 RAPGEF1 Rap guanine nucleotide exchange factor (GEF) 1 1581 204 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB538457.[MT7]-NLSWLEEK[MT7].3y4_1.heavy 436.246 / 662.384 5732.0 36.58340072631836 43 13 10 10 10 1.9158605545915421 40.737353010379486 0.0 3 0.9273084509718456 4.54939696428289 5732.0 22.74302461712447 0.0 - - - - - - - 211.85714285714286 11 14 RAPGEF1 Rap guanine nucleotide exchange factor (GEF) 1 1583 204 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB538457.[MT7]-NLSWLEEK[MT7].3b3_1.heavy 436.246 / 459.268 37460.0 36.58340072631836 43 13 10 10 10 1.9158605545915421 40.737353010379486 0.0 3 0.9273084509718456 4.54939696428289 37460.0 60.228700225394434 0.0 - - - - - - - 628.5714285714286 74 7 RAPGEF1 Rap guanine nucleotide exchange factor (GEF) 1 1585 205 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB539582.[MT7]-AVLQEYGHEER.3y6_1.heavy 492.252 / 790.348 95571.0 24.760799407958984 48 18 10 10 10 13.098628175933307 7.634387254669497 0.0 3 0.9839469253179586 9.72748476035935 95571.0 247.9002066173391 0.0 - - - - - - - 733.6 191 10 TRIM32 tripartite motif-containing 32 1587 205 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB539582.[MT7]-AVLQEYGHEER.3b4_1.heavy 492.252 / 556.357 207516.0 24.760799407958984 48 18 10 10 10 13.098628175933307 7.634387254669497 0.0 3 0.9839469253179586 9.72748476035935 207516.0 201.7618273270325 0.0 - - - - - - - 1228.25 415 12 TRIM32 tripartite motif-containing 32 1589 205 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB539582.[MT7]-AVLQEYGHEER.3b5_1.heavy 492.252 / 685.4 158471.0 24.760799407958984 48 18 10 10 10 13.098628175933307 7.634387254669497 0.0 3 0.9839469253179586 9.72748476035935 158471.0 251.65013036321156 0.0 - - - - - - - 805.1333333333333 316 15 TRIM32 tripartite motif-containing 32 1591 205 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB539582.[MT7]-AVLQEYGHEER.3y5_1.heavy 492.252 / 627.284 360875.0 24.760799407958984 48 18 10 10 10 13.098628175933307 7.634387254669497 0.0 3 0.9839469253179586 9.72748476035935 360875.0 266.4658594680429 0.0 - - - - - - - 800.2 721 5 TRIM32 tripartite motif-containing 32 1593 206 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB540915.[MT7]-NLVHIITHGEEK[MT7].4y5_1.heavy 420.244 / 743.38 37645.0 28.847400188446045 44 18 10 6 10 4.153581062292116 24.075610539502968 0.03439903259277344 3 0.9829985145848247 9.451521029421047 37645.0 163.9980198019802 0.0 - - - - - - - 237.64705882352942 75 17 MYL2 myosin, light chain 2, regulatory, cardiac, slow 1595 206 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB540915.[MT7]-NLVHIITHGEEK[MT7].4b4_1.heavy 420.244 / 608.364 126848.0 28.847400188446045 44 18 10 6 10 4.153581062292116 24.075610539502968 0.03439903259277344 3 0.9829985145848247 9.451521029421047 126848.0 214.8525174213173 0.0 - - - - - - - 667.3333333333334 253 9 MYL2 myosin, light chain 2, regulatory, cardiac, slow 1597 206 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB540915.[MT7]-NLVHIITHGEEK[MT7].4y3_1.heavy 420.244 / 549.3 70497.0 28.847400188446045 44 18 10 6 10 4.153581062292116 24.075610539502968 0.03439903259277344 3 0.9829985145848247 9.451521029421047 70497.0 61.66621288368561 0.0 - - - - - - - 1690.857142857143 140 7 MYL2 myosin, light chain 2, regulatory, cardiac, slow 1599 206 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB540915.[MT7]-NLVHIITHGEEK[MT7].4b3_1.heavy 420.244 / 471.305 336723.0 28.847400188446045 44 18 10 6 10 4.153581062292116 24.075610539502968 0.03439903259277344 3 0.9829985145848247 9.451521029421047 336723.0 266.4330089646577 0.0 - - - - - - - 904.6666666666666 673 3 MYL2 myosin, light chain 2, regulatory, cardiac, slow 1601 207 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54381.[MT7]-EVLEC[CAM]PIC[CAM]MESFTEEQLRPK[MT7].3b4_1.heavy 928.46 / 615.347 N/A N/A - - - - - - - - - 0.0 - - - - - - - TRIM32 tripartite motif-containing 32 1603 207 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54381.[MT7]-EVLEC[CAM]PIC[CAM]MESFTEEQLRPK[MT7].3b5_1.heavy 928.46 / 775.378 N/A N/A - - - - - - - - - 0.0 - - - - - - - TRIM32 tripartite motif-containing 32 1605 207 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54381.[MT7]-EVLEC[CAM]PIC[CAM]MESFTEEQLRPK[MT7].3y8_1.heavy 928.46 / 1144.64 N/A N/A - - - - - - - - - 0.0 - - - - - - - TRIM32 tripartite motif-containing 32 1607 207 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54381.[MT7]-EVLEC[CAM]PIC[CAM]MESFTEEQLRPK[MT7].3b7_1.heavy 928.46 / 985.515 N/A N/A - - - - - - - - - 0.0 - - - - - - - TRIM32 tripartite motif-containing 32 1609 208 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB55351.[MT7]-VEEVEDAISQTSQTLQLLIEHDPVSQR.4y5_1.heavy 802.917 / 586.331 47247.0 53.706899642944336 40 14 10 6 10 2.443908555788334 32.539616576557194 0.03279876708984375 3 0.9445074661398735 5.214539958041556 47247.0 -1.9359557467732014 0.0 - - - - - - - 252.83333333333334 94 6 LIMK2 LIM domain kinase 2 1611 208 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB55351.[MT7]-VEEVEDAISQTSQTLQLLIEHDPVSQR.4b7_1.heavy 802.917 / 916.438 40660.0 53.706899642944336 40 14 10 6 10 2.443908555788334 32.539616576557194 0.03279876708984375 3 0.9445074661398735 5.214539958041556 40660.0 -1.191676436107855 0.0 - - - - - - - 221.33333333333334 81 6 LIMK2 LIM domain kinase 2 1613 208 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB55351.[MT7]-VEEVEDAISQTSQTLQLLIEHDPVSQR.4b6_1.heavy 802.917 / 845.401 34547.0 53.706899642944336 40 14 10 6 10 2.443908555788334 32.539616576557194 0.03279876708984375 3 0.9445074661398735 5.214539958041556 34547.0 -1.012514654161782 0.0 - - - - - - - 173.66666666666666 69 6 LIMK2 LIM domain kinase 2 1615 208 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB55351.[MT7]-VEEVEDAISQTSQTLQLLIEHDPVSQR.4b3_1.heavy 802.917 / 502.263 19098.0 53.706899642944336 40 14 10 6 10 2.443908555788334 32.539616576557194 0.03279876708984375 3 0.9445074661398735 5.214539958041556 19098.0 -5.968125000000001 0.0 - - - - - - - 245.16666666666666 38 6 LIMK2 LIM domain kinase 2 1617 209 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB539965.[MT7]-FFTGSLAEVEK[MT7].2y4_1.heavy 758.419 / 648.369 17032.0 38.13007354736328 44 18 10 6 10 4.916064111802898 16.3523087028357 0.0345001220703125 3 0.9858907533851307 10.377637607096876 17032.0 13.742557939914162 1.0 - - - - - - - 1195.3333333333333 34 9 TRIM32 tripartite motif-containing 32 1619 209 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB539965.[MT7]-FFTGSLAEVEK[MT7].2y5_1.heavy 758.419 / 719.406 24652.0 38.13007354736328 44 18 10 6 10 4.916064111802898 16.3523087028357 0.0345001220703125 3 0.9858907533851307 10.377637607096876 24652.0 41.079540933666124 0.0 - - - - - - - 706.125 49 8 TRIM32 tripartite motif-containing 32 1621 209 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB539965.[MT7]-FFTGSLAEVEK[MT7].2y3_1.heavy 758.419 / 519.326 25548.0 38.13007354736328 44 18 10 6 10 4.916064111802898 16.3523087028357 0.0345001220703125 3 0.9858907533851307 10.377637607096876 25548.0 26.13384816565513 0.0 - - - - - - - 1690.5714285714287 51 7 TRIM32 tripartite motif-containing 32 1623 209 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB539965.[MT7]-FFTGSLAEVEK[MT7].2y10_1.heavy 758.419 / 1224.66 31286.0 38.13007354736328 44 18 10 6 10 4.916064111802898 16.3523087028357 0.0345001220703125 3 0.9858907533851307 10.377637607096876 31286.0 50.868685543540124 0.0 - - - - - - - 779.9 62 10 TRIM32 tripartite motif-containing 32 1625 210 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB53709.[MT7]-ENLEGTLR.2b3_1.heavy 538.297 / 501.279 N/A N/A - - - - - - - - - 0.0 - - - - - - - LIMK2 LIM domain kinase 2 1627 210 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB53709.[MT7]-ENLEGTLR.2y5_1.heavy 538.297 / 575.315 N/A N/A - - - - - - - - - 0.0 - - - - - - - LIMK2 LIM domain kinase 2 1629 210 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB53709.[MT7]-ENLEGTLR.2b4_1.heavy 538.297 / 630.321 N/A N/A - - - - - - - - - 0.0 - - - - - - - LIMK2 LIM domain kinase 2 1631 210 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB53709.[MT7]-ENLEGTLR.2y7_1.heavy 538.297 / 802.442 N/A N/A - - - - - - - - - 0.0 - - - - - - - LIMK2 LIM domain kinase 2 1633 211 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB539960.[MT7]-MIAEEIMEIHR.3b4_1.heavy 505.931 / 589.314 21974.0 38.612098693847656 41 17 6 10 8 4.402529468105469 18.438137494271764 0.0 4 0.9775690315067525 8.224759243222906 21974.0 70.06737564477608 0.0 - - - - - - - 671.0909090909091 43 11 ARNTL aryl hydrocarbon receptor nuclear translocator-like 1635 211 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB539960.[MT7]-MIAEEIMEIHR.3b5_1.heavy 505.931 / 718.356 18111.0 38.612098693847656 41 17 6 10 8 4.402529468105469 18.438137494271764 0.0 4 0.9775690315067525 8.224759243222906 18111.0 98.32580079712108 0.0 - - - - - - - 677.2222222222222 36 9 ARNTL aryl hydrocarbon receptor nuclear translocator-like 1637 211 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB539960.[MT7]-MIAEEIMEIHR.3y4_1.heavy 505.931 / 554.305 23519.0 38.612098693847656 41 17 6 10 8 4.402529468105469 18.438137494271764 0.0 4 0.9775690315067525 8.224759243222906 23519.0 66.53821941747573 0.0 - - - - - - - 725.7272727272727 47 11 ARNTL aryl hydrocarbon receptor nuclear translocator-like 1639 211 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB539960.[MT7]-MIAEEIMEIHR.3y5_1.heavy 505.931 / 685.345 23948.0 38.612098693847656 41 17 6 10 8 4.402529468105469 18.438137494271764 0.0 4 0.9775690315067525 8.224759243222906 23948.0 70.59855441645732 1.0 - - - - - - - 708.25 78 8 ARNTL aryl hydrocarbon receptor nuclear translocator-like 1641 212 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB538753.[MT7]-TFSQNRPAAAR.3b4_1.heavy 454.917 / 608.316 6256.0 18.820100784301758 50 20 10 10 10 9.925888159970379 10.074665197547262 0.0 3 0.9997725426136627 81.82841050991651 6256.0 16.726443618339527 0.0 - - - - - - - 609.0 12 8 OGDH oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide) 1643 212 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB538753.[MT7]-TFSQNRPAAAR.3b5_1.heavy 454.917 / 722.359 5406.0 18.820100784301758 50 20 10 10 10 9.925888159970379 10.074665197547262 0.0 3 0.9997725426136627 81.82841050991651 5406.0 26.520058048544517 0.0 - - - - - - - 187.1304347826087 10 23 OGDH oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide) 1645 212 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB538753.[MT7]-TFSQNRPAAAR.3b3_1.heavy 454.917 / 480.258 9058.0 18.820100784301758 50 20 10 10 10 9.925888159970379 10.074665197547262 0.0 3 0.9997725426136627 81.82841050991651 9058.0 27.842125910265445 0.0 - - - - - - - 764.2857142857143 18 7 OGDH oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide) 1647 212 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB538753.[MT7]-TFSQNRPAAAR.3y5_1.heavy 454.917 / 485.283 86560.0 18.820100784301758 50 20 10 10 10 9.925888159970379 10.074665197547262 0.0 3 0.9997725426136627 81.82841050991651 86560.0 63.71685020813502 0.0 - - - - - - - 1148.5714285714287 173 7 OGDH oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide) 1649 213 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB536476.[MT7]-LALTK[MT7].2b3_1.heavy 417.289 / 442.315 14165.0 27.552200317382812 50 20 10 10 10 6.6000270492701425 15.151453055189886 0.0 3 0.9930602175430104 14.806007400771863 14165.0 8.51913818957476 0.0 - - - - - - - 2268.5714285714284 28 7 PTAR1;MAP4K2;MYST1 protein prenyltransferase alpha subunit repeat containing 1;mitogen-activated protein kinase kinase kinase kinase 2;MYST histone acetyltransferase 1 1651 213 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB536476.[MT7]-LALTK[MT7].2y4_1.heavy 417.289 / 576.384 73756.0 27.552200317382812 50 20 10 10 10 6.6000270492701425 15.151453055189886 0.0 3 0.9930602175430104 14.806007400771863 73756.0 47.82416650099661 0.0 - - - - - - - 858.0 147 1 PTAR1;MAP4K2;MYST1 protein prenyltransferase alpha subunit repeat containing 1;mitogen-activated protein kinase kinase kinase kinase 2;MYST histone acetyltransferase 1 1653 213 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB536476.[MT7]-LALTK[MT7].2b4_1.heavy 417.289 / 543.362 3434.0 27.552200317382812 50 20 10 10 10 6.6000270492701425 15.151453055189886 0.0 3 0.9930602175430104 14.806007400771863 3434.0 1.706534184645129 12.0 - - - - - - - 2185.777777777778 11 9 PTAR1;MAP4K2;MYST1 protein prenyltransferase alpha subunit repeat containing 1;mitogen-activated protein kinase kinase kinase kinase 2;MYST histone acetyltransferase 1 1655 213 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB536476.[MT7]-LALTK[MT7].2y3_1.heavy 417.289 / 505.347 26183.0 27.552200317382812 50 20 10 10 10 6.6000270492701425 15.151453055189886 0.0 3 0.9930602175430104 14.806007400771863 26183.0 23.740106757502375 0.0 - - - - - - - 1240.111111111111 52 9 PTAR1;MAP4K2;MYST1 protein prenyltransferase alpha subunit repeat containing 1;mitogen-activated protein kinase kinase kinase kinase 2;MYST histone acetyltransferase 1 1657 214 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB53707.[MT7]-VAVVAPMSR.2y8_1.heavy 537.317 / 830.455 N/A N/A - - - - - - - - - 0.0 - - - - - - - RAPGEF1 Rap guanine nucleotide exchange factor (GEF) 1 1659 214 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB53707.[MT7]-VAVVAPMSR.2y5_1.heavy 537.317 / 561.281 N/A N/A - - - - - - - - - 0.0 - - - - - - - RAPGEF1 Rap guanine nucleotide exchange factor (GEF) 1 1661 214 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB53707.[MT7]-VAVVAPMSR.2b4_1.heavy 537.317 / 513.352 N/A N/A - - - - - - - - - 0.0 - - - - - - - RAPGEF1 Rap guanine nucleotide exchange factor (GEF) 1 1663 214 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB53707.[MT7]-VAVVAPMSR.2y6_1.heavy 537.317 / 660.35 N/A N/A - - - - - - - - - 0.0 - - - - - - - RAPGEF1 Rap guanine nucleotide exchange factor (GEF) 1 1665 215 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB537327.[MT7]-FVFVDQR.2b3_1.heavy 527.794 / 538.315 67450.0 35.02880096435547 42 12 10 10 10 1.02298123471064 58.640527291379435 0.0 3 0.8975733126637202 3.8227616238150195 67450.0 63.938474077497126 0.0 - - - - - - - 267.5 134 2 ARNTL aryl hydrocarbon receptor nuclear translocator-like 1667 215 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB537327.[MT7]-FVFVDQR.2y5_1.heavy 527.794 / 664.341 57636.0 35.02880096435547 42 12 10 10 10 1.02298123471064 58.640527291379435 0.0 3 0.8975733126637202 3.8227616238150195 57636.0 58.32531167594317 0.0 - - - - - - - 730.0 115 11 ARNTL aryl hydrocarbon receptor nuclear translocator-like 1669 215 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB537327.[MT7]-FVFVDQR.2y6_1.heavy 527.794 / 763.41 57725.0 35.02880096435547 42 12 10 10 10 1.02298123471064 58.640527291379435 0.0 3 0.8975733126637202 3.8227616238150195 57725.0 132.11029463570856 0.0 - - - - - - - 327.1666666666667 115 6 ARNTL aryl hydrocarbon receptor nuclear translocator-like 1671 215 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB537327.[MT7]-FVFVDQR.2b5_1.heavy 527.794 / 752.41 147659.0 35.02880096435547 42 12 10 10 10 1.02298123471064 58.640527291379435 0.0 3 0.8975733126637202 3.8227616238150195 147659.0 302.1387115547265 0.0 - - - - - - - 334.5 295 8 ARNTL aryl hydrocarbon receptor nuclear translocator-like 1673 216 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 BLAT_ECOLX.VAGPLLRSALPAGWFIADK.3y7.peptide 661.38 / 836.43 395764.0 44.20330047607422 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 395764.0 247.80664210376267 0.0 - - - - - - - 266.0769230769231 791 13 1675 216 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 BLAT_ECOLX.VAGPLLRSALPAGWFIADK.3y9.peptide 661.38 / 502.76 677564.0 44.20330047607422 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 677564.0 612.2180452181368 0.0 - - - - - - - 293.8333333333333 1355 6 1677 216 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 BLAT_ECOLX.VAGPLLRSALPAGWFIADK.3y17.peptide 661.38 / 906.51 610408.0 44.20330047607422 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 610408.0 1052.9808296418323 0.0 - - - - - - - 271.44444444444446 1220 9 1679 217 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB542124.[MT7]-DLQLELNSESEVGTPGGR.3y6_1.heavy 682.347 / 544.284 53166.0 34.396400451660156 44 14 10 10 10 1.5491038584854635 44.05538552810599 0.0 3 0.9425631615862143 5.124672967200306 53166.0 14.643100248049706 0.0 - - - - - - - 2731.0 106 3 ID1 inhibitor of DNA binding 1, dominant negative helix-loop-helix protein 1681 217 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB542124.[MT7]-DLQLELNSESEVGTPGGR.3b4_1.heavy 682.347 / 614.363 22922.0 34.396400451660156 44 14 10 10 10 1.5491038584854635 44.05538552810599 0.0 3 0.9425631615862143 5.124672967200306 22922.0 12.30587409734725 0.0 - - - - - - - 1438.5 45 2 ID1 inhibitor of DNA binding 1, dominant negative helix-loop-helix protein 1683 217 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB542124.[MT7]-DLQLELNSESEVGTPGGR.3b5_1.heavy 682.347 / 743.406 32945.0 34.396400451660156 44 14 10 10 10 1.5491038584854635 44.05538552810599 0.0 3 0.9425631615862143 5.124672967200306 32945.0 4.620979696887923 0.0 - - - - - - - 959.0 65 1 ID1 inhibitor of DNA binding 1, dominant negative helix-loop-helix protein 1685 217 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB542124.[MT7]-DLQLELNSESEVGTPGGR.3b3_1.heavy 682.347 / 501.279 30418.0 34.396400451660156 44 14 10 10 10 1.5491038584854635 44.05538552810599 0.0 3 0.9425631615862143 5.124672967200306 30418.0 3.8087257491617112 0.0 - - - - - - - 1133.0 60 1 ID1 inhibitor of DNA binding 1, dominant negative helix-loop-helix protein 1687 218 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54560.[MT7]-RTSHPK[MT7].2b3_1.heavy 507.308 / 489.29 N/A N/A - - - - - - - - - 0.0 - - - - - - - HYAL1 hyaluronoglucosaminidase 1 1689 218 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54560.[MT7]-RTSHPK[MT7].2b4_1.heavy 507.308 / 626.349 N/A N/A - - - - - - - - - 0.0 - - - - - - - HYAL1 hyaluronoglucosaminidase 1 1691 218 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54560.[MT7]-RTSHPK[MT7].2b5_1.heavy 507.308 / 723.402 N/A N/A - - - - - - - - - 0.0 - - - - - - - HYAL1 hyaluronoglucosaminidase 1 1693 219 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB55361.[MT7]-TLRVEEVEDAISQTSQTLQLLIEHDPVSQR.4y5_1.heavy 895.475 / 586.331 47103.0 52.87139892578125 42 12 10 10 10 0.9356409404013637 70.49142257685358 0.0 3 0.8913961158910298 3.7104663478921682 47103.0 193.3466 0.0 - - - - - - - 249.625 94 8 LIMK2 LIM domain kinase 2 1695 219 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB55361.[MT7]-TLRVEEVEDAISQTSQTLQLLIEHDPVSQR.4b9_1.heavy 895.475 / 1215.63 12340.0 52.87139892578125 42 12 10 10 10 0.9356409404013637 70.49142257685358 0.0 3 0.8913961158910298 3.7104663478921682 12340.0 30.45337980686818 0.0 - - - - - - - 233.55555555555554 24 9 LIMK2 LIM domain kinase 2 1697 219 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB55361.[MT7]-TLRVEEVEDAISQTSQTLQLLIEHDPVSQR.4b6_1.heavy 895.475 / 872.496 5619.0 52.87139892578125 42 12 10 10 10 0.9356409404013637 70.49142257685358 0.0 3 0.8913961158910298 3.7104663478921682 5619.0 23.143927241612758 0.0 - - - - - - - 169.44444444444446 11 9 LIMK2 LIM domain kinase 2 1699 219 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB55361.[MT7]-TLRVEEVEDAISQTSQTLQLLIEHDPVSQR.4b9_2.heavy 895.475 / 608.32 45948.0 52.87139892578125 42 12 10 10 10 0.9356409404013637 70.49142257685358 0.0 3 0.8913961158910298 3.7104663478921682 45948.0 156.71914666666666 0.0 - - - - - - - 277.7142857142857 91 7 LIMK2 LIM domain kinase 2 1701 220 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB55229.[MT7]-LLVFATDDGFHFAGDGK[MT7].3b9_1.heavy 700.033 / 1076.57 13179.0 43.29439926147461 43 17 10 6 10 2.9112449603043897 34.34956568874381 0.03900146484375 3 0.9744665669378352 7.706892867253 13179.0 19.170600660066004 0.0 - - - - - - - 814.25 26 8 ITGB2 integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) 1703 220 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB55229.[MT7]-LLVFATDDGFHFAGDGK[MT7].3y6_1.heavy 700.033 / 738.39 35069.0 43.29439926147461 43 17 10 6 10 2.9112449603043897 34.34956568874381 0.03900146484375 3 0.9744665669378352 7.706892867253 35069.0 17.82403833324716 0.0 - - - - - - - 787.6 70 5 ITGB2 integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) 1705 220 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB55229.[MT7]-LLVFATDDGFHFAGDGK[MT7].3y4_1.heavy 700.033 / 520.285 31964.0 43.29439926147461 43 17 10 6 10 2.9112449603043897 34.34956568874381 0.03900146484375 3 0.9744665669378352 7.706892867253 31964.0 21.125255468771048 0.0 - - - - - - - 782.6666666666666 63 3 ITGB2 integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) 1707 220 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB55229.[MT7]-LLVFATDDGFHFAGDGK[MT7].3y5_1.heavy 700.033 / 591.322 48021.0 43.29439926147461 43 17 10 6 10 2.9112449603043897 34.34956568874381 0.03900146484375 3 0.9744665669378352 7.706892867253 48021.0 17.7997306665657 0.0 - - - - - - - 807.6666666666666 96 3 ITGB2 integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) 1709 221 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54171.[MT7]-ELTLQDVELLK[MT7].2y8_1.heavy 794.974 / 1101.66 N/A N/A - - - - - - - - - 0.0 - - - - - - - TRIM32 tripartite motif-containing 32 1711 221 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54171.[MT7]-ELTLQDVELLK[MT7].2y5_1.heavy 794.974 / 745.494 N/A N/A - - - - - - - - - 0.0 - - - - - - - TRIM32 tripartite motif-containing 32 1713 221 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54171.[MT7]-ELTLQDVELLK[MT7].2b4_1.heavy 794.974 / 601.368 N/A N/A - - - - - - - - - 0.0 - - - - - - - TRIM32 tripartite motif-containing 32 1715 221 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54171.[MT7]-ELTLQDVELLK[MT7].2b6_1.heavy 794.974 / 844.453 N/A N/A - - - - - - - - - 0.0 - - - - - - - TRIM32 tripartite motif-containing 32 1717 222 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB55227.[MT7]-ILGILALIDEGETDWK[MT7].3y6_1.heavy 692.061 / 879.433 44582.0 55.387001037597656 44 14 10 10 10 1.5876762165133433 43.495660972474084 0.0 3 0.9431943005174452 5.1533399779136255 44582.0 517.0993604651163 0.0 - - - - - - - 164.19230769230768 89 26 PPA2 pyrophosphatase (inorganic) 2 1719 222 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB55227.[MT7]-ILGILALIDEGETDWK[MT7].3b6_1.heavy 692.061 / 725.504 160299.0 55.387001037597656 44 14 10 10 10 1.5876762165133433 43.495660972474084 0.0 3 0.9431943005174452 5.1533399779136255 160299.0 852.2746489726026 0.0 - - - - - - - 186.875 320 24 PPA2 pyrophosphatase (inorganic) 2 1721 222 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB55227.[MT7]-ILGILALIDEGETDWK[MT7].3b4_1.heavy 692.061 / 541.383 110264.0 55.387001037597656 44 14 10 10 10 1.5876762165133433 43.495660972474084 0.0 3 0.9431943005174452 5.1533399779136255 110264.0 504.30821705426354 0.0 - - - - - - - 674.7142857142857 220 7 PPA2 pyrophosphatase (inorganic) 2 1723 222 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB55227.[MT7]-ILGILALIDEGETDWK[MT7].3b5_1.heavy 692.061 / 654.467 94252.0 55.387001037597656 44 14 10 10 10 1.5876762165133433 43.495660972474084 0.0 3 0.9431943005174452 5.1533399779136255 94252.0 248.57495786990222 0.0 - - - - - - - 205.2 188 25 PPA2 pyrophosphatase (inorganic) 2 1725 223 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB55226.[MT7]-ILGILALIDEGETDWK[MT7].2y8_1.heavy 1037.59 / 1123.5 6990.0 55.38245105743408 43 15 10 8 10 1.8884284431537164 42.80747959072579 0.018199920654296875 3 0.9568210174117744 5.9176727920228505 6990.0 28.45533148112665 1.0 - - - - - - - 145.91304347826087 13 23 PPA2 pyrophosphatase (inorganic) 2 1727 223 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB55226.[MT7]-ILGILALIDEGETDWK[MT7].2b4_1.heavy 1037.59 / 541.383 21305.0 55.38245105743408 43 15 10 8 10 1.8884284431537164 42.80747959072579 0.018199920654296875 3 0.9568210174117744 5.9176727920228505 21305.0 -106.52499999999999 0.0 - - - - - - - 130.6818181818182 42 22 PPA2 pyrophosphatase (inorganic) 2 1729 223 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB55226.[MT7]-ILGILALIDEGETDWK[MT7].2b6_1.heavy 1037.59 / 725.504 14459.0 55.38245105743408 43 15 10 8 10 1.8884284431537164 42.80747959072579 0.018199920654296875 3 0.9568210174117744 5.9176727920228505 14459.0 -30.12291666666667 0.0 - - - - - - - 125.57142857142857 28 21 PPA2 pyrophosphatase (inorganic) 2 1731 223 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB55226.[MT7]-ILGILALIDEGETDWK[MT7].2b5_1.heavy 1037.59 / 654.467 12783.0 55.38245105743408 43 15 10 8 10 1.8884284431537164 42.80747959072579 0.018199920654296875 3 0.9568210174117744 5.9176727920228505 12783.0 -10.652500000000003 0.0 - - - - - - - 134.79166666666666 25 24 PPA2 pyrophosphatase (inorganic) 2 1733 224 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB540652.[MT7]-GLAESLQPDYSER.3y6_1.heavy 536.938 / 766.337 58161.0 31.708900451660156 50 20 10 10 10 7.68898199994633 13.005622851074175 0.0 3 0.9945081882790843 16.64583533750621 58161.0 53.8319851994852 0.0 - - - - - - - 406.6666666666667 116 6 IL2RG interleukin 2 receptor, gamma 1735 224 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB540652.[MT7]-GLAESLQPDYSER.3b4_1.heavy 536.938 / 515.295 31467.0 31.708900451660156 50 20 10 10 10 7.68898199994633 13.005622851074175 0.0 3 0.9945081882790843 16.64583533750621 31467.0 12.735208890720356 0.0 - - - - - - - 721.0 62 1 IL2RG interleukin 2 receptor, gamma 1737 224 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB540652.[MT7]-GLAESLQPDYSER.3b5_1.heavy 536.938 / 602.327 52279.0 31.708900451660156 50 20 10 10 10 7.68898199994633 13.005622851074175 0.0 3 0.9945081882790843 16.64583533750621 52279.0 70.67916378837813 0.0 - - - - - - - 1189.0 104 7 IL2RG interleukin 2 receptor, gamma 1739 224 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB540652.[MT7]-GLAESLQPDYSER.3y4_1.heavy 536.938 / 554.257 36961.0 31.708900451660156 50 20 10 10 10 7.68898199994633 13.005622851074175 0.0 3 0.9945081882790843 16.64583533750621 36961.0 31.000196402984336 0.0 - - - - - - - 771.4 73 10 IL2RG interleukin 2 receptor, gamma 1741 225 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB541469.[MT7]-AQNDQLGWLWGQSR.3b4_1.heavy 601.64 / 573.275 15232.0 42.267099380493164 45 20 10 5 10 9.616785426800464 10.398485103069449 0.040599822998046875 3 0.9966148766419168 21.205696049718018 15232.0 15.34804797552926 0.0 - - - - - - - 2197.4285714285716 30 7 HYAL1 hyaluronoglucosaminidase 1 1743 225 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB541469.[MT7]-AQNDQLGWLWGQSR.3b5_1.heavy 601.64 / 701.333 15979.0 42.267099380493164 45 20 10 5 10 9.616785426800464 10.398485103069449 0.040599822998046875 3 0.9966148766419168 21.205696049718018 15979.0 44.43934322504097 0.0 - - - - - - - 693.4285714285714 31 7 HYAL1 hyaluronoglucosaminidase 1 1745 225 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB541469.[MT7]-AQNDQLGWLWGQSR.3b7_1.heavy 601.64 / 871.439 14933.0 42.267099380493164 45 20 10 5 10 9.616785426800464 10.398485103069449 0.040599822998046875 3 0.9966148766419168 21.205696049718018 14933.0 62.00233207915273 0.0 - - - - - - - 193.0 29 12 HYAL1 hyaluronoglucosaminidase 1 1747 225 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB541469.[MT7]-AQNDQLGWLWGQSR.3y5_1.heavy 601.64 / 633.31 31883.0 42.267099380493164 45 20 10 5 10 9.616785426800464 10.398485103069449 0.040599822998046875 3 0.9966148766419168 21.205696049718018 31883.0 26.512576490618464 0.0 - - - - - - - 313.4 63 5 HYAL1 hyaluronoglucosaminidase 1 1749 226 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB540087.[MT7]-SLVESVSSSPNK[MT7].3y6_1.heavy 507.95 / 763.407 11229.0 27.275449752807617 39 13 10 6 10 1.7115023944932362 51.264165510635294 0.03260040283203125 3 0.9122456925370052 4.135231678110887 11229.0 91.34702380952382 0.0 - - - - - - - 237.6 22 10 PPA2 pyrophosphatase (inorganic) 2 1751 226 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB540087.[MT7]-SLVESVSSSPNK[MT7].3y3_1.heavy 507.95 / 502.311 89114.0 27.275449752807617 39 13 10 6 10 1.7115023944932362 51.264165510635294 0.03260040283203125 3 0.9122456925370052 4.135231678110887 89114.0 51.58722231184528 0.0 - - - - - - - 2447.0 178 1 PPA2 pyrophosphatase (inorganic) 2 1753 226 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB540087.[MT7]-SLVESVSSSPNK[MT7].3b4_1.heavy 507.95 / 573.336 25410.0 27.275449752807617 39 13 10 6 10 1.7115023944932362 51.264165510635294 0.03260040283203125 3 0.9122456925370052 4.135231678110887 25410.0 48.050961538461536 0.0 - - - - - - - 768.0 50 9 PPA2 pyrophosphatase (inorganic) 2 1755 226 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB540087.[MT7]-SLVESVSSSPNK[MT7].3b5_1.heavy 507.95 / 660.369 21523.0 27.275449752807617 39 13 10 6 10 1.7115023944932362 51.264165510635294 0.03260040283203125 3 0.9122456925370052 4.135231678110887 21523.0 45.175880208333325 0.0 - - - - - - - 693.8181818181819 43 11 PPA2 pyrophosphatase (inorganic) 2 1757 227 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54362.[MT7]-VFHLPTTTFIGGQESALPLR.3y6_1.heavy 776.766 / 656.409 N/A N/A - - - - - - - - - 0.0 - - - - - - - OGDH oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide) 1759 227 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54362.[MT7]-VFHLPTTTFIGGQESALPLR.3b4_1.heavy 776.766 / 641.389 N/A N/A - - - - - - - - - 0.0 - - - - - - - OGDH oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide) 1761 227 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54362.[MT7]-VFHLPTTTFIGGQESALPLR.3b3_1.heavy 776.766 / 528.305 N/A N/A - - - - - - - - - 0.0 - - - - - - - OGDH oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide) 1763 227 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54362.[MT7]-VFHLPTTTFIGGQESALPLR.3y10_1.heavy 776.766 / 1027.55 N/A N/A - - - - - - - - - 0.0 - - - - - - - OGDH oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide) 1765 228 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB537338.[MT7]-AALEGVSK[MT7].2y4_1.heavy 531.823 / 534.337 40419.0 24.266000747680664 47 17 10 10 10 3.514668245550026 28.4521875219977 0.0 3 0.979312145047206 8.565506795961213 40419.0 40.39179394937192 0.0 - - - - - - - 713.0 80 8 TRIM32 tripartite motif-containing 32 1767 228 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB537338.[MT7]-AALEGVSK[MT7].2y5_1.heavy 531.823 / 663.379 29857.0 24.266000747680664 47 17 10 10 10 3.514668245550026 28.4521875219977 0.0 3 0.979312145047206 8.565506795961213 29857.0 83.2725659229209 0.0 - - - - - - - 296.64285714285717 59 14 TRIM32 tripartite motif-containing 32 1769 228 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB537338.[MT7]-AALEGVSK[MT7].2b4_1.heavy 531.823 / 529.31 25279.0 24.266000747680664 47 17 10 10 10 3.514668245550026 28.4521875219977 0.0 3 0.979312145047206 8.565506795961213 25279.0 50.28172677595629 0.0 - - - - - - - 730.375 50 8 TRIM32 tripartite motif-containing 32 1771 228 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB537338.[MT7]-AALEGVSK[MT7].2y7_1.heavy 531.823 / 847.5 16689.0 24.266000747680664 47 17 10 10 10 3.514668245550026 28.4521875219977 0.0 3 0.979312145047206 8.565506795961213 16689.0 69.05231578593195 0.0 - - - - - - - 289.05263157894734 33 19 TRIM32 tripartite motif-containing 32 1773 229 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB55237.[MT7]-AIQIDTWLQVIPQLIAR.3y7_1.heavy 708.088 / 810.52 N/A N/A - - - - - - - - - 0.0 - - - - - - - MTOR mechanistic target of rapamycin (serine/threonine kinase) 1775 229 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB55237.[MT7]-AIQIDTWLQVIPQLIAR.3y6_1.heavy 708.088 / 697.435 N/A N/A - - - - - - - - - 0.0 - - - - - - - MTOR mechanistic target of rapamycin (serine/threonine kinase) 1777 229 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB55237.[MT7]-AIQIDTWLQVIPQLIAR.3b4_1.heavy 708.088 / 570.373 N/A N/A - - - - - - - - - 0.0 - - - - - - - MTOR mechanistic target of rapamycin (serine/threonine kinase) 1779 229 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB55237.[MT7]-AIQIDTWLQVIPQLIAR.3b5_1.heavy 708.088 / 685.4 N/A N/A - - - - - - - - - 0.0 - - - - - - - MTOR mechanistic target of rapamycin (serine/threonine kinase) 1781 230 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB55335.[MT7]-TIITYPWFQNSSVILFLNK[MT7]K[MT7].4y4_1.heavy 711.915 / 790.539 N/A N/A - - - - - - - - - 0.0 - - - - - - - GNA11;GNAQ guanine nucleotide binding protein (G protein), alpha 11 (Gq class);guanine nucleotide binding protein (G protein), q polypeptide 1783 230 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB55335.[MT7]-TIITYPWFQNSSVILFLNK[MT7]K[MT7].4b4_1.heavy 711.915 / 573.373 N/A N/A - - - - - - - - - 0.0 - - - - - - - GNA11;GNAQ guanine nucleotide binding protein (G protein), alpha 11 (Gq class);guanine nucleotide binding protein (G protein), q polypeptide 1785 230 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB55335.[MT7]-TIITYPWFQNSSVILFLNK[MT7]K[MT7].4b5_1.heavy 711.915 / 736.436 N/A N/A - - - - - - - - - 0.0 - - - - - - - GNA11;GNAQ guanine nucleotide binding protein (G protein), alpha 11 (Gq class);guanine nucleotide binding protein (G protein), q polypeptide 1787 230 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB55335.[MT7]-TIITYPWFQNSSVILFLNK[MT7]K[MT7].4y6_1.heavy 711.915 / 1050.69 N/A N/A - - - - - - - - - 0.0 - - - - - - - GNA11;GNAQ guanine nucleotide binding protein (G protein), alpha 11 (Gq class);guanine nucleotide binding protein (G protein), q polypeptide 1789 231 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB55239.[MT7]-NVTGHYISPFHDIPLK[MT7].3b6_1.heavy 709.393 / 816.412 5412.0 34.948299407958984 47 17 10 10 10 7.5123919307969445 13.311339573492088 0.0 3 0.9708642202046198 7.212551207124114 5412.0 10.34801290345326 0.0 - - - - - - - 670.4444444444445 10 9 PPA2 pyrophosphatase (inorganic) 2 1791 231 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB55239.[MT7]-NVTGHYISPFHDIPLK[MT7].3y3_1.heavy 709.393 / 501.352 35844.0 34.948299407958984 47 17 10 10 10 7.5123919307969445 13.311339573492088 0.0 3 0.9708642202046198 7.212551207124114 35844.0 44.56268418214793 0.0 - - - - - - - 1166.0 71 7 PPA2 pyrophosphatase (inorganic) 2 1793 231 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB55239.[MT7]-NVTGHYISPFHDIPLK[MT7].3b4_1.heavy 709.393 / 516.29 4170.0 34.948299407958984 47 17 10 10 10 7.5123919307969445 13.311339573492088 0.0 3 0.9708642202046198 7.212551207124114 4170.0 1.6332085146357533 1.0 - - - - - - - 685.4545454545455 12 11 PPA2 pyrophosphatase (inorganic) 2 1795 231 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB55239.[MT7]-NVTGHYISPFHDIPLK[MT7].3b5_1.heavy 709.393 / 653.349 10913.0 34.948299407958984 47 17 10 10 10 7.5123919307969445 13.311339573492088 0.0 3 0.9708642202046198 7.212551207124114 10913.0 13.170862068965516 0.0 - - - - - - - 732.0 21 8 PPA2 pyrophosphatase (inorganic) 2 1797 232 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB542216.[MT7]-NVTGHYISPFHDIPLK[MT7].4y4_1.heavy 532.296 / 614.436 31207.0 34.90810012817383 44 14 10 10 10 2.812280193594118 35.558334559900004 0.0 3 0.9380431593657215 4.932300538859837 31207.0 52.183772917288735 0.0 - - - - - - - 787.7 62 10 PPA2 pyrophosphatase (inorganic) 2 1799 232 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB542216.[MT7]-NVTGHYISPFHDIPLK[MT7].4b4_1.heavy 532.296 / 516.29 63497.0 34.90810012817383 44 14 10 10 10 2.812280193594118 35.558334559900004 0.0 3 0.9380431593657215 4.932300538859837 63497.0 56.93328817932591 0.0 - - - - - - - 492.0 126 1 PPA2 pyrophosphatase (inorganic) 2 1801 232 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB542216.[MT7]-NVTGHYISPFHDIPLK[MT7].4b5_1.heavy 532.296 / 653.349 46761.0 34.90810012817383 44 14 10 10 10 2.812280193594118 35.558334559900004 0.0 3 0.9380431593657215 4.932300538859837 46761.0 142.4710589397235 1.0 - - - - - - - 336.3333333333333 98 12 PPA2 pyrophosphatase (inorganic) 2 1803 232 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB542216.[MT7]-NVTGHYISPFHDIPLK[MT7].4y3_1.heavy 532.296 / 501.352 306754.0 34.90810012817383 44 14 10 10 10 2.812280193594118 35.558334559900004 0.0 3 0.9380431593657215 4.932300538859837 306754.0 222.8465002698272 0.0 - - - - - - - 492.0 613 1 PPA2 pyrophosphatase (inorganic) 2 1805 233 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB538471.[MT7]-TVVVADFGLSR.2y8_1.heavy 654.376 / 864.457 31862.0 37.43840026855469 45 15 10 10 10 3.0916853552147363 32.3448179587002 0.0 3 0.9554028210627045 5.822121831758716 31862.0 47.752255754475705 0.0 - - - - - - - 342.0 63 2 LIMK2 LIM domain kinase 2 1807 233 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB538471.[MT7]-TVVVADFGLSR.2y5_1.heavy 654.376 / 579.325 41929.0 37.43840026855469 45 15 10 10 10 3.0916853552147363 32.3448179587002 0.0 3 0.9554028210627045 5.822121831758716 41929.0 25.80502519038881 1.0 - - - - - - - 391.0 84 3 LIMK2 LIM domain kinase 2 1809 233 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB538471.[MT7]-TVVVADFGLSR.2y9_1.heavy 654.376 / 963.526 28735.0 37.43840026855469 45 15 10 10 10 3.0916853552147363 32.3448179587002 0.0 3 0.9554028210627045 5.822121831758716 28735.0 16.37034566994312 0.0 - - - - - - - 366.5 57 4 LIMK2 LIM domain kinase 2 1811 233 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB538471.[MT7]-TVVVADFGLSR.2y10_1.heavy 654.376 / 1062.59 28930.0 37.43840026855469 45 15 10 10 10 3.0916853552147363 32.3448179587002 0.0 3 0.9554028210627045 5.822121831758716 28930.0 80.36010853970433 0.0 - - - - - - - 234.6 57 5 LIMK2 LIM domain kinase 2 1813 234 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54498.[MT7]-LLWLK[MT7].2b3_1.heavy 480.828 / 557.357 8300.0 41.805551528930664 40 14 10 6 10 2.176507262530729 36.66711251851099 0.036899566650390625 3 0.9438985313867777 5.185894326010065 8300.0 18.373950147396524 0.0 - - - - - - - 229.71428571428572 16 14 MTOR;FGGY mechanistic target of rapamycin (serine/threonine kinase);FGGY carbohydrate kinase domain containing 1815 234 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54498.[MT7]-LLWLK[MT7].2y4_1.heavy 480.828 / 703.462 23928.0 41.805551528930664 40 14 10 6 10 2.176507262530729 36.66711251851099 0.036899566650390625 3 0.9438985313867777 5.185894326010065 23928.0 118.80377395652813 0.0 - - - - - - - 230.23076923076923 47 13 MTOR;FGGY mechanistic target of rapamycin (serine/threonine kinase);FGGY carbohydrate kinase domain containing 1817 234 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54498.[MT7]-LLWLK[MT7].2b4_1.heavy 480.828 / 670.441 3141.0 41.805551528930664 40 14 10 6 10 2.176507262530729 36.66711251851099 0.036899566650390625 3 0.9438985313867777 5.185894326010065 3141.0 3.434872417982989 2.0 - - - - - - - 126.76923076923077 6 13 MTOR;FGGY mechanistic target of rapamycin (serine/threonine kinase);FGGY carbohydrate kinase domain containing 1819 234 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54498.[MT7]-LLWLK[MT7].2y3_1.heavy 480.828 / 590.378 42995.0 41.805551528930664 40 14 10 6 10 2.176507262530729 36.66711251851099 0.036899566650390625 3 0.9438985313867777 5.185894326010065 42995.0 95.168947884814 0.0 - - - - - - - 293.53846153846155 85 13 MTOR;FGGY mechanistic target of rapamycin (serine/threonine kinase);FGGY carbohydrate kinase domain containing 1821 235 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB541686.[MT7]-LNLLTEYIEGGTLK[MT7].3y6_1.heavy 618.027 / 748.432 40902.0 47.03850078582764 44 18 10 6 10 4.180027810739377 19.116257827026555 0.032001495361328125 3 0.9831431842283814 9.492107255647822 40902.0 195.584951108358 0.0 - - - - - - - 676.5 81 8 LIMK2 LIM domain kinase 2 1823 235 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB541686.[MT7]-LNLLTEYIEGGTLK[MT7].3b6_1.heavy 618.027 / 828.495 41193.0 47.03850078582764 44 18 10 6 10 4.180027810739377 19.116257827026555 0.032001495361328125 3 0.9831431842283814 9.492107255647822 41193.0 199.97830984876686 0.0 - - - - - - - 271.5833333333333 82 12 LIMK2 LIM domain kinase 2 1825 235 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB541686.[MT7]-LNLLTEYIEGGTLK[MT7].3b4_1.heavy 618.027 / 598.404 32349.0 47.03850078582764 44 18 10 6 10 4.180027810739377 19.116257827026555 0.032001495361328125 3 0.9831431842283814 9.492107255647822 32349.0 108.98411937888321 0.0 - - - - - - - 714.8571428571429 64 7 LIMK2 LIM domain kinase 2 1827 235 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB541686.[MT7]-LNLLTEYIEGGTLK[MT7].3b7_1.heavy 618.027 / 991.558 24087.0 47.03850078582764 44 18 10 6 10 4.180027810739377 19.116257827026555 0.032001495361328125 3 0.9831431842283814 9.492107255647822 24087.0 62.13679792264165 0.0 - - - - - - - 763.625 48 8 LIMK2 LIM domain kinase 2 1829 236 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54196.[MT7]-LIAINANDPEASK[MT7].2b3_1.heavy 822.464 / 442.315 1068.0 37.35070037841797 38 16 10 10 2 2.0377242254425614 49.07435400307006 0.0 12 0.9694815196594443 7.046446919443379 1068.0 1.4680412371134017 13.0 - - - - - - - 245.35294117647058 3 17 PPA2 pyrophosphatase (inorganic) 2 1831 236 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54196.[MT7]-LIAINANDPEASK[MT7].2y8_1.heavy 822.464 / 975.486 680.0 37.35070037841797 38 16 10 10 2 2.0377242254425614 49.07435400307006 0.0 12 0.9694815196594443 7.046446919443379 680.0 2.1965635738831617 18.0 - - - - - - - 0.0 1 0 PPA2 pyrophosphatase (inorganic) 2 1833 236 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54196.[MT7]-LIAINANDPEASK[MT7].2y5_1.heavy 822.464 / 675.379 2718.0 37.35070037841797 38 16 10 10 2 2.0377242254425614 49.07435400307006 0.0 12 0.9694815196594443 7.046446919443379 2718.0 2.301196029371087 1.0 - - - - - - - 291.0 5 12 PPA2 pyrophosphatase (inorganic) 2 1835 236 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54196.[MT7]-LIAINANDPEASK[MT7].2y9_1.heavy 822.464 / 1089.53 291.0 37.35070037841797 38 16 10 10 2 2.0377242254425614 49.07435400307006 0.0 12 0.9694815196594443 7.046446919443379 291.0 0.8099999999999999 30.0 - - - - - - - 264.05555555555554 2 18 PPA2 pyrophosphatase (inorganic) 2 1837 237 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54195.[MT7]-VEILQHVIDYIR.3y6_1.heavy 547.986 / 778.446 N/A N/A - - - - - - - - - 0.0 - - - - - - - ID1 inhibitor of DNA binding 1, dominant negative helix-loop-helix protein 1839 237 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54195.[MT7]-VEILQHVIDYIR.3b4_1.heavy 547.986 / 599.388 N/A N/A - - - - - - - - - 0.0 - - - - - - - ID1 inhibitor of DNA binding 1, dominant negative helix-loop-helix protein 1841 237 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54195.[MT7]-VEILQHVIDYIR.3b5_1.heavy 547.986 / 727.447 N/A N/A - - - - - - - - - 0.0 - - - - - - - ID1 inhibitor of DNA binding 1, dominant negative helix-loop-helix protein 1843 237 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54195.[MT7]-VEILQHVIDYIR.3y5_1.heavy 547.986 / 679.377 N/A N/A - - - - - - - - - 0.0 - - - - - - - ID1 inhibitor of DNA binding 1, dominant negative helix-loop-helix protein 1845 238 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB542211.[MT7]-K[MT7]LNLLTEYIEGGTLK[MT7].4y5_1.heavy 531.821 / 619.39 43243.0 42.3671989440918 42 12 10 10 10 1.5093036906925508 66.25571819420554 0.0 3 0.8956448752254038 3.786642748649673 43243.0 43.5115900621118 0.0 - - - - - - - 737.875 86 8 LIMK2 LIM domain kinase 2 1847 238 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB542211.[MT7]-K[MT7]LNLLTEYIEGGTLK[MT7].4b7_2.heavy 531.821 / 550.849 61184.0 42.3671989440918 42 12 10 10 10 1.5093036906925508 66.25571819420554 0.0 3 0.8956448752254038 3.786642748649673 61184.0 84.04747313319444 1.0 - - - - - - - 186.28571428571428 127 7 LIMK2 LIM domain kinase 2 1849 238 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB542211.[MT7]-K[MT7]LNLLTEYIEGGTLK[MT7].4b5_1.heavy 531.821 / 870.602 8664.0 42.3671989440918 42 12 10 10 10 1.5093036906925508 66.25571819420554 0.0 3 0.8956448752254038 3.786642748649673 8664.0 68.4985163569344 0.0 - - - - - - - 180.71428571428572 17 14 LIMK2 LIM domain kinase 2 1851 238 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB542211.[MT7]-K[MT7]LNLLTEYIEGGTLK[MT7].4b3_1.heavy 531.821 / 644.433 8971.0 42.3671989440918 42 12 10 10 10 1.5093036906925508 66.25571819420554 0.0 3 0.8956448752254038 3.786642748649673 8971.0 33.94586864458285 0.0 - - - - - - - 221.0 17 17 LIMK2 LIM domain kinase 2 1853 239 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54963.[MT7]-ILFVSESVFK[MT7].3y3_1.heavy 486.293 / 537.352 43476.0 44.048500061035156 37 7 10 10 10 1.495455827853821 48.85751965099257 0.0 3 0.7174598407335931 2.264757203286691 43476.0 169.2740883116883 0.0 - - - - - - - 670.0 86 7 ARNTL aryl hydrocarbon receptor nuclear translocator-like 1855 239 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54963.[MT7]-ILFVSESVFK[MT7].3b4_1.heavy 486.293 / 617.414 72390.0 44.048500061035156 37 7 10 10 10 1.495455827853821 48.85751965099257 0.0 3 0.7174598407335931 2.264757203286691 72390.0 342.8183571428571 0.0 - - - - - - - 235.0 144 14 ARNTL aryl hydrocarbon receptor nuclear translocator-like 1857 239 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54963.[MT7]-ILFVSESVFK[MT7].3y4_1.heavy 486.293 / 624.384 41236.0 44.048500061035156 37 7 10 10 10 1.495455827853821 48.85751965099257 0.0 3 0.7174598407335931 2.264757203286691 41236.0 386.4402285714286 0.0 - - - - - - - 188.125 82 16 ARNTL aryl hydrocarbon receptor nuclear translocator-like 1859 239 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54963.[MT7]-ILFVSESVFK[MT7].3b3_1.heavy 486.293 / 518.346 33325.0 44.048500061035156 37 7 10 10 10 1.495455827853821 48.85751965099257 0.0 3 0.7174598407335931 2.264757203286691 33325.0 184.87440476190477 0.0 - - - - - - - 250.0 66 14 ARNTL aryl hydrocarbon receptor nuclear translocator-like 1861 240 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB537088.[MT7]-QLSPQK[MT7].2y4_1.heavy 494.805 / 603.358 16549.0 20.549400329589844 24 3 10 10 1 0.599635216928792 107.1531560069405 0.0 17 0.5023843935897507 1.6710636805301942 16549.0 32.250451200956604 0.0 - - - - - - - 287.2 33 15 ITGB2 integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) 1863 240 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB537088.[MT7]-QLSPQK[MT7].2y5_1.heavy 494.805 / 716.442 827.0 20.549400329589844 24 3 10 10 1 0.599635216928792 107.1531560069405 0.0 17 0.5023843935897507 1.6710636805301942 827.0 1.3697722567287787 19.0 - - - - - - - 650.625 8 8 ITGB2 integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) 1865 240 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB537088.[MT7]-QLSPQK[MT7].2y3_1.heavy 494.805 / 516.326 1103.0 20.549400329589844 24 3 10 10 1 0.599635216928792 107.1531560069405 0.0 17 0.5023843935897507 1.6710636805301942 1103.0 1.1525387050502052 13.0 - - - - - - - 655.0 18 11 ITGB2 integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) 1867 240 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB537088.[MT7]-QLSPQK[MT7].2b5_1.heavy 494.805 / 698.395 483.0 20.549400329589844 24 3 10 10 1 0.599635216928792 107.1531560069405 0.0 17 0.5023843935897507 1.6710636805301942 483.0 0.0 31.0 - - - - - - - 271.30434782608694 2 23 ITGB2 integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) 1869 241 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB540672.[MT7]-LVEDHLAVQSLIR.3y7_1.heavy 546.322 / 786.483 35701.0 37.264198303222656 43 14 9 10 10 1.2976917397382357 51.65917488155567 0.0 3 0.9399711330591631 5.011704623513557 35701.0 49.39778641742591 1.0 - - - - - - - 756.0 76 8 OGDH;OGDHL oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide);oxoglutarate dehydrogenase-like 1871 241 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB540672.[MT7]-LVEDHLAVQSLIR.3y6_1.heavy 546.322 / 715.446 26680.0 37.264198303222656 43 14 9 10 10 1.2976917397382357 51.65917488155567 0.0 3 0.9399711330591631 5.011704623513557 26680.0 30.07430727874276 0.0 - - - - - - - 754.2857142857143 53 7 OGDH;OGDHL oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide);oxoglutarate dehydrogenase-like 1873 241 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB540672.[MT7]-LVEDHLAVQSLIR.3b4_1.heavy 546.322 / 601.331 48177.0 37.264198303222656 43 14 9 10 10 1.2976917397382357 51.65917488155567 0.0 3 0.9399711330591631 5.011704623513557 48177.0 40.94857806500274 0.0 - - - - - - - 288.0 96 3 OGDH;OGDHL oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide);oxoglutarate dehydrogenase-like 1875 241 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB540672.[MT7]-LVEDHLAVQSLIR.3y5_1.heavy 546.322 / 616.378 40404.0 37.264198303222656 43 14 9 10 10 1.2976917397382357 51.65917488155567 0.0 3 0.9399711330591631 5.011704623513557 40404.0 19.703042416473934 1.0 - - - - - - - 288.0 111 4 OGDH;OGDHL oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide);oxoglutarate dehydrogenase-like 1877 242 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB537344.[MT7]-GGGYSVLIR.2y8_1.heavy 533.312 / 864.494 12572.0 31.902475833892822 39 13 10 6 10 7.96886691103725 12.548835501505913 0.03330039978027344 3 0.9229777752776985 4.418008976855148 12572.0 48.01672335787531 0.0 - - - - - - - 622.7142857142857 25 7 TRIM32 tripartite motif-containing 32 1879 242 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB537344.[MT7]-GGGYSVLIR.2b6_1.heavy 533.312 / 665.338 16316.0 31.902475833892822 39 13 10 6 10 7.96886691103725 12.548835501505913 0.03330039978027344 3 0.9229777752776985 4.418008976855148 16316.0 26.401354591591776 0.0 - - - - - - - 721.3636363636364 32 11 TRIM32 tripartite motif-containing 32 1881 242 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB537344.[MT7]-GGGYSVLIR.2b7_1.heavy 533.312 / 778.422 13801.0 31.902475833892822 39 13 10 6 10 7.96886691103725 12.548835501505913 0.03330039978027344 3 0.9229777752776985 4.418008976855148 13801.0 47.37305505719484 0.0 - - - - - - - 691.5 27 8 TRIM32 tripartite motif-containing 32 1883 242 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB537344.[MT7]-GGGYSVLIR.2b5_1.heavy 533.312 / 566.269 10225.0 31.902475833892822 39 13 10 6 10 7.96886691103725 12.548835501505913 0.03330039978027344 3 0.9229777752776985 4.418008976855148 10225.0 13.68036956467946 1.0 - - - - - - - 730.7692307692307 20 13 TRIM32 tripartite motif-containing 32 1885 243 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB537347.[MT7]-TPLLPGAPR.2y8_1.heavy 533.331 / 820.504 50740.0 30.98010015487671 43 18 10 7 8 3.263252878434178 30.64426929977412 0.029600143432617188 4 0.9812143128152053 8.990142925347287 50740.0 107.30729175027555 0.0 - - - - - - - 633.5 101 8 SLC17A5 solute carrier family 17 (anion/sugar transporter), member 5 1887 243 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB537347.[MT7]-TPLLPGAPR.2y5_1.heavy 533.331 / 497.283 28039.0 30.98010015487671 43 18 10 7 8 3.263252878434178 30.64426929977412 0.029600143432617188 4 0.9812143128152053 8.990142925347287 28039.0 14.522898153675595 0.0 - - - - - - - 2311.1428571428573 56 7 SLC17A5 solute carrier family 17 (anion/sugar transporter), member 5 1889 243 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB537347.[MT7]-TPLLPGAPR.2b4_1.heavy 533.331 / 569.378 9652.0 30.98010015487671 43 18 10 7 8 3.263252878434178 30.64426929977412 0.029600143432617188 4 0.9812143128152053 8.990142925347287 9652.0 30.375153668069473 1.0 - - - - - - - 1234.6 20 10 SLC17A5 solute carrier family 17 (anion/sugar transporter), member 5 1891 243 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB537347.[MT7]-TPLLPGAPR.2y6_1.heavy 533.331 / 610.367 7172.0 30.98010015487671 43 18 10 7 8 3.263252878434178 30.64426929977412 0.029600143432617188 4 0.9812143128152053 8.990142925347287 7172.0 1.4770084971285729 1.0 - - - - - - - 1186.0 71 7 SLC17A5 solute carrier family 17 (anion/sugar transporter), member 5 1893 244 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54688.[MT7]-EVEILNK[MT7].2y4_1.heavy 566.844 / 631.426 N/A 28.440000534057617 44 14 10 10 10 4.930895003316436 20.280293928940225 0.0 2 0.9380081971036794 4.930894776949294 1008.0 0.7840113798008534 25.0 - - - - - - - 1248.0 7 7 RAPGEF1 Rap guanine nucleotide exchange factor (GEF) 1 1895 244 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54688.[MT7]-EVEILNK[MT7].2b3_1.heavy 566.844 / 502.263 N/A 28.440000534057617 44 14 10 10 10 4.930895003316436 20.280293928940225 0.0 2 0.9380081971036794 4.930894776949294 672.0 0.0 41.0 - - - - - - - 1226.909090909091 12 11 RAPGEF1 Rap guanine nucleotide exchange factor (GEF) 1 1897 244 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54688.[MT7]-EVEILNK[MT7].2b4_1.heavy 566.844 / 615.347 26716.0 28.440000534057617 44 14 10 10 10 4.930895003316436 20.280293928940225 0.0 2 0.9380081971036794 4.930894776949294 26716.0 30.45736159610782 0.0 - - - - - - - 1864.0 53 7 RAPGEF1 Rap guanine nucleotide exchange factor (GEF) 1 1899 244 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54688.[MT7]-EVEILNK[MT7].2y3_1.heavy 566.844 / 518.342 58529.0 28.440000534057617 44 14 10 10 10 4.930895003316436 20.280293928940225 0.0 2 0.9380081971036794 4.930894776949294 58529.0 69.0398809765318 0.0 - - - - - - - 765.3333333333334 117 3 RAPGEF1 Rap guanine nucleotide exchange factor (GEF) 1 1901 245 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB55110.[MT7]-VLEAILPLVQNDPR.3y6_1.heavy 574.341 / 728.369 8532.0 46.49679946899414 48 18 10 10 10 4.243844546377909 23.563539829786954 0.0 3 0.9817512563445694 9.12185615908342 8532.0 63.09459929645027 0.0 - - - - - - - 126.28571428571429 17 7 RAPGEF1 Rap guanine nucleotide exchange factor (GEF) 1 1903 245 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB55110.[MT7]-VLEAILPLVQNDPR.3b4_1.heavy 574.341 / 557.341 43719.0 46.49679946899414 48 18 10 10 10 4.243844546377909 23.563539829786954 0.0 3 0.9817512563445694 9.12185615908342 43719.0 83.99473135116115 0.0 - - - - - - - 313.6666666666667 87 3 RAPGEF1 Rap guanine nucleotide exchange factor (GEF) 1 1905 245 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB55110.[MT7]-VLEAILPLVQNDPR.3b5_1.heavy 574.341 / 670.426 28773.0 46.49679946899414 48 18 10 10 10 4.243844546377909 23.563539829786954 0.0 3 0.9817512563445694 9.12185615908342 28773.0 43.886701812460664 0.0 - - - - - - - 314.0 57 9 RAPGEF1 Rap guanine nucleotide exchange factor (GEF) 1 1907 245 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB55110.[MT7]-VLEAILPLVQNDPR.3y8_1.heavy 574.341 / 938.505 17711.0 46.49679946899414 48 18 10 10 10 4.243844546377909 23.563539829786954 0.0 3 0.9817512563445694 9.12185615908342 17711.0 81.1814519376625 0.0 - - - - - - - 152.16666666666666 35 12 RAPGEF1 Rap guanine nucleotide exchange factor (GEF) 1 1909 246 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB536777.[MT7]-K[MT7]VTEDLSK[MT7].3y3_1.heavy 451.277 / 491.331 48321.0 22.014299392700195 47 17 10 10 10 4.208277826792892 23.76268965972941 0.0 3 0.977112515640656 8.142007836438092 48321.0 64.63728635682159 0.0 - - - - - - - 1145.090909090909 96 11 MTOR mechanistic target of rapamycin (serine/threonine kinase) 1911 246 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB536777.[MT7]-K[MT7]VTEDLSK[MT7].3b5_1.heavy 451.277 / 861.492 7075.0 22.014299392700195 47 17 10 10 10 4.208277826792892 23.76268965972941 0.0 3 0.977112515640656 8.142007836438092 7075.0 75.90397350993376 0.0 - - - - - - - 119.88888888888889 14 18 MTOR mechanistic target of rapamycin (serine/threonine kinase) 1913 246 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB536777.[MT7]-K[MT7]VTEDLSK[MT7].3y4_1.heavy 451.277 / 606.358 29554.0 22.014299392700195 47 17 10 10 10 4.208277826792892 23.76268965972941 0.0 3 0.977112515640656 8.142007836438092 29554.0 107.70716091689128 0.0 - - - - - - - 692.3 59 10 MTOR mechanistic target of rapamycin (serine/threonine kinase) 1915 246 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB536777.[MT7]-K[MT7]VTEDLSK[MT7].3y5_1.heavy 451.277 / 735.401 10888.0 22.014299392700195 47 17 10 10 10 4.208277826792892 23.76268965972941 0.0 3 0.977112515640656 8.142007836438092 10888.0 77.82661513151375 0.0 - - - - - - - 163.08333333333334 21 24 MTOR mechanistic target of rapamycin (serine/threonine kinase) 1917 247 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54585.[MT7]-K[MT7]HTVK[MT7].2y4_1.heavy 522.848 / 628.39 1240.0 13.989325046539307 37 11 10 6 10 1.5851265986067515 48.90432799406313 0.03249931335449219 3 0.8792751524832846 3.5155623617748595 1240.0 19.755932203389833 0.0 - - - - - - - 81.89473684210526 2 19 RHOQ ras homolog gene family, member Q 1919 247 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54585.[MT7]-K[MT7]HTVK[MT7].2b3_1.heavy 522.848 / 655.413 177.0 13.989325046539307 37 11 10 6 10 1.5851265986067515 48.90432799406313 0.03249931335449219 3 0.8792751524832846 3.5155623617748595 177.0 2.0924050632911393 6.0 - - - - - - - 0.0 0 0 RHOQ ras homolog gene family, member Q 1921 247 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54585.[MT7]-K[MT7]HTVK[MT7].2b4_1.heavy 522.848 / 754.481 335.0 13.989325046539307 37 11 10 6 10 1.5851265986067515 48.90432799406313 0.03249931335449219 3 0.8792751524832846 3.5155623617748595 335.0 9.124994636344134 1.0 - - - - - - - 0.0 0 0 RHOQ ras homolog gene family, member Q 1923 247 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54585.[MT7]-K[MT7]HTVK[MT7].2y3_1.heavy 522.848 / 491.331 689.0 13.989325046539307 37 11 10 6 10 1.5851265986067515 48.90432799406313 0.03249931335449219 3 0.8792751524832846 3.5155623617748595 689.0 4.992753623188406 2.0 - - - - - - - 0.0 1 0 RHOQ ras homolog gene family, member Q 1925 248 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB55348.[MT7]-RATVAPEDVSEVIFGHVLAAGC[CAM]GQNPVR.4b8_1.heavy 774.156 / 984.523 27872.0 43.313899993896484 45 15 10 10 10 2.3729894014065396 34.51522557793076 0.0 3 0.9562448173200252 5.87829270821033 27872.0 56.592132452828096 0.0 - - - - - - - 690.9 55 10 ACAT2 acetyl-CoA acetyltransferase 2 1927 248 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB55348.[MT7]-RATVAPEDVSEVIFGHVLAAGC[CAM]GQNPVR.4b4_1.heavy 774.156 / 572.364 7755.0 43.313899993896484 45 15 10 10 10 2.3729894014065396 34.51522557793076 0.0 3 0.9562448173200252 5.87829270821033 7755.0 22.37605578904555 0.0 - - - - - - - 745.7142857142857 15 7 ACAT2 acetyl-CoA acetyltransferase 2 1929 248 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB55348.[MT7]-RATVAPEDVSEVIFGHVLAAGC[CAM]GQNPVR.4y11_1.heavy 774.156 / 1142.57 23956.0 43.313899993896484 45 15 10 10 10 2.3729894014065396 34.51522557793076 0.0 3 0.9562448173200252 5.87829270821033 23956.0 50.313113129844965 0.0 - - - - - - - 735.8333333333334 47 12 ACAT2 acetyl-CoA acetyltransferase 2 1931 248 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB55348.[MT7]-RATVAPEDVSEVIFGHVLAAGC[CAM]GQNPVR.4b5_1.heavy 774.156 / 643.401 28793.0 43.313899993896484 45 15 10 10 10 2.3729894014065396 34.51522557793076 0.0 3 0.9562448173200252 5.87829270821033 28793.0 27.83400279517072 0.0 - - - - - - - 1244.0 57 10 ACAT2 acetyl-CoA acetyltransferase 2 1933 249 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB537080.[MT7]-ATDSFSGR.2y5_1.heavy 492.747 / 553.273 18416.0 20.664549827575684 32 8 10 6 8 1.0658609349789463 54.63967418327048 0.03370094299316406 4 0.7687092339280425 2.514971642715163 18416.0 38.85459236544088 0.0 - - - - - - - 697.5 36 8 MKNK2 MAP kinase interacting serine/threonine kinase 2 1935 249 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB537080.[MT7]-ATDSFSGR.2b4_1.heavy 492.747 / 519.253 3069.0 20.664549827575684 32 8 10 6 8 1.0658609349789463 54.63967418327048 0.03370094299316406 4 0.7687092339280425 2.514971642715163 3069.0 0.40514851485148506 5.0 - - - - - - - 1275.4285714285713 43 7 MKNK2 MAP kinase interacting serine/threonine kinase 2 1937 249 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB537080.[MT7]-ATDSFSGR.2y6_1.heavy 492.747 / 668.3 4584.0 20.664549827575684 32 8 10 6 8 1.0658609349789463 54.63967418327048 0.03370094299316406 4 0.7687092339280425 2.514971642715163 4584.0 11.00370520726857 1.0 - - - - - - - 746.4545454545455 9 11 MKNK2 MAP kinase interacting serine/threonine kinase 2 1939 249 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB537080.[MT7]-ATDSFSGR.2y7_1.heavy 492.747 / 769.347 48991.0 20.664549827575684 32 8 10 6 8 1.0658609349789463 54.63967418327048 0.03370094299316406 4 0.7687092339280425 2.514971642715163 48991.0 94.89287092466057 0.0 - - - - - - - 817.3 97 10 MKNK2 MAP kinase interacting serine/threonine kinase 2 1941 250 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54194.[MT7]-VEILQHVIDYIR.2y8_1.heavy 821.476 / 1043.56 N/A N/A - - - - - - - - - 0.0 - - - - - - - ID1 inhibitor of DNA binding 1, dominant negative helix-loop-helix protein 1943 250 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54194.[MT7]-VEILQHVIDYIR.2b4_1.heavy 821.476 / 599.388 N/A N/A - - - - - - - - - 0.0 - - - - - - - ID1 inhibitor of DNA binding 1, dominant negative helix-loop-helix protein 1945 250 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54194.[MT7]-VEILQHVIDYIR.2b5_1.heavy 821.476 / 727.447 N/A N/A - - - - - - - - - 0.0 - - - - - - - ID1 inhibitor of DNA binding 1, dominant negative helix-loop-helix protein 1947 250 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54194.[MT7]-VEILQHVIDYIR.2y7_1.heavy 821.476 / 915.505 N/A N/A - - - - - - - - - 0.0 - - - - - - - ID1 inhibitor of DNA binding 1, dominant negative helix-loop-helix protein 1949 251 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB55344.[MT7]-LSTESVQEQLPYSVTLISMPATTEGR.3y7_1.heavy 994.513 / 731.368 9277.0 44.135674476623535 36 10 10 6 10 1.8130172546783252 44.00012338200394 0.038700103759765625 3 0.8496622093911314 3.142178723635145 9277.0 30.466047977022974 0.0 - - - - - - - 266.72727272727275 18 11 LIMK2 LIM domain kinase 2 1951 251 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB55344.[MT7]-LSTESVQEQLPYSVTLISMPATTEGR.3b9_1.heavy 994.513 / 1146.58 5139.0 44.135674476623535 36 10 10 6 10 1.8130172546783252 44.00012338200394 0.038700103759765625 3 0.8496622093911314 3.142178723635145 5139.0 19.579008441267245 0.0 - - - - - - - 220.69230769230768 10 13 LIMK2 LIM domain kinase 2 1953 251 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB55344.[MT7]-LSTESVQEQLPYSVTLISMPATTEGR.3b5_1.heavy 994.513 / 662.348 3003.0 44.135674476623535 36 10 10 6 10 1.8130172546783252 44.00012338200394 0.038700103759765625 3 0.8496622093911314 3.142178723635145 3003.0 21.147678888231816 0.0 - - - - - - - 214.42857142857142 6 14 LIMK2 LIM domain kinase 2 1955 251 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB55344.[MT7]-LSTESVQEQLPYSVTLISMPATTEGR.3b8_1.heavy 994.513 / 1018.52 4004.0 44.135674476623535 36 10 10 6 10 1.8130172546783252 44.00012338200394 0.038700103759765625 3 0.8496622093911314 3.142178723635145 4004.0 22.262855263896576 0.0 - - - - - - - 240.2 8 15 LIMK2 LIM domain kinase 2 1957 252 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB538326.[MT7]-TLDFGLNVK[MT7].3y3_1.heavy 432.258 / 504.326 67686.0 37.617401123046875 41 11 10 10 10 0.918718484861356 64.94654389175587 0.0 3 0.8789804717131984 3.511189334269022 67686.0 5.340743063142727 1.0 - - - - - - - 322.3333333333333 152 3 LIMK2 LIM domain kinase 2 1959 252 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB538326.[MT7]-TLDFGLNVK[MT7].3b4_1.heavy 432.258 / 621.336 18495.0 37.617401123046875 41 11 10 10 10 0.918718484861356 64.94654389175587 0.0 3 0.8789804717131984 3.511189334269022 18495.0 52.452732801769294 0.0 - - - - - - - 275.53846153846155 36 13 LIMK2 LIM domain kinase 2 1961 252 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB538326.[MT7]-TLDFGLNVK[MT7].3b5_1.heavy 432.258 / 678.358 92087.0 37.617401123046875 41 11 10 10 10 0.918718484861356 64.94654389175587 0.0 3 0.8789804717131984 3.511189334269022 92087.0 156.54371612903228 0.0 - - - - - - - 221.28571428571428 184 7 LIMK2 LIM domain kinase 2 1963 252 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB538326.[MT7]-TLDFGLNVK[MT7].3b3_1.heavy 432.258 / 474.268 58196.0 37.617401123046875 41 11 10 10 10 0.918718484861356 64.94654389175587 0.0 3 0.8789804717131984 3.511189334269022 58196.0 81.64024854605506 0.0 - - - - - - - 290.3333333333333 116 9 LIMK2 LIM domain kinase 2 1965 253 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB55342.[MT7]-VLTLWFDYGHWPDVNEALVEGVK[MT7].4y4_1.heavy 744.644 / 576.347 26443.0 50.97469902038574 36 10 10 6 10 0.7150305166751494 76.85343484675914 0.037601470947265625 3 0.8249011080050521 2.9051581895551024 26443.0 60.5076241789387 0.0 - - - - - - - 760.0 52 9 MTOR mechanistic target of rapamycin (serine/threonine kinase) 1967 253 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB55342.[MT7]-VLTLWFDYGHWPDVNEALVEGVK[MT7].4b7_1.heavy 744.644 / 1019.57 5576.0 50.97469902038574 36 10 10 6 10 0.7150305166751494 76.85343484675914 0.037601470947265625 3 0.8249011080050521 2.9051581895551024 5576.0 20.979987217223112 0.0 - - - - - - - 310.94117647058823 11 17 MTOR mechanistic target of rapamycin (serine/threonine kinase) 1969 253 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB55342.[MT7]-VLTLWFDYGHWPDVNEALVEGVK[MT7].4b4_1.heavy 744.644 / 571.394 10232.0 50.97469902038574 36 10 10 6 10 0.7150305166751494 76.85343484675914 0.037601470947265625 3 0.8249011080050521 2.9051581895551024 10232.0 14.164257505043134 0.0 - - - - - - - 783.25 20 8 MTOR mechanistic target of rapamycin (serine/threonine kinase) 1971 253 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB55342.[MT7]-VLTLWFDYGHWPDVNEALVEGVK[MT7].4y6_1.heavy 744.644 / 788.5 4139.0 50.97469902038574 36 10 10 6 10 0.7150305166751494 76.85343484675914 0.037601470947265625 3 0.8249011080050521 2.9051581895551024 4139.0 14.973994159636598 0.0 - - - - - - - 632.4285714285714 8 7 MTOR mechanistic target of rapamycin (serine/threonine kinase) 1973 254 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB53619.[MT7]-EPLLFSR.2y4_1.heavy 503.296 / 522.304 N/A N/A - - - - - - - - - 0.0 - - - - - - - LIMK2 LIM domain kinase 2 1975 254 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB53619.[MT7]-EPLLFSR.2y5_1.heavy 503.296 / 635.388 N/A N/A - - - - - - - - - 0.0 - - - - - - - LIMK2 LIM domain kinase 2 1977 254 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB53619.[MT7]-EPLLFSR.2b4_1.heavy 503.296 / 597.373 N/A N/A - - - - - - - - - 0.0 - - - - - - - LIMK2 LIM domain kinase 2 1979 254 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB53619.[MT7]-EPLLFSR.2y6_1.heavy 503.296 / 732.44 N/A N/A - - - - - - - - - 0.0 - - - - - - - LIMK2 LIM domain kinase 2 1981 255 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB55341.[MT7]-HFNELEASVVVQDVASALDFLHNK[MT7].4y4_1.heavy 743.395 / 655.401 5002.0 53.25429916381836 43 13 10 10 10 1.4621304637185224 45.38988966502004 0.0 3 0.9206896165924019 4.352956573752712 5002.0 -0.9807843137254899 2.0 - - - - - - - 289.0 10 9 MKNK2 MAP kinase interacting serine/threonine kinase 2 1983 255 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB55341.[MT7]-HFNELEASVVVQDVASALDFLHNK[MT7].4b4_1.heavy 743.395 / 672.322 9902.0 53.25429916381836 43 13 10 10 10 1.4621304637185224 45.38988966502004 0.0 3 0.9206896165924019 4.352956573752712 9902.0 -0.6788834476003931 0.0 - - - - - - - 272.0 19 3 MKNK2 MAP kinase interacting serine/threonine kinase 2 1985 255 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB55341.[MT7]-HFNELEASVVVQDVASALDFLHNK[MT7].4b5_1.heavy 743.395 / 785.406 6482.0 53.25429916381836 43 13 10 10 10 1.4621304637185224 45.38988966502004 0.0 3 0.9206896165924019 4.352956573752712 6482.0 -0.10591503267973934 0.0 - - - - - - - 327.85714285714283 12 7 MKNK2 MAP kinase interacting serine/threonine kinase 2 1987 255 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB55341.[MT7]-HFNELEASVVVQDVASALDFLHNK[MT7].4y3_1.heavy 743.395 / 542.317 11484.0 53.25429916381836 43 13 10 10 10 1.4621304637185224 45.38988966502004 0.0 3 0.9206896165924019 4.352956573752712 11484.0 -0.9839412484700123 0.0 - - - - - - - 276.85714285714283 22 7 MKNK2 MAP kinase interacting serine/threonine kinase 2 1989 256 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54972.[MT7]-TFISPEELIK[MT7].2b4_1.heavy 732.931 / 593.341 3425.0 40.425299644470215 37 16 10 3 8 6.281599098580212 15.919513237099503 0.06380081176757812 4 0.9637192322350261 6.459550062969035 3425.0 1.588098918083462 1.0 - - - - - - - 697.6666666666666 6 12 RAPGEF1 Rap guanine nucleotide exchange factor (GEF) 1 1991 256 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54972.[MT7]-TFISPEELIK[MT7].2y3_1.heavy 732.931 / 517.383 2131.0 40.425299644470215 37 16 10 3 8 6.281599098580212 15.919513237099503 0.06380081176757812 4 0.9637192322350261 6.459550062969035 2131.0 1.3999270072992702 10.0 - - - - - - - 1294.0 4 12 RAPGEF1 Rap guanine nucleotide exchange factor (GEF) 1 1993 256 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54972.[MT7]-TFISPEELIK[MT7].2y6_1.heavy 732.931 / 872.521 5709.0 40.425299644470215 37 16 10 3 8 6.281599098580212 15.919513237099503 0.06380081176757812 4 0.9637192322350261 6.459550062969035 5709.0 9.441308677548564 0.0 - - - - - - - 750.1428571428571 11 7 RAPGEF1 Rap guanine nucleotide exchange factor (GEF) 1 1995 256 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54972.[MT7]-TFISPEELIK[MT7].2y7_1.heavy 732.931 / 959.553 4567.0 40.425299644470215 37 16 10 3 8 6.281599098580212 15.919513237099503 0.06380081176757812 4 0.9637192322350261 6.459550062969035 4567.0 0.6667153284671531 1.0 - - - - - - - 713.625 11 16 RAPGEF1 Rap guanine nucleotide exchange factor (GEF) 1 1997 257 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54485.[MT7]-HNAANK[MT7].2y4_1.heavy 471.772 / 547.332 N/A N/A - - - - - - - - - 0.0 - - - - - - - MTOR mechanistic target of rapamycin (serine/threonine kinase) 1999 257 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54485.[MT7]-HNAANK[MT7].2y5_1.heavy 471.772 / 661.375 N/A N/A - - - - - - - - - 0.0 - - - - - - - MTOR mechanistic target of rapamycin (serine/threonine kinase) 2001 257 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54485.[MT7]-HNAANK[MT7].2b4_1.heavy 471.772 / 538.285 N/A N/A - - - - - - - - - 0.0 - - - - - - - MTOR mechanistic target of rapamycin (serine/threonine kinase) 2003 257 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54485.[MT7]-HNAANK[MT7].2y3_1.heavy 471.772 / 476.295 N/A N/A - - - - - - - - - 0.0 - - - - - - - MTOR mechanistic target of rapamycin (serine/threonine kinase) 2005 258 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB53611.[MT7]-LESTMK[MT7].2y4_1.heavy 498.786 / 610.335 N/A N/A - - - - - - - - - 0.0 - - - - - - - ITPR1 inositol 1,4,5-triphosphate receptor, type 1 2007 258 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB53611.[MT7]-LESTMK[MT7].2y5_1.heavy 498.786 / 739.378 N/A N/A - - - - - - - - - 0.0 - - - - - - - ITPR1 inositol 1,4,5-triphosphate receptor, type 1 2009 258 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB53611.[MT7]-LESTMK[MT7].2b4_1.heavy 498.786 / 575.316 N/A N/A - - - - - - - - - 0.0 - - - - - - - ITPR1 inositol 1,4,5-triphosphate receptor, type 1 2011 258 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB53611.[MT7]-LESTMK[MT7].2y3_1.heavy 498.786 / 523.303 N/A N/A - - - - - - - - - 0.0 - - - - - - - ITPR1 inositol 1,4,5-triphosphate receptor, type 1 2013 259 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB53817.[MT7]-GDLIVADSSR.2y8_1.heavy 588.821 / 860.484 2171.0 32.28719902038574 33 9 10 6 8 1.5243165178090474 59.495036661473435 0.030399322509765625 4 0.8057259388463326 2.753335918055725 2171.0 10.264633781763825 0.0 - - - - - - - 232.34782608695653 4 23 TRIM32 tripartite motif-containing 32 2015 259 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB53817.[MT7]-GDLIVADSSR.2b4_1.heavy 588.821 / 543.326 3006.0 32.28719902038574 33 9 10 6 8 1.5243165178090474 59.495036661473435 0.030399322509765625 4 0.8057259388463326 2.753335918055725 3006.0 1.9018768584379941 3.0 - - - - - - - 1185.8 9 10 TRIM32 tripartite motif-containing 32 2017 259 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB53817.[MT7]-GDLIVADSSR.2y6_1.heavy 588.821 / 634.315 8908.0 32.28719902038574 33 9 10 6 8 1.5243165178090474 59.495036661473435 0.030399322509765625 4 0.8057259388463326 2.753335918055725 8908.0 30.228252033025015 0.0 - - - - - - - 668.0 17 20 TRIM32 tripartite motif-containing 32 2019 259 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB53817.[MT7]-GDLIVADSSR.2y7_1.heavy 588.821 / 747.399 557.0 32.28719902038574 33 9 10 6 8 1.5243165178090474 59.495036661473435 0.030399322509765625 4 0.8057259388463326 2.753335918055725 557.0 1.0258011505079727 36.0 - - - - - - - 674.2222222222222 3 9 TRIM32 tripartite motif-containing 32 2021 260 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB542736.[MT7]-ILNYSQNDLIGQSLFDYLHPK[MT7].4b8_1.heavy 692.373 / 1092.54 16871.0 47.379149436950684 46 20 10 6 10 11.516074468989272 8.683514531734065 0.032199859619140625 3 0.994041818935442 15.980473805808144 16871.0 17.702214326525553 0.0 - - - - - - - 1295.1 33 10 ARNTL aryl hydrocarbon receptor nuclear translocator-like 2023 260 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB542736.[MT7]-ILNYSQNDLIGQSLFDYLHPK[MT7].4b4_1.heavy 692.373 / 648.384 20507.0 47.379149436950684 46 20 10 6 10 11.516074468989272 8.683514531734065 0.032199859619140625 3 0.994041818935442 15.980473805808144 20507.0 17.579769605703902 0.0 - - - - - - - 809.5 41 4 ARNTL aryl hydrocarbon receptor nuclear translocator-like 2025 260 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB542736.[MT7]-ILNYSQNDLIGQSLFDYLHPK[MT7].4b5_1.heavy 692.373 / 735.416 7839.0 47.379149436950684 46 20 10 6 10 11.516074468989272 8.683514531734065 0.032199859619140625 3 0.994041818935442 15.980473805808144 7839.0 17.440192964719007 0.0 - - - - - - - 697.7857142857143 15 14 ARNTL aryl hydrocarbon receptor nuclear translocator-like 2027 260 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB542736.[MT7]-ILNYSQNDLIGQSLFDYLHPK[MT7].4y7_1.heavy 692.373 / 1063.57 9827.0 47.379149436950684 46 20 10 6 10 11.516074468989272 8.683514531734065 0.032199859619140625 3 0.994041818935442 15.980473805808144 9827.0 7.498806055517942 1.0 - - - - - - - 1278.25 19 8 ARNTL aryl hydrocarbon receptor nuclear translocator-like 2029 261 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54481.[MT7]-TFQQIR.2y4_1.heavy 468.773 / 544.32 9927.0 25.160600662231445 47 17 10 10 10 2.778957667620283 28.908713826046085 0.0 3 0.9794966512289314 8.604093555995306 9927.0 14.929333873417434 0.0 - - - - - - - 1258.2857142857142 19 7 OGDH oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide) 2031 261 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54481.[MT7]-TFQQIR.2b3_1.heavy 468.773 / 521.284 7763.0 25.160600662231445 47 17 10 10 10 2.778957667620283 28.908713826046085 0.0 3 0.9794966512289314 8.604093555995306 7763.0 9.48228639511954 0.0 - - - - - - - 808.5 15 12 OGDH oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide) 2033 261 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54481.[MT7]-TFQQIR.2y5_1.heavy 468.773 / 691.389 27543.0 25.160600662231445 47 17 10 10 10 2.778957667620283 28.908713826046085 0.0 3 0.9794966512289314 8.604093555995306 27543.0 43.38380854833352 0.0 - - - - - - - 410.5 55 2 OGDH oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide) 2035 261 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54481.[MT7]-TFQQIR.2b4_1.heavy 468.773 / 649.343 12540.0 25.160600662231445 47 17 10 10 10 2.778957667620283 28.908713826046085 0.0 3 0.9794966512289314 8.604093555995306 12540.0 24.618868740795286 0.0 - - - - - - - 752.5833333333334 25 12 OGDH oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide) 2037 262 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB536483.[MT7]-VAEAFR.2y4_1.heavy 418.741 / 522.267 22701.0 26.239099502563477 48 20 10 10 8 3.0186588001233687 25.21393542666128 0.0 4 0.9904124636802609 12.59392964004267 22701.0 1.5438129982845934 1.0 - - - - - - - 185.0 45 2 HYAL1 hyaluronoglucosaminidase 1 2039 262 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB536483.[MT7]-VAEAFR.2b3_1.heavy 418.741 / 444.258 50726.0 26.239099502563477 48 20 10 10 8 3.0186588001233687 25.21393542666128 0.0 4 0.9904124636802609 12.59392964004267 50726.0 26.456137770072367 0.0 - - - - - - - 1368.0 101 4 HYAL1 hyaluronoglucosaminidase 1 2041 262 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB536483.[MT7]-VAEAFR.2y5_1.heavy 418.741 / 593.304 205271.0 26.239099502563477 48 20 10 10 8 3.0186588001233687 25.21393542666128 0.0 4 0.9904124636802609 12.59392964004267 205271.0 207.43235728024052 0.0 - - - - - - - 296.0 410 1 HYAL1 hyaluronoglucosaminidase 1 2043 262 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB536483.[MT7]-VAEAFR.2b4_1.heavy 418.741 / 515.295 74389.0 26.239099502563477 48 20 10 10 8 3.0186588001233687 25.21393542666128 0.0 4 0.9904124636802609 12.59392964004267 74389.0 41.4822489497152 1.0 - - - - - - - 813.0 172 1 HYAL1 hyaluronoglucosaminidase 1 2045 263 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54184.[MT7]-GLAESLQPDYSER.2y4_1.heavy 804.903 / 554.257 N/A N/A - - - - - - - - - 0.0 - - - - - - - IL2RG interleukin 2 receptor, gamma 2047 263 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54184.[MT7]-GLAESLQPDYSER.2y9_1.heavy 804.903 / 1094.51 N/A N/A - - - - - - - - - 0.0 - - - - - - - IL2RG interleukin 2 receptor, gamma 2049 263 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54184.[MT7]-GLAESLQPDYSER.2b4_1.heavy 804.903 / 515.295 N/A N/A - - - - - - - - - 0.0 - - - - - - - IL2RG interleukin 2 receptor, gamma 2051 263 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54184.[MT7]-GLAESLQPDYSER.2y6_1.heavy 804.903 / 766.337 N/A N/A - - - - - - - - - 0.0 - - - - - - - IL2RG interleukin 2 receptor, gamma 2053 264 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB53816.[MT7]-GNNLQDTLR.2y8_1.heavy 587.818 / 973.506 N/A N/A - - - - - - - - - 0.0 - - - - - - - MTOR mechanistic target of rapamycin (serine/threonine kinase) 2055 264 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB53816.[MT7]-GNNLQDTLR.2y5_1.heavy 587.818 / 632.336 N/A N/A - - - - - - - - - 0.0 - - - - - - - MTOR mechanistic target of rapamycin (serine/threonine kinase) 2057 264 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB53816.[MT7]-GNNLQDTLR.2b4_1.heavy 587.818 / 543.301 N/A N/A - - - - - - - - - 0.0 - - - - - - - MTOR mechanistic target of rapamycin (serine/threonine kinase) 2059 264 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB53816.[MT7]-GNNLQDTLR.2b6_1.heavy 587.818 / 786.386 N/A N/A - - - - - - - - - 0.0 - - - - - - - MTOR mechanistic target of rapamycin (serine/threonine kinase) 2061 265 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB537072.[MT7]-MEIATK[MT7].2b3_1.heavy 490.788 / 518.276 4852.0 25.112550258636475 39 18 10 3 8 4.655235834592207 17.2006426248832 0.07690048217773438 4 0.9894898355724199 12.027531526163886 4852.0 6.03598086124402 1.0 - - - - - - - 1194.3636363636363 9 11 PPA2;PPA1 pyrophosphatase (inorganic) 2;pyrophosphatase (inorganic) 1 2063 265 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB537072.[MT7]-MEIATK[MT7].2y4_1.heavy 490.788 / 576.384 4777.0 25.112550258636475 39 18 10 3 8 4.655235834592207 17.2006426248832 0.07690048217773438 4 0.9894898355724199 12.027531526163886 4777.0 8.372061855670104 0.0 - - - - - - - 1735.375 9 8 PPA2;PPA1 pyrophosphatase (inorganic) 2;pyrophosphatase (inorganic) 1 2065 265 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB537072.[MT7]-MEIATK[MT7].2y5_1.heavy 490.788 / 705.426 5524.0 25.112550258636475 39 18 10 3 8 4.655235834592207 17.2006426248832 0.07690048217773438 4 0.9894898355724199 12.027531526163886 5524.0 15.290822795625425 0.0 - - - - - - - 615.5 11 8 PPA2;PPA1 pyrophosphatase (inorganic) 2;pyrophosphatase (inorganic) 1 2067 265 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB537072.[MT7]-MEIATK[MT7].2b4_1.heavy 490.788 / 589.314 2389.0 25.112550258636475 39 18 10 3 8 4.655235834592207 17.2006426248832 0.07690048217773438 4 0.9894898355724199 12.027531526163886 2389.0 5.025758592111707 3.0 - - - - - - - 727.75 7 12 PPA2;PPA1 pyrophosphatase (inorganic) 2;pyrophosphatase (inorganic) 1 2069 266 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54385.[MT7]-GATNPYTEANYK[MT7]PTFLSDDELK[MT7].3y6_1.heavy 969.498 / 850.427 N/A N/A - - - - - - - - - 0.0 - - - - - - - ARNTL aryl hydrocarbon receptor nuclear translocator-like 2071 266 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54385.[MT7]-GATNPYTEANYK[MT7]PTFLSDDELK[MT7].3y3_1.heavy 969.498 / 533.341 N/A N/A - - - - - - - - - 0.0 - - - - - - - ARNTL aryl hydrocarbon receptor nuclear translocator-like 2073 266 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54385.[MT7]-GATNPYTEANYK[MT7]PTFLSDDELK[MT7].3y4_1.heavy 969.498 / 648.369 N/A N/A - - - - - - - - - 0.0 - - - - - - - ARNTL aryl hydrocarbon receptor nuclear translocator-like 2075 266 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB54385.[MT7]-GATNPYTEANYK[MT7]PTFLSDDELK[MT7].3y8_1.heavy 969.498 / 1110.58 N/A N/A - - - - - - - - - 0.0 - - - - - - - ARNTL aryl hydrocarbon receptor nuclear translocator-like 2077 267 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB542105.[MT7]-FK[MT7]PGYLEATLNWFR.4y5_1.heavy 508.283 / 735.394 6137.0 46.522600173950195 33 7 10 6 10 0.8578309076351138 75.0658105494012 0.03440093994140625 3 0.7458954110103667 2.3944104329384297 6137.0 49.581412429378524 0.0 - - - - - - - 147.5 12 18 PPA2 pyrophosphatase (inorganic) 2 2079 267 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB542105.[MT7]-FK[MT7]PGYLEATLNWFR.4y4_1.heavy 508.283 / 622.31 7258.0 46.522600173950195 33 7 10 6 10 0.8578309076351138 75.0658105494012 0.03440093994140625 3 0.7458954110103667 2.3944104329384297 7258.0 47.23850847457628 0.0 - - - - - - - 145.76470588235293 14 17 PPA2 pyrophosphatase (inorganic) 2 2081 267 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB542105.[MT7]-FK[MT7]PGYLEATLNWFR.4b7_2.heavy 508.283 / 562.323 18647.0 46.522600173950195 33 7 10 6 10 0.8578309076351138 75.0658105494012 0.03440093994140625 3 0.7458954110103667 2.3944104329384297 18647.0 191.2107627118644 0.0 - - - - - - - 156.1764705882353 37 17 PPA2 pyrophosphatase (inorganic) 2 2083 267 C20140306_KEGG1700_set11_02 C20140306_KEGG1700_set11_02 TB542105.[MT7]-FK[MT7]PGYLEATLNWFR.4b5_1.heavy 508.283 / 881.512 2478.0 46.522600173950195 33 7 10 6 10 0.8578309076351138 75.0658105494012 0.03440093994140625 3 0.7458954110103667 2.3944104329384297 2478.0 31.92 0.0 - - - - - - - 106.2 4 10 PPA2 pyrophosphatase (inorganic) 2